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ABSTRACT 
Effective patients’ treatment is predicated on availability of high quality medicines access. The 
outbound segment of pharmaceutical supply chains is critical to achieving this goal.  In this study, 
the pharmaceutical supply chains management in Nigeria with emphasis on the outsourcing of the 
outbound value chains was investigated. The objectives were to study the extent of outsourcing of 
outbound value chain activities in the Nigerian pharmaceutical industry, investigate the rationale 
for outsourcing outbound pharmaceutical value chains in Nigeria, study the critical criteria for a 
successful selection and outsourcing relationship with 3rd  Party Service Providers, identify the 
desired outcomes of outsourcing outbound pharmaceutical value chains and utilize the study 
results to develop a framework for outsourcing and improvement of outbound value chain 
activities in the Nigerian pharmaceutical industry. 
In conducting the study, detailed review of literature on pharmaceutical supply chain management 
in Nigeria, overview of outsourcing in general and pharmaceutical supply chains in particular was 
undertaken. A sequential exploratory mixed method approach with Delphi study preceding a 
quantitative survey was adopted.  The Delphi technique engaged experts from the pharmaceutical 
industry in Lagos, South West Nigeria. The Delphi panel was composed of 17 expert members (10 
Chief Executive Officers, 3 Country Managers and 4 Executive Directors) drawn from the five 
categories in the private sector of the industry: multinational manufacturing - 6 (35.3%), overseas’ 
manufacturers’ representatives – 2 (11.8%), indigenous manufacturers - 3 (17.6%), 
importers/distributors - 4 (23.5%) and large pharmacy chains – 2 (11.8%). Open-ended and closed-
ended questions in the developed questionnaire were used to conduct two rounds of the Delphi 
iterations before a consensus was achieved and data analysed. The quantitative survey was 
conducted with 100 respondents from all the seven categories of the industry.  Data analysis was 
through descriptive and exploratory factor analysis. The findings of quantitative survey were in 
congruence with the Delphi study. 13 (thirteen) factors extracted from the data were used as the 
inputs for the development of a valuable outcome of the research – a framework for outsourcing 
outbound pharmaceutical value chains.  Valuable contributions to knowledge, research 
methodology and policies have been made from the results of this study. Outsourcing in the 
Nigerian pharmaceutical industry is a relatively new and growing practice.  Given the nature of 
products handled in the outbound value chain and the myriad of infrastructural and systemic 
viii 
 
challenges confronting the sector, any outsourcing decision needs to be critically examined and 
carefully taken.  The study has developed a new framework, which will be useful in providing 
organizations with a handy tool in taking the outsourcing decision.  
 
Keywords: Supply chain management; pharmaceutical outbound value chains; framework for 
outsourcing pharmaceutical outbound value chains. 
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CHAPTER 1 
 
BACKGROUND TO THE STUDY 
 
1.1: Introduction  
This chapter provides contextual background information for the research, touching briefly on the 
concept of pharmaceutical supply chains, an overview of the Nigerian pharmaceutical supply 
chains and the practice of outsourcing in the pharmaceutical industry. The chapter further states 
the research problem, objectives, questions, motivation and significance of the study. An outline 
for the study is presented as well.  
 
1.2: Pharmaceutical Supply Chains  
Efficient and effective supply chains for medicines and vaccines are very vital to the delivery of 
health services. Any functional healthcare system requires amongst others, supply chains which 
provides sustained flow of medicines and other medical products throughout the system. 
(Kraiselburd & Yadav, 2014; Yadav, 2015). The supply chain of pharmaceutical products is 
significant in any healthcare system (Jaberidoost et al., 2013).  
 
Pharmaceutical products are very valuable to health systems as alongside other healthcare services, 
they contribute to enhance quality of life by reducing morbidity and mortality rates. 
Pharmaceutical products differ from other commodities, given their form, composition and the 
purpose for which they are used. People depend on them for their health and sometimes, even for 
life itself (Kohler et al., 2012). A functional pharmaceutical supply chain is very vital in creating 
competitive advantages for companies. On the other hand, it has been described as challenging 
because of its complex nature and the strict government regulations in this field (Yousefi et al., 
2015). The primary aim of pharmaceutical supply chains is ensuring timely delivery of good 
quality medicines to the patients. However, 30 to 50 percent of the population living in less 
developed countries have not access to basic medicines (Salem, 2015). 
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1.3: Pharmaceutical Supply Chains in Sub-Saharan Africa 
The configuration of the pharmaceutical supply chains in many resource-poor economies like Sub-
Saharan Africa (SSA), is linked to the organizational structure of the country both at the public 
and private sectors. This results in multiple layers of decision points both for stock storage and 
distribution along the supply chains. (Yadav, 2015). The public-sector supply chains of these 
countries are historically and mostly managed by the various Ministries of Health who operate 
through Central Stores and sometimes, a pool of motor vehicles (Watson & McCord, 2013; 
WHO/Yadav et al., 2011). Subject to the size and number of health facilities, other layers of 
distribution points may be operational. Various funding and partner partners such as USAID and 
Global Fund provide additional storage and distribution locations to complement the governments’ 
efforts. These locations work alone in parallel or sometimes, integrated with the existing supply 
chains of the government. (WHO/Yadav et al., 2011). 
 
The private sector has a different structure comprising of manufacturers (where available), 
importers, wholesalers and other channel members/players like the pharmacy stores and Patent 
and Proprietary Medicine Vendors (PPMVs). Importers and sometimes, wholesalers function as 
the link between the manufacturers and other channel members like retail outlets (pharmacies and 
PPMVs), doctors and hospitals (Yadav, 2015). Over the years, the pharmaceutical supply chains 
(PSC) in SSA have faced many challenges, which have impacted negatively on the performance 
of the chains.  These challenges include but not limited to: Stock-outs and product shortages 
(Odendal, 2013; Gray, 2014; Iyengar et al., 2016; Blanas et al., 2016; Mikkelson-Lopez et al., 
2015; Oyekale, 2017; Poyer et al., 2016; Agyare et al., 2017); Fake and counterfeit products 
(Kohler et al., 2012; Mackey et al., 2013; Cohn et al., 2013; Khan et al., 2015); Disruptions 
(Zegordi et al., 2012; Kohler et al., 2012; Sayed et al., 2016; Hamisu et al., 2016); Product 
Expiration (Jahre et al., 2012; Olatunji, 2013; Oluwatuyi et al., 2014; Sauls, 2016).  Other 
challenges include: Corruption (Transparency International, 2015; Mackey et al., 2016; Tormusa 
et al., 2016; Global Fund, 2016); Poor Infrastructure (Schürenberg-Frosch, 2014; Fowkes et al., 
2016; Arewa, 2016; Ettah, 2017; Yakum et al., 2015) and Weak regulatory systems (Preston et al., 
2012; Giralt et al., 2017). 
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In summary, the pharmaceutical supply chains in both private and public sectors in SSA countries 
still face several challenges. As a result, they have remained weak and ineffective, threatening the 
overall success, efficiency and effectiveness of the various chemotherapies.  Ultimately, the overall 
health system fails in its ability to adequately cater for the healthcare essentials of the population. 
(Yadav, 2015). To varying degrees, these challenges negatively affect the effectiveness and 
efficiencies of the countries’ pharmaceutical supply chains. While some challenges such as weak 
regulatory systems, poor infrastructure and product shortages/stock-outs may cut across these 
countries and may be synonymous with the weak political and socio-economic developments in 
these countries, others like corruption, fake and counterfeit drugs are prevalent to different degrees 
and a reflection of the values and governance structures obtainable in the countries. 
Comparatively, supply chains of the private sector are perceived to be more efficient and effective 
and are characterized by higher levels of availability of medicines, several daunting challenges 
still hinder this sector in the distribution of medicines (Yadav, 2015). According to the study, these 
challenges include: poor availability in rural areas, high prices, poor quality and sub-optimal 
assortment, shortage of manpower and the menace of unlicensed medicine sellers. (Wafula et al., 
2012). 
1.4: The Nigerian Pharmaceutical Supply Chains 
With about 186 million people and an area of 923,768 km2, Nigeria has the largest population in 
Africa.  By 2016, its Gross Domestic Product (GDP) was estimated at $485b. Life expectancy is 
52 years for males and 53 for females respectively. Nigeria is a major crude oil producer and 
generates most of its revenue (80%) from the product (Oxford Business Group, 2017). 
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                Figure 1. 1: The Nigerian Pharmaceutical Supply Chains (GAVI, 2015 & Yadav, 2015). 
LGAs = Local Government Areas; PPMVs = Proprietary & Patent Medicine Vendors. 
 
As shown in Figure 1.1, in the Nigerian public sector, the supply chains of medicines is both 
centralized and regionalized. (Attaran et al., 2012; Iwokwagh, 2013).    The procurement, storage 
and distribution of medicines are done by the various tiers of government and institutions.   Each 
state in all the geo-political zones of Nigeria has its own Central Medical Store and manages the 
supply chains from these facilities (Onwujekwe et al., 2009).    Drugs   for   some disease and 
infections like HIV are managed centrally by the Federal government (Erhun & Babalola, 2004).   
 
Wholesalers (both licensed and unlicensed) are significant players in the supply chains 
(Aisagbonhi & Ilomuanya, 2016; Sieverding & Beyeler, 2016).  At the last segment of the chains, 
the delivery to the patient is through the health facilities and institutions (hospitals, clinics, primary 
healthcare centres) and the retail outlets (pharmacies & PPMVs). 
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The Nigerian public health system faces several challenges in delivering services (Abimbola et al., 
2014; Abimbola et al., 2015) with public facilities in many states without adequate infrastructure 
and trained personnel (World Bank, 2010; Abimbola et al., 2015). In the rural areas, the health 
facilities lack basic services and often experience stock outs and shortages of medicines. 
Pharmacies are also few in these areas (Sieverding and Beyeler, 2016). Scarcity of some drugs and 
poor drug regimens further complicate the problems of pharmaceutical supply chains in Nigeria 
(Akinwande et al., 2009).  
 
In a study of multi-drug resistant tuberculosis treatment in Nigeria, delay in drug delivery was 
identified as a supply chain limitation. In resource-poor with inadequate transport infrastructure, 
this, amongst others, contribute to the preponderance of drug stock outs (Jatau et al., 2015).  
Managing supply chains in countries like Nigeria with expansive geography is often problematic. 
Sometimes, the storage/distribution points and the various health facilities can be separated by 
wide geographies (Jatau et al., 2015). These supply chains limitations cause ultimately, poor/sub-
optimal health outcomes. Despite the efforts of the government, private sector and foreign donor 
agencies over the last decade, the status of the public supply chains was summarised as follows: 
“The Nigerian public sector (national) supply chain for pharmaceuticals and other healthcare 
products has been plagued over several years with numerous challenges resulting mainly from 
inadequate funding, infrastructure and coordination.  Specific challenges include weak capacity, 
poor supply and demand management and parallel systems by different programmes and 
Implementers.  These have resulted in stock-outs, damages, expiries, and other forms of wastages, 
which ultimately lead to sub-optimal health outcomes” (FMOH, 2016:5). 
Some of these challenges have been the subject of different researches with many necessitating 
further studies. Palafox et al. (2014) assessed the composition and structure of the private sector 
distribution chains with focus on anti-malarial drugs in a study conducted in six countries including 
Nigeria. Their report confirms the presence of multiple layers and channels between the 
manufacturer and retailers. They concluded that the supply chains of antimalarial medicines vary 
across countries and any effort aimed at improving these supply chains access to quality treatment 
should recognise this unique structure. Ubajaka et al. (2016) in their article, reviewed relevant 
literatures published from 2004 to 2015 on drug counterfeiting in Nigeria and analysed the factors 
promoting the sales and distribution of counterfeit drugs in Nigeria. They found out that poor and 
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ineffective legislation, chaotic distribution system and lack of cooperation from government 
agencies, amongst others were the major factors associated with drugs counterfeiting in Nigeria.  
Although the study by Isola & Mesagan (2016) provided insights into the relationships and 
performance of the Nigerian pharmaceutical industry, it did not address the issues of supply chains 
in the industries. In their findings, they concluded that the market structure was a predominant 
factor in determining the performance of the pharmaceutical industry in Nigeria. Findings from 
other studies have highlighted factors such as limited access to drugs (Adebisi, 2013; Obuaku, 
2014; Onwuka, 2016) and fake drugs syndrome (Oluwatuyi, 2014) as limitations of 
pharmaceutical supply chains in Nigeria.  
1.5: Outsourcing in Pharmaceutical Supply Chains 
Outsourcing as a concept and practice has become key and strategic for many organizations in 
their quest for costs reduction and focus on their core areas. Many developments have contributed 
greatly to the practice of outsourcing globally.  These include but not limited to such contemporary 
issues as globalization, perceptive customers, organizational restructuring and various 
technological advancement (Gerbl et al., 2015). In pharmaceutical supply chains (PSCs), some 
activities both in the inbound and outbound segments have been outsourced in both sectors of the 
industry. An extensive investigation by GAVI and Transaid (2015) in some sub-Saharan African 
countries including Nigeria focused on outsourcing of public pharmaceutical supply chains. The 
report focused on how to outsource public PSCs to the private sector in SSA. It analysed the 
existing methods being used, the challenges and lessons learned from the cases with each country 
under focus.  
For Nigeria, they focused on establishing a modern supply chain and noted amongst others, the 
significant improvement/transition with the public sector outsourcing its supply chains to the 
private sector logistics service providers.  
An older study on outsourcing by Transaid (2010) carried out in Kano, Northern Nigeria focused 
on understanding the structure, costs of the public PSCs and capacity of the private sector service 
providers. They concluded that with the adequate in-house management capacity/arrangement for 
3PL relationship management and contracting, the public PSCs could be outsourced to the private 
sector. A review of these studies show that most of the studies focused on only one component or 
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challenge of pharmaceutical supply chains in one sector (the public sector). Few studies have 
focused on the private pharmaceutical chains and no comprehensive, simultaneous studies have 
been conducted on both sectors. Despite the progress recorded in the restructuring of the public 
supply chains (GAVI, 2015) and the assistance from foreign donor agencies like USAID and the 
Global Fund, the Nigerian government still acknowledged the existence of some 
limitations/challenges in managing its pharmaceutical supply chains (FMOH, 2016).  
Recently, a Pharmaceutical/Medical Warehouse facility was built and launched in Abuja and 
Lagos, Nigeria by USAID & Global Fund (Owoseye, 2017) to assist the Federal Government in 
the storage of pharmaceutical and health commodities. This will no doubt assist in the reducing 
some of the challenges along the outbound value chain resulting from poor storage of product. The 
management of this storage facility was outsourced to a private organization, perhaps heralding 
the beginning of a strategic shift towards outsourcing some aspects of the pharmaceutical supply 
chains in Nigeria. 
By far the greatest challenges of the Nigerian PSC are in the outbound segment of chain – the 
Pharmaceutical Value Chain (PVC). This consists of activities that occur between the point/time 
of manufacture or import of any medicine to the point/time it is received by a patient before use 
(Aitken, 2016). The outbound segment of the Nigerian PSC is weak and uncoordinated. This 
situation has been a perennial problem to the pharmaceutical sector in particular and to government 
in general, because of the deleterious effect on the national healthcare system (Chukwu, 2012; 
Jatau et al., 2015).  
Furthermore, preliminary interview sessions with some Chief Executives and other industry 
captains such as the President of the Pharmaceutical Society of Nigeria (PSN) confirmed that “pain 
points” in their supply chains lie mostly in the outbound segment of the value chain (Ayebae, 2017; 
Oyenuga, 2017; Yakassai, 2017). The role of outsourcing in ameliorating or otherwise these “pain 
points” needs to be further investigated. 
 
In conclusion, the Nigerian outbound pharmaceutical supply chains are sub-optimal, necessitating 
the need for investigation to identify the gaps and challenges and hence, solutions for their 
improvement. Using SCOPUS, EBSCO, Emerald Insight, Taylor & Francis, Ujoogle, etc., to 
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search all the databases, no other studies/references could be found that relate to the Nigerian 
pharmaceutical supply chains or and outsourcing of outbound value chains, other than those 
considered in this review. This research/literature gap will be addressed with this study.  
 
1.6: Problem Statement 
Although there has been a growth in the practice of outsourcing in both public and private 
pharmaceutical supply chains over time, scholarly, empirical studies on outsourcing of the 
outbound value chains have been none existent. Few scholarly researches on outsourcing in the 
Nigerian Health sector have been carried out (Magaji et al., 2007; Transaid, 2010; GAVI, 2015). 
The limitations of these researches are their main focus on the public sector and States with 
relatively smaller pharmaceutical/health sectors like Kano and Kaduna states.  Limited work has 
been done or no mention of outsourcing in the private sector as a focus.  
 
Transaid’s study was focused on the structure and costs of public PSCs and the capacity of the 
private sector service providers. It did not focus on the private sector PSCs neither did it evaluate 
the substantive outsourcing contracts being managed by the state government.   Even though by 
far more comprehensive in scope in its study of some sub-Saharan African countries including 
Nigeria, the GAVI/Transaid white paper only focused on how to outsource public PSCs and not 
on the reasons and the framework for such outsourcing decisions. 
 
From the foregoing, the problem is, no holistic empirical study has been carried out on the Nigerian 
pharmaceutical supply chains using the outbound value chain approach. Almost all of the few in-
depth studies that have been conducted, focused on a single element of the supply chains.  This 
study adopts the outbound value chain approach in its investigation. Also, earlier studies focused 
on only one sector of the industry. This study evaluates both sectors. Furthermore, most of the 
earlier researches adopted single methods - either the quantitative or qualitative methods to collect 
data unlike the mixed method used in this study. Finally, no framework presently exists for 
outsourcing of outbound value chain activities in the Nigerian pharmaceutical industry.  This study 
developed one.  
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1.7: Research Questions 
From the foregoing, the problems and gaps in the previous studies on the pharmaceutical supply 
chains in Nigeria, the research questions for this study are: 
1. What is the extent of outsourcing of outbound value chain activities in both sectors of 
the Nigerian pharmaceutical industry? 
 
2. What is the rationale for outsourcing outbound pharmaceutical value chains in Nigeria? 
 
3. What are the critical criteria for a successful selection and outsourcing relationship with 
a 3rd Party Service Provider in the Nigerian pharmaceutical sector? 
 
4. What are the desired outcomes of outsourcing outbound pharmaceutical value chains in 
Nigeria 
 
5. What framework and future improvement practices can be adopted for outsourcing 
outbound pharmaceutical value chains in Nigeria? 
 
 
1.8: Objectives of the Study 
The objectives of the study are: 
1. To study the extent of outsourcing of outbound value chain activities in both private and 
public sectors of the Nigerian pharmaceutical industry.  
2. To investigate the rationale for outsourcing outbound pharmaceutical value chains in 
Nigeria. 
3. To study the critical criteria for a successful selection and outsourcing relationship with a 
3rd Party Service Provider in the Nigerian pharmaceutical sector. 
4. To identify the desired outcomes of outsourcing outbound pharmaceutical value chains in 
Nigeria 
5. To develop a framework for outsourcing outbound value chain activities in the Nigerian 
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pharmaceutical industry. 
1.9: Motivation of Study 
The achievement of a functional healthcare system in Nigeria depends on, amongst others, the 
universal access to medicines necessary for the treatment of identified, communicable diseases 
like HIV/AIDS for those who need it (United Nations, 2015). In line with these targets, it is 
imperative that the speedy, secure and sustained delivery of health commodities is crucial in the 
attainment of these goals. The effectiveness and efficiency of the outbound segment of the supply 
chains of these medicines to patients will be crucial in attaining these goals. 
In line with these targets, it is imperative that the speedy, secure and sustained delivery of health 
commodities to all who need them in a timely manner is crucial in the attainment of these goals.  
The involvement and support of donor agencies has contributed to improvements in the 
distribution and consequently, the availability of these essential medicines in Nigeria due to in 
part, their support and promotion of the practice of outsourcing in the public sector (Lawson, 
2013). Even though outsourcing does not answer all the supply chain questions in the 
pharmaceutical sector, it does offer some performance improvements. Furthermore, the practice 
of outsourcing outbound distribution of drugs in both sectors of the industry will be studied. 
Finally, the development of a framework for outsourcing pharmaceutical outbound value chains 
to complement the efforts of health authorities and the donor agencies in Nigeria in 
effective/efficient pharmaceutical supply chain management will be a valuable outcome of this 
study 
 
1.10: Research Methodology 
1.10.1: Study Area 
Nigeria is divided into 3 layers of government with the central federal government supervising the 
2nd layer – the 36 states who in turn have 774 local government areas under them. Furthermore, 
the states are aggregated into six geo-political regions. The study was conducted in Lagos, South-
West region of the country and with focus on the outbound pharmaceutical supply chains. The 
pharmaceutical sector in Lagos State government and the private pharmaceutical companies in the 
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State were used as target population. Lagos State was selected as the target State for this because 
it is the most populated and industrialized in the country (World Population Review, 2016). 
Furthermore, out of the over fifty registered foreign pharmaceutical companies’ representative 
companies/importers in the country, 30 are located in the State. Also, out of the 154 registered 
pharmaceutical manufacturing companies in the country, 45 are based in the State. It therefore 
provided a good repository of respondents and industry experts whose opinions were very valuable 
in the study. 
 
1.10.2: Sampling Procedure/Technique 
A mixed method was used in this study. The qualitative method was the Delphi technique, while 
the quantitative method was a survey conducted with the aid of structured questionnaire. This 
approach (mixed method) has become popular in researches (Bryman & Bell, 2015).  Given the 
challenges of outbound value chains in a developing economy like Nigeria and the debate around 
the value of outsourcing, Delphi method offers a well-justified methodological approach to gaining 
expert opinions on the subject of study. An advantage of the Delphi technique is achieving 
unanimity among a group experts on the subject under investigation (Kache & Seuring, 2017). 
While the Delphi technique was used to provide an expert ranking of the latent variables 
investigated, the quantitative study was used to complement the Delphi study and the factors 
extracted from the data analyses used to develop the outsourcing framework. 
 
1.10.3: Sample size 
Seventeen (17) panel members/experts selected from the pharmaceutical industry were used for 
the Delphi study to enhance the success rate for the study. This ensured the final number at the 
final round of iteration did not drop below a critical number. The sample size for the quantitative 
survey was determined with the Krejcie & Morgan (1970) table.  The table contains standards for 
determining sample size from a finite population. 
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1.10.4: Data Collection Instruments 
This study made use of structured questionnaires for data collection in both methods. The details 
of the structure and contents of the questionnaires are given in chapter four. The Delphi technique 
consisted of a panel of experts drawn from the pharmaceutical industry in Lagos, South West 
Nigeria. The Delphi panel was composed of 17 expert members (10 Chief Executive Officers, 3 
Country Managers and 4 Executive Directors) drawn from the five categories in the private sector 
of the industry: multinational manufacturing - 6 (35.3%), overseas’ manufacturers’ representatives 
– 2 (11.8%), indigenous manufacturers - 3 (17.6%), importers/distributors - 4 (23.5%) and large 
pharmacy chains – 2 (11.8%). Questionnaire containing closed and open-ended questions was used 
to conduct two rounds of the Delphi iterations before a consensus was achieved and data analysed. 
The quantitative survey was conducted with 100 respondents drawn from all the seven categories 
of both sectors of the industry which in addition to the five (5) listed above, include the State level 
and Local Government Area level pharmaceutical services categories of the public sector. 
1.10.5: Data Analysis Technique 
The Delphi data was analysed with spreadsheet, calculating the group means and median values, 
which were the measures of consensus adopted. The quantitative results were analysed with the 
software, SPSS version 25. Outputs were descriptive measures like means, standard deviations and 
exploratory factor analysis (EFA). The tests for reliability of data were done in all cases prior to 
the EFA.  
 
1.10.6: Specific Delphi Research Objectives 
The specific Delphi research objectives this study set out to achieve include: 
1. To identify the level of outbound supply chain outsourcing in the last decade in 
Nigeria. 
 
2. To determine the age of the outsourcing relationships 
 
3. To identify the main factors influencing the decision to outsource outbound 
pharmaceutical supply chains 
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4. To identify the main roles of outsourcing in outbound pharmaceutical supply chains 
 
5. To identify the level of satisfaction of the outbound supply chain services currently 
being outsourced by the Pharmaceutical companies 
 
6. To determine the underlying risk factors in the outsourcing relationship 
 
7. To determine the criteria for a successful selection and outsourcing relationship with 
a 3rd Party Service Provider 
 
8. To evaluate the vital pre-engagement activities by the outsourcing organizations 
9. To determine the challenges in the pharmaceutical outbound value chains 
 
1.10.7: Study Scope 
Study took place in Lagos State, South-West Nigeria. It involved a cross section of both sectors of 
the pharmaceutical industry in the State. All the five categories in the private sector of the industry 
(multinational manufacturing, overseas’ manufacturers’ representatives, indigenous 
manufacturers, importers/distributors and large pharmacy chains) and the two categories in the 
public sector (State and Local Government Pharmaceutical Services) as earlier described in section 
1.10.4 above, were sampled. While the qualitative study (Delphi technique) used experts from the 
five categories of the private sector, the quantitative survey was conducted with respondents drawn 
from all the seven categories of the industry.  
 
1.11: Study Outline 
Chapter One: This chapter provides contextual background information for the research, touching 
briefly on pharmaceutical supply chains concept, general, Nigerian overview and the practice of 
outsourcing in the pharmaceutical industry. The chapter further states the research problem, 
research aim, research objectives, questions, motivation and significance of the study.  
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Chapter Two: This chapter was focused on logistics and supply chain management (SCM) – 
theories, concepts, role, current trends and the concept of value chain.  
 
Chapter Three: Focuses on pharmaceutical supply chain management, pharmaceutical value 
chain, concept and components of the pharmaceutical outbound value chain, the state and 
challenges of outbound pharmaceutical logistics and supply chains in Nigeria & sub-Saharan 
Africa, the concept of outsourcing and outsourcing of pharmaceutical supply chains.  
 
Chapter Four: Describes the research method adopted.  It contains details about the design, tools 
collection of data, treatment of the data, research technique used, population and the sampling 
design and the interpretation of results.  
 
Chapter Five: Presents findings and discussions of the Delphi study, with results presented as 
statistical measures and tables.  
 
Chapter Six: Contains the results of the quantitative study, presented as statistical measure, tables 
and graphical plots.  
 
Chapter Seven: Contains discussions of the quantitative study and overview of both the Delphi 
and quantitative studies.  It also contains the development and comments on the framework for 
outsourcing outbound value chain developed from the output of the EFA conducted from the 
survey findings. 
 
Chapter Eight: Contains a summary the outcomes of the study, contributions and value, 
recommendations for policy, research, practice and recommendations for further studies further 
studies. 
 
 
 
 
 
15 
 
CHAPTER 2 
 
THEORETICAL UNDERPINNING ON SUPPLY CHAIN & 
SUPPLY CHAIN MANAGEMENT 
 
2.1: Introduction 
Supply Chain Management (SCM) has undergone rapid evolution in the last two decades not only 
to involve the  traditional role of managing the functional logistic activity, but now; includes the 
management and co-ordination of activities across the supply chain. These activities include 
amongst others, Planning, Managing supply and demand management, warehouse Management, 
inventory control, transportation and distribution. Furthermore, we have also seen the increased 
use of some terminologies hitherto used in production and operations management. Such 
terminologies as JIT (Just-In-Time) and others have now been included in the concept and 
processes (Acharya, 2016). This chapter reviews the concepts of logistics, supply chain - 
management, theories and value chain concept.  
 
2.2: Logistics 
Logistics is defined as “the process of planning, implementing, and controlling the efficient, 
effective flow and storage of goods, services, and related information from point of origin to point 
of consumption for the purpose of conforming to customer requirements” (CSCMP, 2013:117)   
The resources managed and by implication, the flows in logistics include the intangible items such 
as products and goods or the intangibles such as time and information. Based on the flows, logistics 
is divided into three, namely: inbound, outbound and reverse logistics. 
Even though logistics has been largely associated with third-party operations (3PL), it also 
includes such internal operations as transport, warehousing, retail and wholesale distribution 
(Shepherd & Tamanaka, 2015). 
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2.3: Supply Chain  
The term ‘supply chain’ (SC) was introduced by a team of management experts (Oliver & Webber, 
1982) who referred to is it as “a network of organizations involved in the different processes and 
activities that deliver value in the form of products and services in the hands of the ultimate 
consumer” (Asgari et al., 2016). Since then, many studies have been carried to gain more insight 
into how the integration of material, information and money flow can be achieved for greater 
market support and competitiveness of the chain (Stadtler & Kilger, 2011; Hill & Hill, 2012). 
 
 
 
Figure 2. 1: The Basic Supply Chain (Adapted from Desmukh & Vasudevan, 2014) 
 
Many definitions of “supply chain” have emerged and been advocated. Though different in 
language and scope, these definitions still retain the essence and refer to the same core principles 
(Vlok & Du Toit, 2014). Whitley and Ulmer (2013:123) define supply chains to encompass “all 
activities that are associated with the flow and transformation of goods and services from raw 
materials to the end-users, as well as the associated information flows”. It has also been also been 
defined as “a set of facilities, suppliers, customers, products and methods of controlling inventory, 
purchasing and distribution” (Chen & Gong, 2013:1003). 
 
The typical supply chain has been described as potentially more complex than the simple flows 
earlier stated, and in some instances, may include other enterprises and organizations (Casson & 
Wadeson, 2013). Many factors now force organizations to ensure both supply chains/product 
quality improvement and manufacturing costs reduction (Arawati, 2013).   
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2.4: Supply Chain Management   
Supply chain management is defined as “encompassing the planning and management of all 
activities involved in sourcing and procurement, conversion and all logistics management 
activities” (CSCMP, 2013:187). This definition “also includes coordination and collaboration with 
channel partners, such as suppliers, intermediaries, third-party service providers, and customers”.  
It has two main constituents - the logistical activities on one hand and the coordination of the 
parties that form the entire chain on the other.  
 
Since its advent, SCM has now become a major source of organizational competitiveness (Ellram 
& Cooper, 2014; Anand & Grover, 2015).  It cuts across the boundaries and management of single 
entities, and in practice, harnesses the resources of business partners to achieve organizational 
goals and competitive edge in the marketplace (Zhang et al., 2015).  Furthermore, it involves the 
integration of the operations management with the flow of material and information (Beh et al., 
2016). Companies have realised the critical role and benefits of SC management (SCM) and 
nowadays, pay more attention to its effective design and execution even in the face of some 
inherent and obvious challenges (Palma-Mendoza et al., 2014; Trkman et al., 2015).  
 
As business processes grow in complexity, so also are the difficulties in managing the supply 
chains.  These difficulties include amongst others, sharing of information, integration, visibility 
and flexibility along the chain (Palma-Mendoza et al., 2014). Despite the challenges and volatility 
associated with and along the supply chains, organizations and companies with well-managed 
supply chains ultimately achieve optimum value creation, system-wide effectiveness, efficiency 
and competiveness (Arawati, 2013; Lambert, 2014; Gilling et al., 2016).  
 
 
 
2.4.1: Existing Conceptual Framework for Understanding Supply Chain 
Management 
 
One of the most comprehensive frameworks for the understanding of supply chain management is 
that developed by Vlok & Toit (2014).  This framework is used in this study to explain further, the 
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concept of Supply Chain Management (SCM). As shown in Figure 2.2, they illustrated SCM using 
the organizational supply chain strategy, which directly derives from the overall organizational 
strategy.  
 
Figure 2. 2: Framework for understanding SCM (Vlok & du Toit, 2014) 
 
As shown in the framework, the organizational strategy are SCM strategy and SC management 
plans. They explained that SCM consists of three main components: participants, lifecycle 
activities, and support functions. They further added that SC participants link directly to SCM 
plans and are involved in the life-cycle activities. The other parts of the framework are the enablers 
- the internal organizational resources, systems and structures such as the IT, Human Resources 
and infrastructure. Performance measurement is included in the framework as a source of feedback 
for continuous improvement, which affects the overall SC strategy and management.  
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2.4.2: Participants in SCM 
As explained by Vlok and Toit (2014), the Participants in SCM are both internal and external 
parties/enterprises who play one role or the other along the supply chains stretching from the 
inbound, through the core/internal processes of the organization, to the external and channel 
members.  They include suppliers to the organization from the inbound segment, the 
organization/company itself, (sometimes a manufacturer), distributors, wholesalers, retailers and 
finally, the customers.  In their architecture, Vlok & Toit (2014) position the participants next to 
the other part of the framework called the life cycle activities, which are described next. 
 
2.4.3: Activities in Supply Chain Management 
The activities in the SC according to Vlok & Toit (2014) are categorized into the primary and the 
support functions.  They referred to the primary activities as the lifecycle activities, and as the 
name suggests, these are the activities involved all through the supply chain.  The lifecycle 
activities are those also listed as the basic process of the Supply Chain Operations Reference 
(SCOR) model of plan, source, make, deliver, and return (Jothimani & Sarmah, 2014). In essence, 
these are the basic supply chain activities in the product conceptualization from the raw material 
stage/sourcing, through the conversion/manufacturing stage, to when the end product reaches the 
ultimate customer and sometimes, the process for returning finished product(s) through the same 
(but reverse) process to the organization/manufacturer.  The lifecycle activities support the product 
throughout its “lifetime”. The other activities in the SC are the support functions, which are internal 
management functions, needed to support and manage the various lifecycle activities and may be 
needed at particular stages of the “lifetime” of the product.   
2.5: The Supply Chain Operations Reference Model 
The Supply Chain Operations Reference (SCOR) model now widely acclaimed worldwide as 
valuable supply chain management tool, was introduced in 1996 by the then Supply Chain Council 
(SCC). It is very useful framework for supply chain business processes and performance 
measurement. It has five different activities/processes (Plan, Source, Make, Deliver and Return) 
and three levels. The model can be used for the design, configuration and performance 
measurement of supply chains (Tsay, 2014; Jothimani & Sarmah, 2014). 
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2.6: Supply Chain Concepts and Theories. 
Over time, and in response to some emerging dynamics like technology, scope and complexity of 
businesses, supply chains have changed and evolved. This evolution, correspondingly, has a direct 
impact on how the supply chains are controlled and managed (Russo et al., 2012; Lee & Cheng, 
2013; Hahn, 2015). Supply chains can also become obsolete when the technology and/or process 
for supported products becomes obsolete (Fritz, 2014; Wang et al., 2015). In addition to 
technology, economic, political, strategy and regulations are the other exogenous factors that can 
influence the changes in supply chain over time (Woody, 2012; Casson, 2013; Gereffi, 2014; Jia 
et al., 2014; MacCarthy et al., 2016).  
Many researchers have explained and propounded supply chain definitions, concepts & theories 
from different perspectives and focus areas. In their review, LeMay et al. (2017), reviewed the 
various development works on SCM processes, definitions, concepts & theories by different 
authors over a period of about fifteen years from 1992 to 2015 beginning from studies on supply 
chain processes (Cox et al., 1992) to more recent studies on the broader areas of definition, 
concepts and theories (Ellram and Cooper, 2014; Carter et al., 2015). Thy concluded that a global 
consensus on the definition of SCM was still lacking unlike the definitions of its sub-disciplines 
(LeMay et al., 2017). 
In supply chain management, there is no unified theory. By about decade ago, more than 180 
theories, mostly adapted from other management fields have been used both directly/explicitly and 
indirectly/implicitly in various researches in logistics and SCM (Defee et al., 2010; Halldórsson 
et al., 2015).  The basis of this study is on some of these theories, which also underpin other 
previous researches in the fields of supply chain management and outsourcing. These include the 
Transaction Cost Economics (TCE), the Core Competency (CC); Resources Based View (RBV) 
and the Value Chain theory (VCT).  By far the most popular theories used in SCM are four inter-
organizational theories first outlined by Halldorsson et al. (2007) and then revisited in a succeeding 
article Halldorsson et al. (2015). These theories are outlined below: 
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2.6.1: The Principal Agent Theory  
The theory primarily deals with the relationship between two contracting organizations - the 
principal, outsourcing tasks to the other (the agent), who is the provider. (Selviaridis, & Norrman, 
2014). This theory is now well established in field of SCM and most of the researches in this field 
based on the PAT focus on the buyer-seller relationship (Fayezi et al., 2012).  Selviaridis & 
Norrman (2014) have used this theory in the study of performance-based service supply chain.   
 
2.6.2: Transaction Cost Economics  
Developed by Williamson (1975; 1985), TCE  is a valuable theory in the studies of outsourcing, 
logistics and SCM (Schermann et al., 2014; Grimm et al., 2015; Pomponi et al., 2015; Liang et 
al., 2016).  TCE and RBV are often used together in outsourcing researches/decision as TCE assists 
to clarify why organizations exist, while RBV explains why the organizations may perform 
differently. For instance, outsourcing may be worthwhile from the perspective of TCE, but, for 
competitive reasons, based on RBV, the function may be performed in-house. (Halldórsson et al., 
2015). 
 
2.6.3: The Resource-Based View (RBV) 
Developed by Barney (1991), this theory recognises the organization as possessing resources and 
assets that are valuable in the creation of the organizational competitive advantage if utilised in 
distinctive ways. RBV has been used in outsourcing decision studies as it makes up for the 
limitation in using TCE as the only basis for study.  This limitation stems from the fact that TCE 
mainly covers the parameters, which relate to transaction economics and costs (Hanafizadeh & 
Ravasan, 2018).  The RBV is essential in the study of outsourcing and is a strategic management 
theory which emphases how an organization employs its resources and capabilities (Gerbl et al., 
2015; Mandal et al., 2016). 
2.6.4: Core Competency Theory 
Propounded by Prahalad and Hamel (1990), this theory is popular in various management studies 
of supply chain and outsourcing. (Mubarik et al., 2012; Hanafizadeh & Ravasan, 2018). In many 
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supply chain studies and application, the use of these theories are combinatory and complementary 
(MacCarthy and Jayarathne, 2013).  
2.7: Supply Chain Integration 
Supply Chain Integration (SCI) refers to how all the various processes and activities (both internal 
and external) in an organizational supply chain are linked and seamlessly managed to achieve an 
efficient and effective flow of the different components of chain in order to ensure a seamless 
value delivery to the final customer (Liu et al., 2013). It involves inter-organizational collaboration 
and partnership (Huang et al., 2014), and in some instances, may involve technological and 
information systems’ integration of the different players across the entire chain. (Lee et al., 2016) 
2.8: Green Supply Chain Management (GSCM). 
Recently, compelling factors such as societal awareness and commitment towards the conservation 
of the environment, various public legislation and the ever-increasing need for, and global 
campaigns for sustainable development have influenced a number of researchers and professionals 
into more focus on the concept of GSCM. (Lau, 2011). GSCM incorporates various environment-
friendly practices into the different aspects of SC activities from the beginning, through to final 
users and various reverse logistic activities in the chain (Min & Kim, 2012; Cosimato & Troisi, 
2015). The incorporation of the practice of GSCM in the concept and practice of SCM has seen it 
evolve into a system that is now more cognizant of our environment and the potential hazards our 
activities have on it. However, despite the trend in awareness, some organizations are yet to fully 
embrace the practice due to some factors such as ignorance on its implementation, lack of 
government regulation and some misconceptions about it.  Hence the commitment of both the 
government and organizations in private and public sectors will be needed if GSCM must be fully 
incorporated into the various SC activities of the various sectors (Jaggernath & Khan, 2015). Due 
to increasing government regulations and increasing public awareness and campaigns, many 
organizations are now undertaking steps to incorporate GSCM practices into their SCM strategies 
(Zhu et al., 2013; Mirhedayatian et al., 2014; Singh & Trivedi, 2016). 
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2.9: The Role of Supply Chain Management 
Globally, SCM is very critical in the economic growth of many nations. At the organizational 
level, the lack of SCM expertise hinders processes effectiveness (Aniki, 2014). Correspondingly, 
SCM has become widespread among researchers, practitioners and organizations in search of 
competitiveness (Sundram et al., 2011; Truong et al., 2017). Organizations who successfully 
implement the practices can now expect to have successful and effective SCM (Gorane & Kant, 
2015). 
2.10: Supply Chain Management in Sub-Saharan Africa (SSA) 
Owing to factors such as the state of development, governance structure and infrastructural 
deficits, the management of supply chains in SSA is very challenging. Accordingly, businesses 
and products produced/distributed in this sub-region face a lot of challenges in competitiveness. 
These and are other nation-specific challenges have been studied and confirmed in South Africa, 
arguably the most developed country in the region (Badenhorst-Weiss & Waugh, 2015). 
2.11: The concept of Value Chain 
The value chain concept introduced by Michael Porter (1985), illustrates the various activities in 
the internal and external space of an organization, and relates them to its competitive strength. He 
postulates that the ability of the organization to carry out these activities confers competitiveness.   
 
 
 
 
 
 
 
Figure 2. 3: Illustration of Michael Porter’s Value Chain 
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In this concept, the organizational competitiveness is directly related to resources within the chain 
(Arya & Lin, 2007; Prajogo et al., 2016). Porter further differentiates between the activities and 
designates them as primary activities and support activities. As shown in Figure 2.3, the primary 
activities are those directly associated with the production of the products and services (inbound 
logistics, operations, outbound logistics, marketing and sales, and service) while the support 
activities (procurement, technology development including research and development, human 
resource management, and infrastructure) which the primary are linked to, help to ensure the 
overall success of the primary activities.  
Generally, the value chain concept considers the role performed by the various players and 
stakeholders in processes involved in products transformation. Specifically, it also comprises the 
internal activities within the organization combining together to deliver a product (Ojadi & 
Walters, 2015). 
 
2.11.1: Primary Activities of the Value Chain 
In the primary activities in the Porter’s value chain model, value is added at every level of the 
continuum in the chain, which ultimately creates the organizational competitiveness. 
As shown in figure 2.3, the primary activities include the following: 
 Inbound logistics: This includes all the activities concerned with the receipt, storage and 
inventory management of raw materials preparatory for production.  
 
 Operations: This comprises all processes required to convert the inputs into finished 
products or services. 
 
 Outbound logistics: This critical activity of the value chain takes the output of operations 
(production) to the end-user (customer). 
 
 Sales and Marketing: All efforts and strategies deployed by the organization to draw the 
attention of potential customers to its products and services are categorised under this part 
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of the value chain. It includes such activities as advertisement and promotion, channel 
management and pricing.  
 
 Service: Service is the final part of the primary activities of the value chain of the 
organization and it encompasses activities that ensure the customer experiences delight 
during and after sales. One of the several ways that organizations create and win with this 
segment of the value chain is to achieve significant cost efficiencies along the chain and 
ultimately pass the savings to the end-user through competitive pricing. 
 
2.11.2: Support Activities 
Also called “overhead costs” of an organization, these activities enable the functionality of the 
primary activities the value chain and include such activities as the organizational structure, 
Technology, Human Resources, etc. Achieving productivity in any of these activities ultimately 
passes the advantage to one or more of the five primary activities. 
 
2.11.3: Applying Value Chain Analysis  
The use of value chain analysis (VCA) broadens the investigation and documentation of the 
various activities within an organization and its supply chains. It helps in looking at the 
organizational systems from the perspective of their capacity to produce and ensure value delivery 
as required by the final customers (Taylor & Fearne, 2009), thereby unfolding the significant 
drivers of consumers’ demand for products within the chain. Peterson et al. (2015) have used the 
VCA to study the drivers and sustainability of traditional medicine in South Africa. VCA is a 
useful tool in the understanding of both organizational behavioural and policy patterns in the global 
economy (Peterson et al., 2015). It also helps in identifying organizational supply chain 
improvement opportunities internally and in the policy environment (Fearne et al., 2012). 
2.12: Conclusion 
The construct of supply chain enables organizations to see the overall web/networks of inter-
organizational relationships relating to their activities, and their linkages to those networks. It has 
helped to widen organizational view of their systems from the various individual activities to a 
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broader perspective. Supply chains and its management play major part in individual organizations 
and national economies. The main goals of supply chain are to seamlessly supply products and 
services in their right forms to the final consumer.  
The value chain approach has moved the emphasis organizations put on their various activities to 
the external perspective of the value that the end-user, the customer, derives from its products and 
services. How effective and efficient an organization does this, will have a critical effect on its 
overall success and competitiveness.  
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CHAPTER 3 
 
OVERVIEW OF PHARMACEUTICAL SUPPLY CHAINS 
3.1: Introduction  
The pharmaceutical sector plays major role in healthcare delivery system (Shabaninejad et al., 
2014). On account of its peculiar products, demand/supply architecture, it is closely controlled in 
most countries of the world (Mehralian et al., 2014; 2015). The developing role and use of 
medicines in healthcare systems globally, advances in  research, increasing investments and the 
rising access to these products have all accentuated the need for a greater focus and attention on 
the pharmaceutical value chain (Aitken, 2016). Understanding this unique chain entails a 
comprehensive understanding of the elements and components of the chain from its origin at the 
manufacturers’ end, to the terminating point of the end-user; the consumer/patient.  Sometimes, 
this understanding includes tracking the course of the medicines, treatment plan and the backward 
journey (reverse logistics) that the medicines sometimes make back to the source. 
3.2: The Pharmaceutical Value Chain 
The Pharmaceutical Value Chain has three main components. 
 
 
 
 
 
 
 
 
Figure 3. 1: Major Constituents of the Pharmaceutical Value Chain (Aitken, 2016) 
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1. Manufacturing of the medicine: The manufacturing of medicine differs from other 
manufacturing both in processes and regulatory approvals. Based on the type of medicines and 
country involved, the typical process commences at an earlier stage with research and other pre-
approval processes such as clinical trials before the actual manufacturing process can commence. 
The next phases of commercialization, which may include sales and advertisement also come 
under the purview of the regulatory bodies.  
 2. Distribution to the dispensing point: Distribution of medicines is affected various factors 
such as location of manufacturer and/or importer, the nature of the medicine and the 
location/distance of the dispensing point. Special handling protocols and vehicles may be required 
for some medicines like vaccines to preserve their potency along the supply chain. 
3. Dispensing to the end-user: The ultimate value a consumer/patient gets from any medicine is 
a successful treatment outcome.  This critical value is a product of the final steps undertaken to 
provide the patient with the right medicine, correct dosage form timely.  The latter (timing) is more 
critical in pharmaceutical supply chain than other chains as it may determine the survival or 
otherwise of the final user, the patient. Right usage of medicine is assured through counselling by 
specialised personnel like Pharmacists. 
3.3: The Pharmaceutical outbound value chain 
In this study, we define outbound value chain as the outbound logistics (distribution) segment of 
the value chain. Accordingly, the following illustrations – from the modification of Aitken’s 
model, are presented as follows: 
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Figure 3. 2: The Pharmaceutical Outbound Value Chain (adapted from Aitken, 2016) 
 
As shown in Figures 3.2, the components of the Outbound Value Chain (OVC) are as follows: 
3.3.1: Haulage (Long distance transportation) 
Long distance transportation (haulage) is a significant end-point activity in supply chain, as it is 
the logistical activity which ensures physical movement of products through different locations, 
sometimes across long distance geographies. This is a value-adding activity (Kwateng et al., 2014). 
A functional transport system is a significant part of an effective supply chain strategy. Hitherto 
regarded as peripheral, transportation has become very critical to strategic management, and is 
nowadays, a source of competitive advantage to organizations who manage it efficiently and 
effectively (Mubarik et al., 2012). 
A major problem for healthcare systems developing countries like Nigeria is in the delivery of 
medicines to locations in rural areas separated from the points of origin, mostly in the urban areas 
by vast geographies and maintaining the potency of the medicines along the chain. Harsh 
environmental and weather conditions of high temperatures and humidity can negatively affect the 
potency of medicines if the resources for maintaining controlled temperature and humidity are 
limited.  
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3.3.2: Warehousing (Storage) 
From the beginning, warehousing was seen as an integral part of physical distribution or business 
logistics (Ackerman, 1990). Like transportation, warehousing plays a vital role in pharmaceutical 
supply chain.  Serving as significant storage activity, warehousing ensures a consistent supply of 
medicines along the chain especially at the point of need. Modern challenges facing the 
warehousing of pharmaceutical products include: variety of store-keeping units (SKUs), 
increasing demands by customers (patients) and information management.  These and other 
challenges can be effectively addressed with the right mix of personnel training, warehouse 
information and performance management systems (USAID/Deliver, 2014). 
 
3.3.3: Distribution 
The final logistical transport activity in the pharmaceutical supply chain is distribution.  This 
activity, sometimes called “last mile distribution” ensure that all efforts across the entire supply 
chains are not wasted. In the pharmaceutical industry, efficient and effective drug distribution 
contributes to the overall success of the healthcare delivery systems. Many organizations and 
persons are involved in this critical activity of the value chain at various stages and scope. Some 
may be restricted to single segment while others may be involved in multiple segments of the 
distribution processes (Oyamo & Mburu, 2014). The distribution system is also the critical link 
between the points of prescription of the medicine, to the consumption by the final user, the patient. 
It also includes other processes that ensure that the right quality and quantity of medicine 
prescribed is administered to the patient. Preventing dispensing error of a prescription, which can 
be very deleterious is a very important feature of high quality healthcare system. (Jahantigha & 
Malmirb, 2015). 
Based on the set-up of a drug distribution system, many channel players act as a critical link 
between drug manufacturers (especially the overseas-based) and retailers. Some of these players 
include importers, distributors and wholesalers.  The number and layers of these players active in 
each market/country differ and will in most cases, depend of the complexity of the markets, the 
geographies of the country and to some extent, the nature of the medicines being distributed. Like 
in other supply chain activities, drug distribution is also subject to strict regulatory procedures to 
ensure that the appropriate and applicable standards are maintained (Aitken, 2016). 
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Indeed the importance of an optimal distribution model as a means of making and improving 
corporate profitability has never been greater than in this era of inflation, rapid technological 
change, globalization, competitive market and recession. These have combined to produce an 
environment in which the options for corporate strategy are much constrained. Yet at the same 
time, for many organizations, these same conditions have provided a major opportunity for growth 
and improvement in performance through revised approach to the distribution strategy (Sumaila, 
2014).  
 
3.3.4: Cold Chain 
Some categories of medicines are very thermolabile (highly temperature-sensitive) and can be 
destroyed if not properly stored and/or handled. Vaccines and some medications like insulin and 
other biological products fall into this category. For these pharmaceutical products, the supply 
chain is termed “cold chain”, with products stored at temperatures as low as +2˚C to +8˚C. Cold 
chains are very critical in ensuring proper storage, transport and handling for these drugs to 
maintain their potency at the point of administration to the patient (Chiodini, 2014; Sharma & Pai, 
2015). The cold chain is a critical component for the various immunization programmes in 
developing countries with high temperatures (Yakum et al., 2015). 
Given the state of infrastructure especially roads, transport and power, the management of 
pharmaceutical cold chain has always been a critical problem in Nigeria and other developing 
countries. This problem is heightened by the limited resources at the disposal of these countries. 
The cold chains for vaccines and other related, thermolabile products in such countries are often 
sub-optimal, with inadequate storage and transport facilities (Chen et al., 2015).  Making vaccines 
readily available at the final delivery point is critical measure of successful healthcare supply 
chains. For a country of Nigeria’s size, the challenges posed by the geography of the country, 
funding, information management, etc, make this goal a daunting one (Sarley et al., 2017) 
 
3.4: The Nigerian Pharmaceutical Supply Chains  
In Nigeria, PSC structure is both centralized and decentralized (Attaran et al., 2012; Iwokwagh, 
2013).    While most drugs can be procured and stored by the various healthcare institutions,   
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supply chains for drugs   for some diseases like HIV,   malaria   and tuberculosis are centralized. 
For this category of drugs, the storage and distribution points is Federal Central Medical Store 
(CMS). (Erhun & Babalola, 2004).  All the States in the country maintain their respective 
pharmaceutical supply chains, which are similarly managed from their own Central Medical Stores 
(Onwujekwe et al., 2009).    
 
The Nigerian Private Sector pharmaceutical distribution is mostly managed through a network of 
channel players such as distributors and wholesalers. Widely-known, although unacceptable, is the 
fact that many other unlicensed wholesalers and players are very prominent at this level of the 
national private sector pharmaceutical supply chain (Aisagbonhi & Ilomuanya, 2016; Sieverding 
& Beyeler, 2016).   
Much of the documentation on the Nigerian health sector SCM has been carried out by Non-
Governments Organizations (NGOs) and donor agencies like USAID and TRANSAID. 
Furthermore, these reports have focused mainly on the public sector. This study will offer a unique 
opportunity for a simultaneous research into both sectors (public and private) and specifically, the 
practice of outsourcing in the outbound segment of the supply chains. 
 
3.5: Challenges of Pharmaceutical Supply Chains in Nigeria and Sub-Saharan 
Africa  
Over the years, the PSC in Nigeria and SSA have faced several obstacles with negative impacts 
on the performance of the chains.  These challenges include but not limited to: 
 
3.5.1: Stock-outs and product shortages 
Stock-outs and product shortages in the pharmaceutical sectors have become a worldwide 
phenomenon and not restricted to countries of low- income levels in recent years. This trend can 
be a consequence of several causes, including, but not limited to procurement and supply chain 
management-related issues (Iyengar, et al., 2016). In Senegal, stock-outs of anti-malaria 
medications have been reported in over half of the sites used for a new community study in the 
district of Saraya, South East Senegal (Blanas et al., 2016). In the result from a study by 
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Mikkelson-Lopez et al. (2015) a significant number of health facilities in Tanzania were totally 
out of stock of first line anti-malarial drugs.  The stock-outs were reported to have been caused by 
insufficient and irregular supplies amongst others. In a study to assess Primary Health Centre 
(PHC) facilities’ service readiness with focus on availability of essential drugs and medical 
equipment covering 2480 healthcare facilities from all the 6 geopolitical zones of Nigeria, Oyekale 
(2017) reported availability of some basic drugs as low as between 10.48 and 25.2%. Nigeria also 
recorded low availability of malaria test kits in its health facilities in a study in 8 sub-Saharan 
African countries (Poyer et al., 2016).  
 
In Nigeria, stock-outs of basic medicines in rural healthcare facilities have been reported 
(Sieverding and Beyeler, 2016). In Ghana, periodic shortages of anti-malarials in the supply chain 
system of the nation’s ministry of health has been attributed to why some public hospitals procure 
medicines from the open market (Agyare et al., 2017). Similarly, in South Africa, stock-outs of 
drugs have been reported not only in the critical Human Immuno-Virus (HIV) and Tuberculosis 
(TB) supply chains, but also in the supply chains for other diseases (Odendal, 2013). Shortages of 
basic drugs are becoming a global challenge with attendant impact on healthcare quality and costs. 
(WHO, 2015). In the health sectors of sub-Saharan Africa including the more developed countries 
like South Africa, there is a shortage of not only drugs, but also on information about the trend, 
which can be accessed by the public (Gray, 2014). 
 
3.5.2: Fake and counterfeit products 
Similar to the issue of the shortage of medicines, availability of good quality medicines has become 
a global problem (Kohler et al., 2012). The issue of fake and counterfeit drugs has become a global 
challenge and is now endemic in the various drug supply chains (Mackey et al., 2013). Falsified 
antiretroviral medicines have been found in Kenya (Cohn et al., 2013). Statistically, between 13 
to 35% of worldwide sales of fake and counterfeit drugs come mainly from India, Nigeria and 
Pakistan (Khan et al., 2015).  
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3.5.3: Disruptions 
Supply chains are exposed to disruptions consequential from various sources, factors and risks that 
hinder the performance of one or more of their constituent entities (Sayed et al., 2016). Some of 
these risks are disruptions that physically prevent product flows and even in end-product failures 
across the supply chains (Zegordi et al., 2012). PSC management in disrupted regions where there 
are severe sectarian, tribal, religious conflicts and overall weak systemic governance can be very 
challenging (Kohler et al., 2012). The security challenge of the Boko Haram Islamic terrorists’ 
group in Nigeria has had massive negative impact on the regional pharmaceutical supply chains 
and healthcare delivery systems as destruction of facilities, and sometimes, killing of personnel, 
are typical outcomes (Hamisu et al., 2016). 
 
3.5.4: Expired Drugs 
Medicines are unlike some products, which have no expiry dates.  Medicines expire and lose 
potency.  Accordingly, any incidence of expiration of medicine poses a critical problem across the 
pharmaceutical supply chain (Sauls, 2016). In Uganda, expired drugs have been found at all levels 
of the health facilities especially the rural areas of the public sector chains (Jahre et al., 2012). The 
chaotic drug distribution system in Nigeria allows for easy occurrence of expired drugs in the 
pharmaceutical supply chains (Olatunji, 2013). Some unscrupulous drug traders have been 
reportedly found re-packaging foreign expired drugs for re-sale in Nigeria (Oluwatuyi et al., 2014). 
 
3.5.5: Corruption 
Corruption has been likened to an infectious illness. Corruption in any aspect of the global 
healthcare system is deleterious and a big threat to all aspects of human health, economic 
developments and international safety (Mackey et al., 2016). The efficiency of healthcare delivery 
in any country involves judicious management of both human, financial and other resources in 
serving the sick population (Tormusa et al., 2016). Corruption is a big threat to all aspects of 
national development.  
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At a rank of 144 out of 180 countries by 2018; Nigeria is classified as one of the most corrupt 
nations in the world (Transparency International, 2019). According to Transparency International, 
“corruption is everywhere: even the health and medical services, considered the least corrupt 
government institution, are considered very corrupt by 41 per cent of Nigerians” (Transparency 
International, 2015:1). Only recently, the Global Fund for the control of HIV/AIDs in Nigeria 
found widespread of corruption involving program funds running into millions of US Dollars 
(Global Fund, 2016).  
 
3.5.6: Infrastructure 
Despite the various laudable economic developmental strides and growth that have been recorded 
by many sub-Saharan African countries, persistent infrastructure deficits still pose a number of 
challenges (Arewa, 2016). Poor infrastructure has been identified as one of the significant 
structural barriers in the health systems of sub-Saharan African countries (Fowkes et al., 2016). In 
comparison with other economies like the middle- and high-income countries, sub-Saharan Africa 
has poor road networks, with approximately 200 metres of roads per km2 paved compared to 1400 
metres in developed economies (Schürenberg-Frosch, 2014).  
In some SSA countries like Nigeria, one of the problems that continue to plague the productive 
sector and businesses generally is, the continuing acute electricity supply deficits (Ettah, 2017).  
This is particularly worrisome in the supply chains of pharmaceuticals where steady, uninterrupted 
electricity is required for the storage and potency of thermolabile products like vaccines and 
antibiotics.  The absence of a stable source of power also negatively affects certain aspects of the 
pharmaceutical supply chains especially the cold chains (Yakum et al., 2015).  The Nigerian public 
health system faces several challenges in delivering services (Abimbola et al., 2014; Abimbola et 
al., 2015) with poor infrastructure in a number of public facilities (World Bank, 2010; Abimbola 
et al., 2015). 
3.5.7: Weak regulatory systems 
Weak regulatory systems in many SSA impact negatively on the pharmaceutical supply chains. 
Many regulatory bodies and agencies in these countries lack adequate resources for effective 
control of medicines in their respective markets (Preston et al., 2012). This is not only a challenge 
in itself, it also gives rise to a critical problem of poor quality medicines in the pharmaceutical 
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supply chains (Giralt et al., 2017). As high as 90% of national drug regulatory bodies in SSA are 
unable to effectively discharge their basic regulatory functions (Giralt et al., 2017).  
In summary, drug distribution system of Nigeria still suffers a lot of setbacks ranging from un-
coordination (Chukwu, 2012), weak distribution and transportation, amongst others (Jatau et al., 
2015).  
 
3.6: The Concept of Outsourcing 
Denicolai et al. (2015:4) define outsourcing as “the procurement by a focal firm of goods and/or 
services from independent outside suppliers, when those goods and/or services had previously 
been provided internally within the firm”.  Globally, organizations have been increasingly been 
embracing outsourcing – the externalisation of work activities traditionally performed in-house; to 
enhance their competitiveness and improve business operations and performance. This trend is not 
surprising, given the purported benefits of outsourcing that have been touted in both academic and 
professional circles over the years (Adeleye, 2011). The major factor that has led to increased 
outsourcing is focus on core competencies by organizations, while freeing up other valuable 
resources and capabilities (Musau, 2016; Cheng et al., 2014). The practice of outsourcing has been 
adopted by the Nigeria public sector for over a decade now.  The gains from the adoption have 
however not been confirmed as realised, vis-à-vis, the intentions and reason for the outsourcing 
strategy in the first instance (Acti & Ekezie, 2014).  Outsourcing as a concept has evolved over 
time in the same way as supply chain management (O’Riordan & Sweeney, 2007). With more 
advanced technologies and infrastructure, the developed countries have embraced the practice, 
especially in the private sectors while the developing countries have seen an increasing rate of 
adoption of the practice even by the public sectors where traditionally, many services are still being 
provided by the government (USAID/DELIVER PROJECT, 2010).  With increased globalization 
and economic developments across borders, many organizations have adopted the concept of 
outsourcing in their supply chains.  In public health systems and supply chain management, several 
potential functional areas can be outsourced. Many developing countries such as Cambodia, 
Madagascar and Senegal have outsourced certain aspects of their public healthcare systems. 
(Loevinsohn, 2008).   
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3.6:1: Outsourcing in Pharmaceutical Supply Chains in Nigeria and SSA. 
Outsourcing practice is becoming increasingly widespread throughout SSA and the low and 
medium income countries (LMICs) for various supply chains activities, which were hitherto 
undertaken by the government agencies and institutions. Nigeria is one of the countries where this 
practice has been adopted, studied and documented (Watson & McCord, 2013; Bornbusch et al., 
2014). Despite this positive trend, there is a high degree of reluctance by the public sector to 
outsource its supply chain activities, with factors of higher costs, loss of control, other motives, 
lack of expertise cited as possible reasons for this reluctance (UNCoLSC, 2014).  
 
There has been a growth of the outsourcing in the public sectors of various African countries in 
the last decade. Private logistics services providers have been engaged, with improved 
performance in countries like Senegal, South Africa, Nigeria, etc (Gavi & Transaid, 2015; Lydon 
et al., 2015). In the private sector, outsourcing has been beneficial to the pharmaceutical 
companies, with significant improvements in their supply chains (Mubarik et al., 2012).  
 
The scope and role of outsourcing in pharmaceutical supply chains have been the subject of some 
studies. Although many aspects of the pharmaceutical supply chains can be outsourced, the 
services that are mostly outsourced are the outbound logistics services of storage and distribution 
services (Lydon et al., 2015; Aman & Khan; 2015). In South Africa, the outsourcing of storage 
and transport of vaccines by the government improved efficiency and speed of delivery (Lydon et 
al., 2015). It has been reported that outsourcing distribution is an obvious example where 
substantial efficiency gains could be made in pharmaceutical supply chains, especially in 
developing and resource-weak countries, where the last mile distribution is weak (VillageReach, 
2012).  As a way of overcoming their supply chain challenges, outsourcing is increasingly 
becoming a common strategy throughout developing countries. (Bornbusch et al., 2104). 
In December 2014, the Nigerian government, through the Federal Ministry of Health (FMOH), 
launched the Nigerian National Drug Distribution Guidelines, which provides a 2-channel 
approach to drug distribution with the establishment State Drug Distribution Centers (SDDCs) and 
Mega Drug Distribution Centers (MDDCs) by the private sector (FMOH, 2014). This new policy 
set the stage for a national strategy towards the streamlining of drug distribution in the country and 
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an incentive and promotion of the practice of outsourcing in the private sector on one hand, and 
Public-Private Partnerships (PPP) in the management of the SDDCs on the other hand. 
 
3.6:2: Existing Frameworks for Outsourcing Process, Capability & 
Relationships 
Alongside the studies into the various aspects of outsourcing since its evolution in the last three 
decade, there have been studies into the development of frameworks for the practice of 
outsourcing.  While many frameworks have been theoretical, others have been empirical and 
evidence-based. Furthermore, some have been generic while others have been specific to certain 
functions, industries and sectors.  Some of the developed frameworks are considered in the next 
section. 
3.6.2:1: Bolumole et al., Framework 
Bolumole et al. (2007) developed a framework for logistics outsourcing using some social science 
theories. 
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Factors Influencing Logistics 
Outsourcing Decisions 
The Supply Chain Role of 3rd Party 
Logistics Providers 
Transaction-costs Contractual 
Resource-based Coordination 
Control-issues Logistics Integration 
1. Reasons for Outsourcing 
Cost reduction, Resource Acquisition, Value Creation 
2. Strategic Orientation of Client Firm: 
Internal, External       
3. Extent of Logistics Outsourcing (In-house vs. Outsourced resources) 
Operational, Tactical, Strategic     
4. Nature of the Client - 3PL Relationship: 
Arms-length, Contractual, Relational, Partnership 
Figure 3. 3: A framework for evaluating logistics outsourcing strategies (Bolumole et al., 2007) 
 
In their framework (figure 3.3), their draw from the multiple theories such as TCE, RBV and the 
network theory (NT). From these theories, which underpin the framework, various factors which 
influence logistics outsourcing were identified. In line with TCA, TCE and RBV perspectives, 
these factors are categorised as external or internal, resource or transaction cost-based. 
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They further posit that at the heart of the decision by organization to outsource are two underlying 
principles. The first, which is the internal principle is the acknowledgement that it lack the 
domestic competencies to achieve a competitive advantage and therefore must seek for external 
resource with which the internal resources/competencies can be combined to achieve the 
maximum value in the marketplace. Furthermore, this framework posits that the availability of 
resources is not enough to attain competitive advantage, but the optimal exploitation and 
deployment of these resources as critical components in the organization’s decision-making 
processes. Conversely, the external principle takes cognisance of the organization’s external 
competitive environment and the need to deliver products and services at an optimal minimal costs 
through access to external resources (Bolumole et al., 2007).  
3.6.2.2: Vitasek & Manrodt’s Framework 
The Vitasek & Manrodt’s (2012) framework is called “vested outsourcing”. As the name suggests, 
the framework is founded on the principle of collaboration between the contracting parties – the 
outsourcer and the service provider (3PL).  The core principle governing the framework is 
establishing a win-win collaboration with mutual or “vested” commitment to achieving the pre-set 
goals of the engagement. It is a deviation from the traditional transactional outsourcing relationship 
contracted at arm’s length. It is a dynamic model designed to be a successful, long-lasting 
relationship based on shared values and outcomes (Figure 3.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. 4: The Vested Relationship Framework (Vitasek & Manrodt, 2012)  
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They then went ahead to outline five rules and ten elements for achieving a vested relationship 
centered on governance, pricing, operating principles and defined and measurable outcomes. The 
elements give details to the rules and include such critical components as shared vision, business 
objectives, performance, relationship and exit management. They opine that with this framework, 
organizations can move from transactional/adversarial to a truly collaborative relationship in 
practice (Vitasek & Manrodt, 2012), 
3.6.2.3: Qureshi et al.’s Framework  
In this framework, Qureshi et al. (2013) developed a model for use in developing countries for 
outsourcing decisions. It is best suited for use in a manufacturing organization and is based on a 
series of steps in which the decision to outsourced is appraised. The steps in logical sequence are 
decision matrix, core competency check, balance scorecard and cost equations models. The entire 
framework is depicted in flowchart in Figure 3.6. 
 
In this model: 
A) In this first step, the core competency check seeks to consider if the organization has core 
competency for the activity. Furthermore, it checks if the decision to outsource is marginal 
or negative.  This step is further explored by series of questions used to determine if the 
activity is specialised, critical, strategic, and easily-sourced, etc.  Depending on the 
outcome of this step, the next step of decision matrix is undertaken.  
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Figure 3. 5: Qureshi et al’s Framework/Flowchart for Strategic Outsourcing 
 
A. Decision Matrix: If the check produces a marginal or negative outcome, the decision 
matrix is applied. This is a graphical chart (Figure 3.6) that uses the impact of two main 
factors to make a reliable and easy outsourcing decision.   
 
 
 
 
 
 
 
 
Figure 3. 6: Qureshi et al’s Decision Matrix for Outsourcing 
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The two factors in the decision matrix are “strategic value” (y – axis) and “critical to final product” 
(x – axis).  In essence, these factors check if the activity under consideration is of strategic value 
and or critical to the final product.  As shown in the figure, the intersection/interaction of these 
two factors give rise to 6 regions, which are decision zones for the organization.  
Region 1: The activities in this region are those of high strategic value to the organization but not 
critical to the final product. For these activities/services, keeping them in-house will not be ideal, 
hence outsourcing will be the best decision taken under careful consideration using the balance 
scorecard approach since a successful outsourcing decision can have an impact on the 
competitiveness of the organization. 
Region 3: In this region, the activities are of high strategic value to the organization and are also 
highly critical to the final product. Because of this, the decision outcome is not to outsource but to 
adopt an in-house sourcing approach. 
Region 4: This region has the activities or components which are neither of any strategic value nor 
critical to the final product of the organization. The approach is either to totally eliminate it or 
minimise the focus on it to avoid waste of organizational resources and energy. 
Region 6: The activities and or components in this region are of low strategic value to the 
organization but are very critical to the final product. As in region 1, a careful outsourcing decision 
using the balance scorecard approach is proposed by Qureshi et al.  
Region 2 and Region 5: Finally, in the Qureshi et al model, the two regions 2 and 5 have activities 
and or components that average contribution to the final product.  They however differ in being 
either of high strategic value (region 2) or low strategic value (region 5) to the organization. The 
final decision to outsource or not is taken after cost evaluation and further investigation using the 
cost equation models (Qureshi et al., 2013) 
3.6.2.4: Pratap’s Framework 
Developed by Sankalp Pratap (2014), this framework seeks to go beyond the traditional debate in 
outsourcing – the outsourcing decision and “What to outsource”. The main emphasis of this 
framework is the evaluation of “outsourcing capability” as a tool for optimal management of 
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outsourcing relationships. It proposes that failures from outsourcing relationships can be prevented 
if organizations do not see outsourcing as a one-off transactional engagement but as a strategic 
continuous one requiring management. 
This framework classifies the firm’s internal processes into four different classes requiring 
different skill sets for their management. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. 7: The Pratap’s FARM’s framework for outsourcing capability 
 
This framework is based on an analogy with a typical farmland where the farmer deals with varied 
conditions using various skills and techniques to optimise farmland output. Similarly, 
organizations have to use varied strategies for different classes of outsourced processes. The 
analogy FARM is the outsourcing matrix and is derived from the various capabilities of Flexibility 
(F), Absorptive Capacity (A), Relationships (R) and Monitoring (M).  
Quadrant 1: This quadrant (see Figure 3.8) also called the “uncertain drizzle” quadrant contains 
the processes and activities that are not deeply entrenched and connected with other processes in 
the organization.  Furthermore, the differential capability of suppliers of the services do not 
improve at a rate faster than that of the focal organization.  Conversely, the approach is to expend 
minimal energy on the arrangement with systems and incentives schemes put in place to monitor 
the suppliers to ensure a commitment to continuous performance improvement. On account of the 
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moderate benefits accrued, the organization keeps only short-duration contracts to allow room for 
other suppliers with better capabilities to be signed on in the future.  Finally, in this quadrant, 
flexibility and effective monitoring systems are critical skills the organization requires to ensure 
an effective information feedback system (Pratap, 2014) 
 
Quadrant 2: This quadrant is called “bright sunshine” and contains marginal activities and 
processes where the differential capability of suppliers of the services improve at a rate faster than 
that of the focal organization with processes and activities that are not deeply entrenched and 
related to other internal processes. Because of the autonomous nature of the processes in this 
quadrant, the possibility of the organization exploring/entering into contracts with several 
suppliers exists.  This is possible because of the relatively low switching costs involved. Critical 
skill required by the organization to be able to effectively identify new development/knowledge is 
its “absorptive capacity” – referring to its internal base of knowledge. 
Quadrant 3: This quadrant also referred to as “thunderstorms” contains processes and activities, 
which are both deeply entrenched and connected with other processes in the organization and have 
suppliers whose differential capabilities improve at a rate faster than that of the focal organization. 
Because of these deep connections and capability of the supplier, the competiveness of the 
organization could be impacted in various ways, hence effective collaboration with the supplier, 
involving close relationship management at both the shop-floor and top management levels. This 
arrangement is more than a short-term transaction and spans for a longer term with deeper 
commitment and collaboration from both contracting parties - similar in format to the vested 
outsourcing relationship propounded by Vitasek & Manrodt (2012). In some cases, there are 
exchange programmes involving the employees of both organizations. Suppliers’ selection in this 
arrangement is a more careful process which considers such long term, mutually-strategic issues 
as vision and values (Pratap, 2014). 
Quadrant 4: Also referred to as “monsoons”, this quadrant contains the processes and activities 
which are both deeply entrenched and connected with other processes in the organization but with 
suppliers whose differential capabilities and innovative capacities are not different from that of the 
focal organization. The approach here is to outsource such processes so as to reduce the 
administrative burden on the outsourcing, focal organization. In some instances, the process is 
45 
 
spun off as a separate business unit to achieve optimum solution to its management. Under this 
arrangement, the focal organization still maintains a close watch over the process/business unit for 
development and performance while its employees are encouraged to excel in their new roles of 
management the process as a core activity. Close monitoring and relationship management are 
critical for the success for this arrangement (Pratap, 2014). 
 
3.6.2.5: The MIT - Zaragoza’s Framework 
In conjunction with Transaid & VillageReach, the MIT-International Zaragoza Logistics Centre 
developed perhaps the most extensive framework for the outsourcing of Public distribution 
services and thereafter, applied the framework in Kano State, Northern Nigeria. 
In the framework, in emphasizing the latent benefits that third party service providers can give, 
they first highlighted the key factors that underpin supply chain performance.  These key factors 
include the structure, management approach and the individual capabilities of the SC 
actors/decision makers. The competence of both parties in the public distribution system and 
potential 3PLs are necessary for supply chain performance, and hence given considerable attention 
in this framework (Figure 3.8).  
 
 
 
 
 
 
 
 
 
Figure 3. 8: The MIT-Zaragoza’s Framework for Outsourcing Public Sector Pharmaceutical Distribution (MIT-
Zaragoza Logistics Centre, 2011        
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According to this framework, the best approach in the successful determination of the suitable 
outsourcing decision with the involvement of 3PL providers or not, should be a series of step-by-
step analyses instead of a system of complex mapping. These steps include amongst others, the 
generation and validation of various potential solutions. This approach is needed because of the 
implications of the probable changes in the supply chain especially those orchestrated by the use 
3PL providers. Technical, resources and politics may be the constraints of these implications. 
 
In this framework, they first classified the opportunities for improvement in supply chain using 
the key drivers of supply chain performance they earlier identified. Next, they considered 
constraints earlier outlined, and thereafter, they then examined the consequences of the use of 3PLs 
and the performance simulation model. Finally, they described the step-by-step process of the 
analyses required to determine the most appropriate outsourcing decisions. 
 
3.6.3: Value Chain-based studies and frameworks 
Since the development of the value chain model by Michael Porter (1985), several studies have 
been carried out utilizing the model. While researchers adapted the components of the model for 
further studies, others based their studies and or framework on some aspects/components of the 
model. 
Horne (2014), adapted the model to develop a framework based on value and performance for use 
in the identification and prioritization of process improvement projects, while Prajogo et al. (2016) 
adapted it to develop a research model that explores the interconnectivity between supply chains 
integration and operational performance based on the RBV theory. McPhee (2014), made a 
modification of the model, renamed some of the primary and secondary activities and a model 
which helps to incorporate sustainability in business strategies for competitive advantage.  On their 
part, Koc and Bozdag (2017) used the model to study the association between innovation and 
operations.  
One of the earliest and most comprehensive frameworks in the field of outsourcing using the 
Porter’s value chain approach is that of McIvor (2000). This framework helps in the assessment 
the decision to outsource, utilizing a four-step approach in analysing organization’s costs and 
integrating other constituents of the value chain into the framework process. 
47 
 
 
3.7: Gaps in Existing Literature and Frameworks 
Apart from the reports of foreign donor agencies (USAID, MIT-Zaragoza, Transaid, VillageReach, 
etc.), there is little or no academic literature on the framework and scope of outsourcing in the 
pharmaceutical supply chains in Nigeria. One of the most recent researches in outsourcing in the 
Nigerian healthcare sector only investigated the effect of outsourcing peripheral services on 
delivery of healthcare (Arisi-Nwugballa, 2016).   
In Mozambique, Beale et al., (2015) reviewed transport practices within the Ministry of Health 
(MISAU) and highlighted existing trends in commercial transport with a view to presenting 
considerations in which the two sectors could collaborate to achieve improved reliability and 
increased efficiency of the distribution of medical commodities. The authors found that MISAU 
recognized the mounting challenges it would face in continuing to support the current model and 
are now pursuing a path of decentralization and private sector engagement. In Kenya, Muthoni 
(2016) investigated outsourcing of supply chain processes and performance of manufacturing 
firms including 6 pharmaceutical firms. He concluded that primary supply chain processes 
outsourcing improves performance for manufacturing firms. Similar studies on SC and 
outsourcing have been conducted in other African economies including major economies like 
South Africa and Kenya. Some of these studies include logistics outsourcing in the private sector 
(Kujawa, 2003; Githinji, 2010; Waugh & Luke, 2011; Mulama, 2012; Mugo, 2013; Ngonela et al., 
2014; Gakure et al., 2014; Mwelu et al., 2014). Conversely, in Nigeria, available data have come 
mostly from the few scholarly researchers in the field of outsourcing on one hand (Okolie, 1998; 
Akewushola & Elegbede, 2013; Okeudo & Uche, 2013; Kolawole & Agha, 2015) and logistics 
management by private sector on the other hand (Ojadi, 2001; Aniki et al., 2014; Somuyiwa & 
Adebayo, 2014; Sumaila, 2014).  None focused on pharma logistics and SC outsourcing. 
In developing outsourcing frameworks, process, capabilities and relationships, all the frameworks 
considered in the literature here focused on one aspect of the industry – either the public or the 
private sector.  Neither considered both sectors simultaneously as will be considered in this study 
nor employed a panel of experts from the respective sectors as will be done with the Delphi 
approach of this study. The added value of this study is in its consideration of both private and 
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public sectors in this same study, whilst also developing a framework that can be used in either 
sectors, to outsource the outbound value chains. 
3.8: Conclusion 
The goal of any organization is value creation for its customers. Given the present and emerging 
socio-economic environment, organizations should constantly seek ways of improving their 
operations and delivering value to their customers. Efficient and effective SCM strategies are not 
only valuable to the overall organizational competitiveness, they have been become very critical 
to achieving the value creation goals of the organizations.  This may be achieved by various 
management options including outbound value chain outsourcing.  
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CHAPTER 4 
 
RESEARCH METHODOLOGY 
 
4.1: Introduction  
As spelt out earlier, this study aims to study the extent of outsourcing of outbound value chain 
activities in the Nigerian pharmaceutical industry; the rationale, critical risk factors, 3PL selection 
criteria and the desired outcomes of outsourcing outbound pharmaceutical supply chains Nigeria. 
This chapter contains details of the research methodology employed to achieve these objectives.  
It contains, among others, the research design, the basis and justification of the mixed methods 
(qualitative and quantitative) used, the sample selection, administration and analysis of the 
research instruments. 
 
4.2: Quantitative versus qualitative research methodology 
The successful management of supply chains entails synchronizing several activities across the 
spectrum of the chain. Over the years, there has been an increasing consciousness that issues 
related to and associated with SCM are becoming complicated and complex and accordingly, 
require more diversity in the approaches to studying these paradigms. In this way, more reliable 
outcomes are ensured (Craighead et al., 2007; Golicic & Davies, 2012).  According to Stewart 
(2007:2), multiplicity in research methods “is a healthy characteristic and suggests an intellectual 
vitality in a discipline”.  In this and other recent studies, more than one research method have been 
used. 
 
Customarily, earlier researchers in supply chain management depended greatly on procedures 
involving quantitative methods (Boyer and Swink, 2008). On the other hand, Qualitative methods 
have been predominant of recent and in particular among European researchers (Craighead et al., 
2007). Use of mixed methods in the same study has been less common until recently (Golicic & 
Davies, 2012). A mixed method consisting of a Delphi technique (qualitative) involving pre-
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qualified and selected industry experts and a quantitative study (a survey) involving respondents 
from the industry was adopted for this study.  
 
4.2.1:  Quantitative methodology 
Quantitative research is as “a research strategy that emphasizes quantification in the collection and 
analysis of data and that: entails a deductive approach to the relationship between theory and 
research, in which the emphasis is on the testing of theories; has incorporated the practices and 
norms of the natural scientific model and of positivism in particular, and takes a view of the social 
realty as an external, objective reality” (Bryman & Bell, 2015:37).  It has been stated that  “a 
researcher using quantitative methodology has to follow a number of steps in conducting their 
research which usually include, generating the research problem, coming up with expectations 
based on reality, generating hypothesis, defining variables, sampling, data collection, analysis of 
data, report of findings and relating findings to the theory” (Kent 1999:11).  The predominant use 
of only quantitative methodology in studies weakens the versatility of the frame of supply chain 
investigations in several ways. First, depending on a single method restricts investigation to only 
the research enquiries that can investigated by the method alone. It is agreed that a multiple 
approach is vital in study a field as multidimensional as SCM (Golocic & Davies, 2012) Second, 
using only one method can incorporate some biases (Spens and Kovacs, 2006).  
In this study, the two methods employed complemented each other, making up for the inherent 
gaps and deficiency in using either method alone, especially against the background of the 
relatively limited respondents (100) used for the study. 
 
4.2.2: Qualitative methodology 
Qualitative research is “a research strategy that usually emphasizes words rather than 
quantification in the collection and analysis of data and that: predominantly emphasizes an 
inductive approach to the relationship between theory and research, in which the emphasis is 
placed on the generation of theories; has rejected the practices and norms of natural scientific 
model and of positivism in particular in reference for an emphasis on the ways in which individuals 
interpret their social world; and takes a view of the social reality as a constantly shifting emergent 
property of individuals’ creation” (Bryman & Bell, 2015:38). 
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It is the preferred method in researches involving humans and their environment, enabling the 
researcher understand the perspectives of the subject (Bryman, 2001). Despite the seeming 
advantages and impact of qualitative methodology in research procedures, it has some drawbacks 
which include deficiency in efficacy and precision (Sarantakos, 2005), occurrence of subjectivity 
in observation, interpretation and the difficulty in generalizing the outcomes of the research easily 
as the smaller number of sample sizes used in comparison with quantitative studies makes the 
outcomes likely to be controlled. Accordingly, it is difficult to reproduce and (Bryman, 2001). The 
dilemma therefore becomes how the number of cases can be considered as representing bulk of 
the population being considered. However, supporters of qualitative research posit that 
generalizing the outcomes of qualitative research are acceptable considering the fact that they are 
based and supported by solid fundamental theoretical reasoning (Mitchel, 1983). 
 
4.2.3: Mixed method – combined quantitative & qualitative methodology 
Mixed methods research design makes up for the inadequacy of either Quantitative or Qualitative 
method by encouraging the application of both approaches within a single study to create several 
viewpoints (Golicic & Davies, 2012). Mixed methods research involves “the collection or analysis 
of both quantitative and qualitative data in a single study in which the data are collected 
concurrently or sequentially, are given priority, and involve the integration of data” (Creswell et 
al., 2003:29),  In this study, data collection was done sequentially. Qualitative method used was 
the Delphi Technique (more details later on in this chapter), utilizing experts in the Pharmaceutical 
industry of Lagos, Nigeria. Considering, the focus of the research, it was desirable to get the 
consensual opinions of the industry experts as they constitute the body of knowledge, policy 
makers and strategic decision makers of the sector. Decisions on the supply chain and outsourcing 
in any organization is a strategic one which derives from the overall corporate strategy of the 
organization. Strong linkages exist between supply chain initiatives and the organizational 
strategic goals (Okongwu et al., 2014).  The Quantitative method used was closed questionnaires 
to a wider target respondents drawn from the various categories of pharmaceutical organizations 
of the industry. The respondents to the quantitative questionnaires were the functional role players 
with knowledge and direct/indirect involvement in the supply chain and outsourcing practices of 
their respective organizations.  
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Stage 3 Stage 2 Stage 1 
    Need for study 
Literature review 
Research Questions 
Objectives 
Delphi 
Questionnaire 
Analyse data and evaluate 
factors associated with 
Pharma outsourcing  
Develop framework for 
Pharma outsourcing in 
Nigeria 
Conclusion & 
recommendations 
4.3: Research design and procedure 
The design of the procedure and detailed structure adopted to guide and conduct the research are 
explained in this section. Two types of mixed method designs and procedures have been developed 
and used, with each differing according to the timing of data collection. These include  concurrent 
mixed method, where there is a simultaneous or concurrent form of data collection and the 
sequential mixed method where the data collection is done in sequence with one form (e.g., 
qualitative data) following the other (e.g., quantitative data) (Creswell and Plano Clark, 2007).  
 
                                          
 
 
 
 
 
 
 
         
 
 
 
 
 
 
Figure 4. 1: Research Design Outline (Manu, et al., 2010; Musonda, 2012) 
 
Creswell et al. (2003) further categorize both sequential and concurrent mixed methods into three 
types, giving a total of six (6) types of mixed method designs that can be employed in mixed 
method research, according to the design and focus of the study. The six (6) types are: (a) 
Sequential Explanatory (b) Sequential Exploratory (c) Sequential Transformative (d) Concurrent 
Triangulation (e) Concurrent Embedded and (f) Concurrent Transformative Design. Sequential 
Exploratory Design was adopted with the quantitative method following the Delphi (qualitative) 
method in this study.  
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4.3.1: The Delphi method 
The Delphi technique is an extensive and established method for collecting data from participants 
in a field of expertise. It is “designed as a group communication process which aims to achieve a 
convergence of opinion on a specific real-world issue” (Ab Latif et al., 2017:91). Since its 
introduction in 1950s, many researchers have adopted many variations of this method (Okoli & 
Pawlowski, 2004).  It is used to elicit unanimity among experts on a particular subject in focus 
(Miller, 1993). Even though it is majorly considered as qualitative, the Delphi method is also able 
to yield quantitative results, with some degree of explorative and predictive elements (Cuhls, 
2003). It is generally accepted that Delphi is a comparatively controlled process where hitherto 
unknown facts are unraveled by experts (Häder & Häder, 1995).  
 
In its basic form, the procedure requires the experts to contribute their opinions and answers to 
structured questions put forward by the researcher who centrally coordinates the process. The 
coordinator analyses each round of responses to check for common and extreme tendencies 
(Grisham, 2008). The procedure is repeated in 2 or more stages until a unanimity of opinions is 
achieved. Despite unanimity achieved, at the end of the exercise, the identities of the participants 
are veiled from each other in order to remove biases in their responses. A commonly used variant 
of the Delphi technique is the “ranking-type” Delphi (Okoli & Pawlowski, 2004).  Notwithstanding 
the advantages of the Delphi method, it has its drawbacks. But despite the shortcomings, the Delphi 
Technique has come to be widely accepted as veritable tool for carrying out insightful qualitative 
studies in many fields of research. 
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Figure 4. 2: Theoretical Framework of the Delphi Technique (Habibi et al., 2014) 
 
4.3.1.1: Components of the Delphi technique 
The main components of the Delphi Technique which were also adopted in this study are the five 
listed below: 
 i. A panel of judiciously selected experts with deep insights and experience on the subject 
matter. The experts are usually anonymous. 
iii. The researcher who coordinates and conducts the process and rounds 
iv. The iterative process also called “rounds” which may involve 2 or more rounds of 
questionnaires and feedback 
v. The output, which sums up the results of the study.  
In the data analysis, some researchers have suggested a goal of 60 – 80% consensus or when a 
stability of the data occurs. (Green et al., 1999; Crisp et al., 1997).  60% was used as the threshold 
of the panelists’ consensus for this study.  
 
4.3.1.2: Panel Selection and size 
A crucial aspect of the Technique is selection of panel members (otherwise called panelists or 
participants). The selection process is very critical success of the technique and study (Hasson et 
al., 2000). The panelists must show a high degree of expertise, commitment and interest (Hasson 
et al., 2000). 
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Two critical criteria have been established for the experts to be selected.  First, is the possession 
of a high degree of relevant knowledge and expertise and secondly, they must be representatives 
of the profession in which the study is being carried out to enhance the extrapolation and 
generalization of the findings to the wider population (Rodgers and Lopez, 2002). Furthermore, 
Adler and Ziglio (1996) posit that the experts, in addition to the criterion of knowledge, must 
possess good communication abilities and adequate time for the study. 
In selecting the panelists for this study, the following criteria were used: 
I. Residency: Must be based and manage a Pharmaceutical operation in Lagos 
 
II. Knowledge: Has sufficient knowledge of Pharmaceutical sector policies, regulations and 
current dynamic issues in the outbound value chain. 
 
III. Academic Qualification: Has a university degree or its equivalent in Pharmacy or related 
field 
 
IV. Experience: Has a proven experience or currently managing a pharmaceutical operations, 
services and/or SC role of the organization at the strategic level. 
 
V. Employment: Currently in employment in a pharmaceutical organization in Lagos 
 
VI. Membership: Must belong to a professional body where extrapolation of the results of 
the study can easily be done. 
 
VII. Willingness:  Should have willingness to full participate in the study 
 
In the selection process, the target panelists from across the various categories of the 
Pharmaceutical Industry were contacted through emails and telepohone.  A pre-selection scrutiny 
of their curriculum vitae to ensure they all met the seven criteria set out above was done. Thereafter 
a physical visit was made to them to explain the study objectives. Those who gave their consent 
were thereafter given the questionnaire for the Delphi Study (See Appendix A).  
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4.3.1.3: Delphi questionnaire 
In research, the questionnaire is a commonly used and versatile data collection instrument. It’s a 
common phenomenon to associate questionnaires with research. Given their popularity, it may be 
easy to assume, albeit wrongly, that the design and use of questionnaires is easy. The contrary is 
the case, as a lot of skill and inputs go into the design of a good questionnaire that will attract 
commensurate response in effective research procedures (Rowley, 2014). Prior to the conclusion 
of the questionnaire, interview sessions were conducted by the researcher with the key 
stakeholders in the Private Pharmaceutical Sector.  Notable among these were the National 
President of the Pharmaceutical Society of Nigeria (PSN), Executive Secretary of the 
Pharmaceutical Manufacturing Group (PMG-MAN), some CEOs of Pharmaceutical Companies 
including Multinational and Indigenous, Publicly quoted and privately-owned, the Chairman of 
the Pharmaceutical Manufacturing Group of the Manufacturers’ Association of Nigeria (PMG-
MAN). The responses from these industry players and leaders were helpful in re-enforcing the 
focus of the study.  The questionnaire used in both the Delphi and quantitative methods were 
similar, differing only in the impact scale used, number of questions and iterations in the data 
collection processes.  Whereas the Delphi study had an impact scale of 1 – 10, the impact scale 
used for the quantitative study was the Likert scale of 1 – 5.  
 
The Delphi questionnaire had three sections, A, B & C. 
 Section A had three questions designed to gather preliminary information about the 
respondent’s organization as follows: 
o Q1: The status of the organization 
o Q2: The products’ portfolio 
o Q3: The number of employees & value of products sold and/or handled in a year 
 
 Section B contained the main questions.  In this section, there were 98 closed-ended 
questions under 10 major questions and 3 open-ended questions as follows: 
o Q1: Had 5 questions on the degree of outsourcing 
o Q2: Had 5 questions on the satisfaction level  
o Q3: Had 5 questions on the age of outsourcing relationship 
o Q4: Had 12 questions on the rationale for outsourcing 
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o Q5: Had 16 questions on the critical success factors 
o Q6: Had 15 questions on the critical risk factors 
o Q7: Had 15 questions on the pre-selection activities 
o Q8: Had 6 questions on the challenges of outbound value chain 
o Q9: Had 12 questions on the desired outcomes of outsourcing  
o Q10: Was an open-ended question on critical issues affecting the outsourcing of 
pharmaceutical outbound supply chains that may have been omitted from the 
questions above 
o Q11: Was an open-ended question on what they envisage will be future pivotal 
context of the pharmaceutical distribution. 
 Section C was to gather the personal information of the respondent - gender, qualification, 
years of experience, membership of professional bodies, current employer and position. 
  
A total of 24 target panelists were invited/contacted. Of this number, 21 (87.5%) consented to 
participate, out of which 17 (81%) finally participated in the study. The ideal number of panelists 
for ranges from 3 to 80 (Delbecq et al., 1975; Rowe & Wright, 1999; Okoli and Pawlowski, 2004; 
Hallowell & Gambatese, 2010). No system exists for fixing Delphi panelists (Habibi et al., 2014; 
William & Webb, 1994). Despite this seeming non-agreement on the size of panelist, a prevailing 
pattern can be easily noticed as earlier stated above. Over time, the factors that have influenced 
the composition of the panel and size include the skills set of the members, the duration, topic, 
scope and money available for the study. (van Zolingen & Klaassen, 2003). The choice of members 
with diverse specialties and skills in favour of those with homogenous skills has been supported 
(Powell, 2003; Somerville, 2008). It is expected that “Delphi subjects should be highly trained and 
competent within the specialized area of knowledge related to the target issue” (Hsu and Sandford 
2007:42). Most panels’ composition range from less than 10 to 100 (Malone et al., 2005; Strasser 
et al., 2005; Kelly & Porock, 2005; Meadows et al., 2005). Therefore, at 17, the number of the 
panelists used for this study was considered adequate.   
 
The panel had 2 females and 15 males. The respondents were all University degree holders. The 
panelists were mainly pharmacists – 13 (76.4%). Others were specialists in supply chain 
management - 1 (5.9%), operations management - 2 (11.8%). 1 was a civil engineer (5.9%). This 
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functional diversity in the background of the panelists was an advantage. Furthermore, of the 17 
experts chosen as panel members, 10 were CEOs of their organizations, 3 were Country Managers 
(a title mostly used by multinational companies to designate their head of in-country operations) 
and 4 were Supply Chain Executive Directors of their organizations. With an average experience 
of 26 years, the panel was considered very experienced. There were five (5) categories covering 
the entire private pharmaceutical sector where the panelists were drawn from and have past 
experience and/or current experience. Predictably, the private sector provided more diversity in 
line with the structure of the industry. Furthermore, the panelists were drawn from all the 
categories of pharmaceutical products being handled and/or sold in the pharmaceutical industry. 
The least handled and/or sold is the vaccine category which is well known to require facilities and 
specialized skills in the storage and handling of the products.  All the categories of drugs are widely 
and evenly sold by all the organizations.  
 
4.3.1.4: The Delphi Process 
The Delphi study consisted of two rounds conducted over 6 months. The questionnaire designed 
and used for round 1 had 91 structured closed-end questions grouped under nine major questions 
(Q1 – Q9) and two open-ended question (Q10 & Q11). (See Appendix A). The output of the first 
formed were input into the second round. The selection of Delphi experts was from the private 
sector only. This is because the practice of outsourcing in pharmaceutical industry in Nigeria is 
primarily pursued by the private sector that have attained a maturity in the practice of outsourcing. 
Besides, little to no outsourcing is practiced in the public sector considering the regularized supply 
chain processes available through the various government entities. Also, the open-ended questions 
in the questionnaire were analysed using the principal content analysis methodology.  
 
By the first round, a clear pattern of consensus was achieved for most of the questions by the 
panelists. Therefore, in the second round, the panelists were contacted by phone for them to review 
their round one responses and state/justify their final responses/positions.  Over the two rounds, 
agreement was achieved on most of the questions and factors investigated.  The Delphi study was 
carried out through hard-copy questionnaires personally delivered by the researcher, with face-to-
face discussions for clarifications and follow-up telephones calls where needed by some panelists. 
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The panelists were required to respond to an impact scale from 1 – 10 in ascending degree of 
agreement and/or impact for the question(s) under consideration.  The group mean and median 
values of all the responses received from the panelist were calculated from each question. This is 
the prescribed procedure for determining the measure of central tendency and arriving at the 
consensus by the panelists. Okoli & Palowski (2004:6) states that “the Delphi study is flexible in 
its design, and amenable to follow-up interviews. This permits the collection of richer data leading 
to a deeper understanding of the fundamental research questions”.   After the second round, the 
medians and mean values were calculated. Consensus was reached after the second round and the 
process concluded as there was no need to proceed to the third round. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. 3: Delphi Outline (Thangaratinam & Redman, 2005:124) 
 
Round 1  
Q 
Round 2 
Researcher actions Expert panel actions 
Circulates questionnaire to 
expert panelists 
Computes Group medians 
and contacts panelists 
Rates factors associated with 
Pharma outsourcing in Nigeria and 
responds to other issues 
Reviews earlier responses in view 
of the group’s mean and median 
values. Gives reason if required 
Determines consensus and 
terminates process 
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A high degree of anonymity was maintained all the entire Delphi Process.  As stated earlier, this 
was done to remove bias and undue influence on other members. This was critical to enhance the 
credibility of the process. Figure 4.8 shows a schematic diagram of how the entire study data was 
conducted. 
4.3.1.5: Computation of Data  
Computation of the median and mean values of the various responses was carried out using 
Microsoft Excel.  The results are presented in chapter 5.  The findings and summary of consensus 
show the various factors associated with the outsourcing and challenges of pharmaceutical 
outbound value chains in Nigeria in ranking order of impact. 
 
4.3.1.6: Consensus  
Several methods exist which have developed and used by researchers in determining consensus in 
Delphi studies. Some have proposed the number of rounds as a basis, with 2 to 10 rounds reported 
in several articles (Windle, 2004; Habibi et al., 2014). Some others have used frequency 
distribution as a measure to establishing consensus, setting the 51% mark as the threshold for 
agreement (McKenna, 1994).  
 
In this study, the group mean and median values were employed in calculating and determining 
consensus. Other methods which have been developed and used include: percentage agreement & 
convergence of importance ranking (Holey et al., 2007), Kendall's coefficient of concordance, 
with values ranging from zero to one in ascending order of consensus/agreement (Schmidt et al., 
2001). The various studies/method cited above confirm the established fact that there is no 
unanimity in a single method for determining consensus. However, it is recognised that for 
consensus to be determined, there must be a common agreement. In this study, the measures of the 
common agreement and convergence were the mean and median values of the responses, with 
60% as threshold values for both measures. 
 
In this study, consensus was determined through the following: 
1. A threshold of at least 60% agreement of responses on any question. 
The degree of consensus used for this study are the mean and median values listed as follows: 
1. Strong - 9-10  
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2. Good - 7-8.99 
3. Weak - ≤ 6.99 
4.4. Quantitative study 
The quantitative survey conducted in this study followed the Delphi as required in the sequential 
exploratory technique of mixed method. 
 
4.4.1: Quantitative Study Population & Sample Size  
The sample of respondents for the quantitative survey was drawn from the same population (the 
pharmaceutical industry of Lagos, South West Nigeria) that produced the Delphi panelists. 
However, unlike the Delphi panel which were drawn from the private sector alone, the respondents 
for the quantitative were drawn from both sectors of the Industry. The following criteria were pre-
determined for a respondent to meet: 
I. Residency: Must be based in Lagos 
 
II. Knowledge: Has sufficient knowledge of the outbound value chain processes of the  
Pharmaceutical organizations that produce the Delphi panelists 
 
III. Academic Qualification: Has a university degree or its equivalent in Pharmacy or related 
field 
 
IV. Experience: Has a proven experience or currently managing a supply chain or related role 
in the pharmaceutical industry at a functional level. 
 
V. Employment: Currently in the employment of the pharmaceutical industry. 
 
In determining the population, preliminary interviews were conducted to determine the number of 
qualified potential respondents are outlined above and accordingly, the questionnaires were 
administered to them. Determination of the adequate size of the respondents in the survey was 
through the use of the Krejcie & Morgan (1970) table.  
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Table 4. 1: The Krejcie & Morgan (1970) Determining Size of sample for given population. 
 
 
 
A cross sectional non-random sampling using the Krejcie & Morgan model was used. The 
population from which the respondents were sampled consisted of a cross section of both sectors. 
The public sector had 28 Heads of Pharmaceutical services in the 28 General Hospitals and also 
28 Head Pharmacists covering the 288 primary healthcare centres in the State. Of this, 23 primary 
healthcare centres and 8 General Hospitals were sampled since both layers of the government 
facilities had the same standardized processes. In the private sector as listed earlier in chapter 1, 
Lagos has 75 companies as manufacturers and importers of pharmaceutical products. Together 
with the 3 large pharmacy chains, the total population of organizations was 134. From the Krejcie 
and Morgan’s table, the adequate size was 97. Accordingly, 68 organizations containing 34 each 
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from both sectors were sampled and given an average of 2 questionnaires each, depending on the 
size of the organizational structure. In total, 133 questionnaires were given out to the respondents.  
 
4.4.2: Quantitative questionnaire 
As earlier stated in chapter four, the questionnaire used in both research methods were similar, 
differing only in the impact scale used, number of questions/latent variables and iterations 
(rounds) in the data collection process.  Whereas the Delphi study had an impact scale of 1 – 10, 
the impact scale used for the quantitative study was the Likert scale of 1 – 5.  Furthermore, 
whereas the Delphi questionnaire had 10 close-ended questions, 98 latent variables and 2 open-
ended questions, the quantitative instrument had 9 close-ended questions and 91 latent variables, 
with no open-ended questions. A cover letter addressed to the respondent contained brief 
summary of the survey process and the contact details of the researcher.  
  
4.4.3: Validation of Questionnaire 
Before the administration of the instrument, the questionnaire was sent to the statistical department 
of the University for validation and confirmation of its amenability to statistical analysis after 
completion and collection of data.  
 
4.4.4: Data Collection 
After determining the sample size as illustrated earlier, the questionnaires were personally 
administered to all the respondents that were targeted.  Considering the likelihood of not getting 
100% completion rate and running the risk of not getting enough responses to meet up with the 
determined sample size, a total number of 133 questionnaires were administered. In some 
instances, especially in the public sector, the researcher had to sit in with the respondents to 
complete the questionnaires, giving further clarification to some areas as appropriate. 103 
questionnaires (77%) were completed and returned.  The instrument administration and collection 
took a total of four (4) months from October 2018 and January 2019.  The summary of the 
preliminary information about the respondents’ organizations and their personal information as 
given in Sections A & C of the questionnaire are given in chapter 6. 
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Respondents from all the various categories of sub-sectors in the pharmaceutical industry 
completed the questionnaires. There were 5 categories in the private sector (Multinational 
Manufacturing, Overseas’ Manufacturers’ Representatives, Indigenous Manufacturers, 
Importers/Distributors and Large Pharmacy Chains) and two categories in the public sector (State 
General hospitals and the primary health care centres) of the State. 
  
The categories of the products’ portfolio of the respondents’ organization were over the counter 
(OTC), ethical/prescription drugs and vaccines, which account for the least on account of the 
specialization it their storage and handling. All the respondents met the minimum requirement for 
educational qualification with 65% & and 35% having Bachelor’s and Master’s degrees 
respectively. All the survey respondents in the public sector were Pharmacists with 12 as average 
years of experience.  Given their functional roles and positions in their organizations, this value is 
quite adequate and sufficient for them to be knowledgeable enough to respond to the issues and 
questions raised in the questionnaire.  
 
4.4.5: Data Analysis 
Before date, the responses were inputted into a Microsoft excel sheet before being transposed into 
a format for use by SPSS version 25, the software used for the analysis. The statistical analyses 
that were done include descriptives like frequencies, means and distribution. Inferential statistical 
and exploratory factor analyses using the principal components analysis and principal axis 
factoring.  
  
4.4.6: Missing Values 
There were some missing values in the data which though no desirable, but was and is inevitable 
in a research like this involving many questions.  On closer investigation, it was found that this 
occurrence may not only be because of limited knowledge about some of the questions being 
asked, but because some of the questions were not applicable to the respondents’ situation and 
operations.  For instance, many whose organizations are not involved in a particular area or 
category of pharmaceutical operations and/or the outsourcing of same, may choose to refrain from 
responding. 
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4.4.6: Data reliability & validity 
To ensure data reliability and validity, the results of previous/similar studies were considered in 
the design of the questionnaires as this measure enhances the quality and validity of surveys 
(Olson, 2010:313). Furthermore, a formal approval was obtained from the Department of Quality 
and Operations Management, University of Johannesburg to conduct the research.  The reliability 
of the scale was tested and confirmed using the Cronbach’s alpha coefficient as this is the most 
frequently used measure of internal consistency of scale. Principal axis factoring and component 
analysis were used for the data extraction method while data rotation was with varimax with Kaiser 
Normalisation and Oblimin with Kaiser Normalisation respectively.  Prior to the discussion of the 
results, the factors extracted were grouped and named based on their commonalities. 
 
4.5: Delimitations of the study 
These refer to those features that explain the limits of the research study. Respondents for this were 
most pharmacists with strategic role in the pharmaceutical services and supply chain functions in 
Lagos State, Nigeria. The choice of Lagos as the study area was due to the highly industrialized 
status and number of pharmaceutical organizations in the State.  This study investigated the state 
of pharmaceutical supply chains in the State and the various factors associated with the outsourcing 
of the outbound value chains. 
  
4.6: Ethical consideration 
In this study, no ethical challenges were encountered. The works of previous researches referred 
to in the study were properly cited and acknowledged.  The confidentiality and anonymity of the 
respondents were protected. Formal letters from the Lagos State government and the Department 
of Quality and Operations Management, University of Johannesburg were obtained and affixed to 
the survey instruments used in the study. 
4.7: Conclusion  
The design and methodologies adopted in this study have been detailed in this chapter. It described 
the methodology adopted, with details of the design of both the Delphi technique and quantitative 
survey. Furthermore, it explains the Delphi process – selection, composition, method for consensus 
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and computation of data. The quantitative study population, sample size, data collection and 
analytical techniques utilized have also been outlined. Finally, the delimitation and ethical 
consideration of the entire study are included. 
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CHAPTER 5 
 
RESULTS & DISCUSSIONS OF DELPHI STUDY 
 
5.1: Introduction 
In this study, the Delphi technique was adopted in exploring the Nigeria pharmaceutical supply 
chains in general and specifically, to request experts’ opinions on the various factors associated 
with the outsourcing of the pharmaceutical outbound value chains in Nigeria. The technique 
solicited from the panel of experts, critical issues relating to various aspects of outsourcing 
pharmaceutical outbound supply chains in Nigeria. Also, tested through this were their views on 
the critical success and risk factors associated with outsourced relationships and finally, to 
determine from their views, the challenges of the pharmaceutical outbound value chains and their 
prediction of the future landscape of the pharmaceutical distribution system in Nigeria. Two 
rounds of iterations were conducted before the Delphi panelists achieved unanimity. 
 
This chapter summarizes the output of the iterations.  Calculations were done for each question as 
they relate to the different factors that are associated with the outsourcing of the outbound 
pharmaceutical value chains. The analysis of the results from the different computations described 
above are presented in this section. Finally, the discussions of the results based on the earlier set 
objections are also presented.  
 
5.2: Specific Delphi Research Objectives 
The objectives set to be achieved with the Delphi study as early stated in Section 1.7.6 are as 
follows:  
DSO1: To identify the level of outbound supply chain outsourcing in the last   decade in 
Nigeria. 
 
DSO2: To determine the age of the outsourcing relationships 
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DSO3: To identify the main factors influencing the decision to outsource outbound 
pharmaceutical value chains 
 
DSO4: To identify the level of satisfaction of the outbound value chain services currently 
being outsourced by the Pharmaceutical companies 
 
DSO5: To determine the underlying risk factors in the outsourcing relationship 
 
DSO6: To determine the criteria to a successful selection and outsourcing relationship 
with a 3rd Party Service Provider 
 
DS07: To evaluate the vital 3PL pre-selection activities by the outsourcing organizations 
 
DSO8: To determine the challenges in the pharmaceutical outbound value chains 
 
DSO9: To identify the desired outcomes of outsourcing outbound pharmaceutical value 
chains 
 
The philosophy guiding the objectives stated above was to investigate various aspects of the 
outsourcing of outbound pharmaceutical value chains in Nigeria and to develop a framework for 
a successful outsourcing process.  Upon the completion, the responses of the experts to the 
questions in round one were analysed, with the outcome forming the basis for round two. The 
intention of this round was to allow the panelists review their responses in round one against the 
background of the substantive position of other panelists. After the second round, the panelists 
were in agreement on almost all the factors investigated, hence achieving consensus and 
completion of the technique.  The various statistical values (median & mean) were computed for 
each question responded to by the experts. Finally, content analysis approach was used to analyse 
the various experts’ answers/responses to the open-ended questions.  
 
In general, a perfect consensus which is rare in practice is achieved only when all (100%) the 
experts are in agreement on the various issues. However, a two-thirds consensus is considered 
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acceptable and adequate (Stitt-Gohdes & Crews, 2004). A minimum of 60% agreement was 
considered as acceptable consensus for this research. From the findings of the Delphi study, a 
summary and ranking of the various latent variables/factors associated with outsourcing of 
outbound pharmaceutical supply chains was made.  The table of results from Delphi Study as they 
related the specific Delphi objectives are presented in the next section.  
 
5.3 Delphi Study Results. 
5.3.1: Section A – Preliminary information about respondents & organizations 
This section contains the key information about the respondents and their organizations. 
5.3.1.1: Gender Distribution 
The gender distribution of the respondents is presented in Table 5.1 It shows the panel was made 
up of 15 males and 2 females representing 88.2 and 11.8% respectively. 
 
 
Table 5. 1: Gender distribution of panelists 
Gender No % 
Male 15 88.2 
Female 2 11.8 
Total 17 100 
 
5.3.1.2: Educational Qualification of Respondents 
From the results shown in Table 5.2, the respondents were all University degree holders at 
different level including Master’s and Doctorates degrees. 
Table 5. 2: Educational qualification of panelists 
Qualification No % 
Bachelor 3 17.6 
Masters 12 70.6 
Ph.D 2 11.8 
Total 17 100 
 
5.3.1.3: Years of experience of Respondents 
Table 5.3 shows the years of relevant professional experience of the respondents.  It shows that 
the respondents have an average of 25.9 years as experience. 
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Table 5. 3: Years of experience of panelists 
Years of experience No % 
0 - 5 0 0 
6 - 10 1 6 
11 - 15 0 0 
16 - 20 3 17 
21 - 25 1 6 
26 - 30 9 53 
above 30 3 17 
Total 17 100 
  Mean 25.9 
  SD 7.4 
 
5.3.1.4: Areas of specialization of respondents 
As shown in Table 5.4, the panelists were mainly pharmacists – 13 (76.4%). Others were 
specialists in supply chain management - 1 (5.9%), operations management - 2 (11.8%). 1 was a 
civil engineer (5.9%). 
 
Table 5. 4: Areas of specialization of panelists 
Area of Specialization No % 
Pharmacy 13 76.4 
Supply Chain 1 5.9 
Accounting 0 0 
Operations 2 11.8 
Sales & Marketing 0 0 
Others (civil engineering) 1 5.9 
Total 100 100 
 
5.3.1.5: Categories of Respondents’ Organizations 
The respondents were drawn from all the categories in the Pharmaceutical sector.  As shown in 
Table 5.5, the categories and the panelists from them are multinational manufacturing - 7 (41.1%), 
overseas’ manufacturers’ representatives - 3 (17.6%), indigenous manufacturers - 5 (29.4%), 
importers/distributors - 8 (47.1%) and large pharmacy chains – 2 (11.8%) 
Table 5. 5: Categories of Respondents’ Organizations 
No. Category Responses % 
1 Multinational Manufacturing 7 41.1 
2 Overseas’ Manufacturer’s Representatives 3 17.6 
3 Indigenous Manufacturer 5 29.4 
4 Importer/Distributor 8 47.1 
5 Large Pharmacy Chain 2 11.8 
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5.3.1.6: Employees’ number of panelists’ organizations 
Table 5.6 shows the employees’ number of the panelists’ organizations. 1 (5.9%) had less than 50; 
6 (35.3%) had between 51 – 200 employees; 6 (35.3%) had between 201 – 500 employees while 
the largest of the organizations - 4 of them (23.5) had between 501 – 1000 employees.  None of 
the organizations had more than 1000 employees.  
Table 5. 6: Employee number of panelists’ organizations 
 
Number 
 
Frequency 
 
% 
 
Cumulative % 
501 – 1000 4 23.5 23.5 
201 – 500 6 35.3 58.8 
51 – 200 6 35.3 94.1 
Less than 50 1 5.9 100.0 
 
5.3.1.7: Portfolio of products handled by panelists’ organizations 
Table 5.7 is a summary of the categories of pharmaceutical products being handled and/or sold by 
the organizations from which the panelists were drawn. The least handled and/or sold is the vaccine 
category which is well known to require facilities and specialized skills in the storage and handling 
of the products.  All categories of medicines are widely and evenly sold by all the organizations.  
 
 
Table 5. 7: Portfolio of products handled by panelists’ organizations 
S/N Products’ portfolio Number % 
1 Over the Counter Products 14 35 
2 Ethical/Prescription Drugs 16 45.7 
3 Vaccines 5 14.3 
Note: Some of the panelists’ organizations handle more than one product portfolio, hence the number (35) are not 
equal to 17. Same explains why the % don’t add up to 100 
 
5.3.1.8: Turnover/value of products handled by panelists’ organizations 
In Table 5.8, the values of the annual turnover or products handled by the panelists’ organizations 
are presented.  It shows 1 (5.9%) had less than N100m and between N100m – N500m each, 
respectively; 7 (41.1%) had between N1b – N5b while 8 (47.1%) had more than N5b as annual 
turnover or value of products handled. 
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Table 5. 8: Turnover/value of products handled by panelists’ organizations 
 
Value (Naira) 
 
Frequency 
 
% 
 
Cumulative % 
More than N5b per annum 8 47.1 47.1 
N1b - N5b per annum 7 41.1 88.2 
N100m - 500m 1 5.9 94.1 
Less than N100m 1 5.9 100.0 
 
5.4: Section B – Results from the responses to the questionnaire and Delphi 
specific objectives 
Results of the responses and computed consensus of the panelists on the various questionnaire 
questions (Q1 – Q11) and the Delphi specific objectives are presented in this section. 
 
5.4.1: DSO1 - To identify the level of outbound supply chain outsourcing in the last 
decade in Nigeria. 
Table 5.9 shows the level of outsourcing of the outbound supply chain services examined in this 
study (Transportation, Warehousing, Distribution, Cold Chain & Reverse logistics) by the 
responding experts’ organizations.   
 
Table 5. 9: Level of outsourcing 
Function Median Mean Ranking 
Transportation 9.0 8.1 1 
Distribution 8.0 7.1 2 
Reverse Logistics 8.0 6.4 3 
Warehousing 7.0 6.4 4 
Cold Chain 2.0 3.7 5 
 
The assessment of the responses of the experts was based on the ordinal scale of 1 – 10 in 
increasing order of impact or influence of the variable being considered.  Furthermore, the level 
of consensus was rated as weak with mean values at less than 7, good at 7, strong at 8 and very 
strong at 9 – 10.  In this study, the services mostly outsourced with the highest degree of mean 
value & median (8 & 9 respectively) was Transportation, (otherwise called Haulage or long-
distance transport in Nigeria), followed by Distribution (mean & median values of 7 & 8 
respectively) and Warehousing (mean & median values of 7 & 7 respectively).  Cold chain 
services with both mean and median values of 6 and Reverse Logistics (with mean & median 
values of 4 & 3 respectively) were the least outsourced services. 
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5.4.2: DSO2 - To determine the age of the outsourcing relationships 
Table 5.10 shows the feedback on the age of outsourced relationships by the responding experts’ 
companies. 
Table 5. 10: Age of outsourcing (years) 
Function Median Mean Ranking 
Transportation 12.0 11.9 1 
Distribution 11.0 10.4 2 
Reverse Logistics 7.0 9.6 3 
Warehousing 8.0 8.7 4 
Cold Chain 5.0 5.6 5 
 
The responses are the absolute number of years these outbound supply chain functions have been 
outsourced by the organizations and not subject to any consensus as the data represents 
information of facts.  This table is similar to Table 5.9 as Transportation came out as the function 
with the oldest outsourced function at a mean & median values of 12 years.  Distribution which 
usually refers to secondary transport or last-mile distribution services ranked second on the age 
with mean and median values of 10 & 11 years respectively.  Closely following the Distribution 
services is the reverse logistics service (with mean & median values of 10 & 7 years respectively) 
which in form and format is a type of transport services employed by these organizations for 
product recall and other forms of “out-in” movements of products along the outbound value 
chains.  Once again, cold chain services comes out as the newest outsourced service by these 
organizations, predictably because of fewer number of players, scope and the technicality of the 
storage/handling involved.  The mean & median values for these specialized service were 6 and 
5 years respectively.   
 
5.4.3: DSO3 - To identify the main factors influencing outsourcing of outbound 
pharmaceutical value chains 
 
In Table 5.11, responses on the critical factors that influence the outsourcing of outbound 
pharmaceutical value chains are presented.  The list of these factors were generated from 
comprehensive literature of the various studies on outsourcing in Nigeria and elsewhere and the 
few that have been carried out in the pharmaceutical sector in both sub-Saharan African countries 
and the more developed countries. The most critical factors as reflected in this table with both the 
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mean and median values of 9, showing a very strong consensus are focus on core competence and 
cost savings. 
 
 
Table 5. 11: Factors influencing outsourcing decisions 
Function Median Mean Ranking 
Focus on core competence 9.0 8.8 1 
Cost savings 9.0 8.5 2 
Improvement in Customer service 8.5 8.3 3 
Flexibility 8.0 8.3 4 
Lack of Capacity 8.0 8.1 5 
Corporate Strategy 8.0 7.9 6 
Market expansion 8.0 7.0 7 
Lack of in-house expertise 8.0 6.9 8 
Transfer of risks to 3PL 8.0 6.9 9 
Industry best practice 7.0 6.9 10 
Access to Specialised skills 7.0 6.9 11 
Technological advancement 6.0 6.5 12 
 
The other factors of influence with strong consensus among the experts are flexibility of 
operations by the 3PL, market expansion, improvement in customer service, lack of capacity (by 
the outsourcing organization) and corporate strategy.  Other factors (Access to Specialised skills, 
Transfer of risks to 3PL, Lack of in-house expertise, Industry best practice and Technological 
advancement) were considered were considered of less critical influence judging from the 
moderate consensus by the experts. 
  
5.4.4: DSO4 - To identify the level of satisfaction of the outbound value chain 
services currently being outsourced by the Pharmaceutical companies 
 
Table 5.12 contains the satisfaction level the organizations have derived from the outsourced 
services 
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Table 5. 12: level of satisfaction from outsourced services 
Function Median Mean Ranking 
Warehousing 8.0 7.7 1 
Distribution 7.5 7.0 2 
Transportation 7.0 6.9 3 
Reverse Logistics 7.0 6.3 4 
Cold Chain 7.0 4.9 5 
A closer look at the responses shows a reversal of ranking between these services in terms of 
satisfaction levels shown here and the degree of outsourced services presented in Table 5.9 earlier.  
In this table, the organizations derived the highest degree of satisfaction from warehousing 
services than Transportation and Distribution services which were the most outsourced services.  
The positions occupied by the reverse logistics and cold chain services (4 & 5 respectively) were 
similar to those reported earlier in Table 5.9.  The satisfaction levels recorded by these 
organizations may not be unconnected with the nature and vicissitudes associated with these 
mobile components of the outbound supply chains.  
 
5.4.5: DSO5 - To determine the underlying risk factors in the outsourcing 
relationship 
 
Table 5.13 shows the list of risks associated with outsourcing, their mean and median values and 
the ranking. 
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Table 5. 13: Underlying risk factors in the outsourced relationship 
Function Median Mean Ranking 
3PL Underperformance 9.0 8.9 1 
Service levels not achieved 8.0 7.9 2 
Corporate governance 8.0 7.8 3 
Value misalignment 8.0 7.6 4 
Loss of confidentiality 8.0 7.4 5 
Loss of flexibility 7.0 7.3 6 
No continuous improvement by 3PL 7.0 7.2 7 
Cost reduction not realised 7.0 6.9 8 
Obsolete Technology 7.0 6.9 9 
Undertrained vendor’s employees 6.0 6.7 10 
Hidden costs 6.0 6.7 11 
Loss of control of outsourced function 7.0 6.5 12 
Internal HR issues 6.0 6.4 13 
Vendor employee turnover 6.0 6.4 14 
Loss of expertise 6.0 6.3 15 
 
Several studies have reported various risks associated with outsourcing of supply chain activities.  
The degree of risks which vary according to the service being outsourced, sector and country were 
listed for the expert panelists to evaluate in this study.  Their responses are presented in the Table 
5.13.  Attaining a very strong consensus level (mean & median values of 9 respectively) is the 
risk of the underperformance of the 3PL Service Provider which the experts rated/ranked very 
high.  This is followed by a closely-related risk of service levels not achieved.  These two risks 
topped the list of risks the panelists accord the outsourcing process as they represent a failure of 
this critical strategic decision.  Other risks rated high but in order of descending criticality are 
corporate governance & Value misalignment.  All other risks were rated as moderate to low as 
reflected in the levels of consensus (mean values of 6 to 7) recorded for these risks.  This is 
probably so because of the ease and availability of mitigating plans against these risk factors.   
 
5.4.6: DSO6 - To determine the criteria for a successful selection and outsourcing 
relationship with a 3rd Party Service Provider 
 
Table 5.14 contains the criteria for the selection of 3PL service providers, mean, median scores 
and the ranking of the criteria. 
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Table 5. 14: Criteria for successful selection of 3PL service provider 
Function Median Mean Ranking 
Speed of service delivery 10 9.5 1 
Service reliability 9.0 9.2 2 
Operational flexibility 9.0 8.9 3 
Pedigree/history of performance 9.0 8.9 4 
Financial strength 9.0 8.7 5 
Quality policies and procedures 9.0 8.7 6 
National/geographical spread 8.5 8.7 7 
Management structure & expertise 8.0 8.2 8 
Customer orientation 8.0 8.1 9 
Stable industrial relations 8.0 8.1 10 
Flexible payment regimen 8.0 8.1 11 
Innovation 8.0 7.9 12 
Organizational culture 8.0 7.9 13 
Corporate values 8.0 7.9 14 
Availability of latest ICT tools 8.0 7.7 15 
Indemnity 8.0 6.7 16 
 
Many criteria for selecting 3PL service providers have been documented by many experts and 
authors.  While some may be peculiar to certain industries and sectors, others are common criteria 
which cut across sectors and industries and are considered both fundamental and critical to the 
success of any outsourced relationship.  These criteria have been listed and formed the basis for 
the results in Table 5.14 which summarizes the responses of the expert panelists to their ranking 
of these criteria. 
 
As shown in the table 5.14, the most critical of the factors with the highest ranking and strongest 
consensus is service reliability. Next in order of consensus and ranking by the experts is another 
service-related factor – service reliability. Other critical factors showing very strong consensus 
are service reliability, financial strength, operational flexibility, pedigree/history of performance 
and operational flexibility; which, when examined closely are factors closely associated the 
service provider’s the ability or otherwise to deliver on their service. All the other factors -
innovation, organizational culture, customer orientation, operational flexibility, corporate values, 
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flexible payment regimen and indemnity were considered to be of moderate to high importance 
in the selection process and successful outsourced relationship with a 3PL service provider.  At 
the lowest ranking by the expert panelists was availability of latest ICT tools. Considering level 
of ICT infrastructure in the country and scope of the outsourced functions, it is easily 
understandable while these experts place the lowest emphasis on this criterion. 
 
5.4.7: DS07 - To evaluate the vital pre-selection activities by the outsourcing 
organizations 
 
Table 5.15 contains the list of pre-selection activities engaged in by the outsourcing organizations  
 
Table 5. 15: Pre-selection activities by the outsourcing organizations 
Function Median Mean Ranking 
Analysing present costs of function(s) 10.0 9.2 1 
Adequate due diligence 10.0 9.2 2 
Visiting 3PLs’ locations 10.0 9.0 3 
Developing service levels agreement 
(SLA) 10.0 9.0 4 
Contract preparation 9.0 9.0 5 
Contract negotiation 9.5 8.8 6 
Corporate governance checks 9.0 8.7 7 
Developing critical proactive Corrective 
And Preventive Action (CAPA) plans 9.0 8.4 8 
Preparing an exit plans/provisions 8.5 7.9 9 
Verification of listed references 8.5 7.9 10 
Developing a back-up plan 8.0 7.9 11 
Engaging present clients of potential 3PL 
partner 8.0 7.6 12 
Appointing a relationship manager 8.0 7.6 13 
Developing a transition plan 8.0 7.5 14 
Advertising a Request for proposal  (RFP) 
7.0 6.2 15 
 
Depending on the structure and operational system of an organization, many processes are 
available and documented on the various pre-selection activities they engage in before the 
appointment of a 3PL service provider. In table 5.16, these various activities and the results of the 
expert panelists’ responses are presented. Topping the list of these activities is the assessment of 
their present cost structures. This activity is considered critical and uppermost in the list of pre-
selection activities as comparative analysis of the costs of in-house performed and outsourced 
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functions will be crucial in determining if the outsourcing decision will deliver on one of the pre-
determined goals of costs reduction or not as earlier listed. Following this activity are adequate 
due diligence & visiting 3PL locations; two activities which are critical in evaluating the capacity 
of the potential 3PL Partner. The other activities in order of importance are: contract preparation 
and negotiation, developing service levels agreement (SLA) and developing critical proactive and 
corrective and preventive Action (CAPA) plans. These are the next activities these organizations 
engage in after ascertaining the competence of the service provider and have scaled through the 
earlier evaluation stages. These activities are those related to how the newly-contracted 
relationship will be governed and administered.   Other activities, although important in the pre-
selection processes were considered less critical than those listed above. 
 
5.4.8: DSO8 - To determine the challenges in the pharmaceutical outbound value 
chains 
Tables 5.16 contains the challenges of outbound pharmaceutical value chains 
 
Table 5. 16: Challenges of outbound pharmaceutical value chains/outsourcing 
Function Median Mean Ranking 
Road Infrastructure 9.0 
8.8 
1 
Power Infrastructure 9.0 
8.7 
2 
Absence of competent 3rd Party Service 
Providers 7.5 
7.5 
3 
Inadequate Policy & Regulation 7.5 
7.1 
4 
Lack of skilled personnel 7.0 
6.7 
5 
Pilferages along the chain 6.0 
5.5 
6 
 
The outbound pharmaceutical value chains in Nigeria like most resource-limited countries are 
bedeviled by a myriad of challenges which are both external and internal to the sector. Apart from 
information from literature review, in compiling these challenges peculiar to the Nigeria 
environment, interviews were conducted with Industry leaders and experts in addition to those 
engaged later as Delphi panelists.   As shown in Table 5.16, the most critical of these challenges 
with very strong consensus and mean/median values of 9 are two factors that are environmental 
– road & power infrastructure. These factors reflect succinctly, the nature of the products in the 
supply chain – pharmaceutical and thermolabile products, which require regular power for 
storage. Road infrastructure is critical for the smooth delivery of these products.  The other factor 
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next in the list of critical challenges is the absence of competent 3PL service providers with the 
capacity to handle pharmaceutical products.  Lastly, among the challenges listed by the panelists 
are the inadequate policy & regulation, lack of skilled personnel and pilferages along the chains. 
 
5.4.9: DSO9 - To identify the desired outcomes of outsourcing in outbound 
pharmaceutical value chains 
 
In Table 5.17, the expert panelists were asked to state the desired outcomes of their outsourcing 
decisions as a reflection of the accrued benefits listed out in the variable factors compiled from 
extant literature.  The rating of these outcomes as in other questions, was 0 to 10 based on the 
discrete level of benefits.  The mean and median consensual values are presented in the table. 
These responses also reflect how much of the pre-determined reasons/rationale for outsourcing as 
listed in Table 5.11 these outsourcing organizations desire as outcomes of their outsourcing 
decisions. 
Table 5. 17: Desired outcomes of outsourcing outbound pharmaceutical value chains 
Function Median Mean Ranking 
Focus on core competency 9.0 8.8 1 
Reduced Capital expenditure 9.0 8.0 2 
Geographical representation 8.0 8.0 3 
Speed & Agility 8.0 7.8 4 
Improvement in Customer service 8.0 7.7 5 
Market expansion 8.0 7.7 6 
Cost advantage/benefit 8.0 7.6 7 
Reduced manpower 8.0 7.5 8 
Efficiency 8.0 7.4 9 
Market share 7.0 6.9 10 
Access to Specialised skills 7.0 6.8 11 
Indigenous expertise 7.0 6.5 12 
 
Achieving strong to very strong consensus values are 8 out of the 12 possible benefits from the 
outsourcing process.  Focus on core competency received the highest and very strong consensus 
with mean & median values of 9 each.  The other seven benefits (reduced capital expenditure, 
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geographical representation, improvement in customer service, speed & agility, cost 
advantage/benefit and reduced manpower) followed in the ranking with good consensus and mean 
values of 8. The other benefits (efficiency, access to specialised skills, market share and 
indigenous expertise) were ranked of least importance. 
 
5.4.10: DSO10 - To determine the future pivotal context of the pharmaceutical 
distribution in Nigeria 
 
In this open-ended question, the expert panelists were asked to forecast, what will be the ideal 
pivotal context for an effective pharmaceutical distribution in the next decade in Nigeria.  The 
following were the responses received: 
1. Control of access & implementation of good distribution practice. 
2. The current chaotic drug distribution system needs to be sanitized with long lasting 
solution. 
3. Enforcement & implementation of the National Drug Distribution policy 
4. Provision of infrastructure & enforcement of policies towards a structured and 
better regulated distribution system that will include operations of wholesale 
outlets in the distribution chain. 
5. Government-driven national distribution centres, FDI increase, completion and 
erosion of margins, improvement of governance. 
6. More integrated approach with greater government oversight   
7. Mega drug distribution centers and closure of open drug markets 
8. Specialization in line with the new drug distribution guidelines 
9. Full implementation of the National Drug Distribution Guidelines (NDDG) 
integrated with an IT platform. This will lead to emergence of specialised and 
definitely resourced distribution companies with capacity to provide demand 
fulfilment on behalf of  its clients( importers& manufacturers) 
10. Streamlining the chaotic drug distribution with medicines delivered to consumers 
with intact integrity 
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5.4.11: Other Critical Issues affecting Pharmaceutical Supply Chains in Nigeria 
Furthermore, when the expert panelists were asked to identify any critical issues affecting the 
pharmaceutical outbound supply chains and the outsourcing, that have been omitted from the 
questions above, they listed the following: 
1. Lack of credible industry data for planning & accurate forecasting to help implementing 
of outsourced services 
2. Enhanced regulation of the distribution system to a more regulated structure 
3. Few reliable and structured 3PL service providers (may be one). There is need for healthier 
competition to lift up/expand the industry. 
4. Soft infrastructure (human resource) , insurance, unregulated markets, financing 
5. Sustainability/Environmental considerations 
6. Law enforcement agencies e.g. the National Drug Laws Enforcement Agency (NDLEA) 
and the Police cause unnecessary harassment/ delays. 
7. Regulatory compliance by the outsourcing company 
8. Compliance  by the 3PL staff to our business ethic, need for training and retraining of staff 
in the face of high staff attrition, know-how/control of products enter or leave the supply 
chain, getting through the last mile in good condition. 
9. Multiple taxation on roads by various states local government, insecurity issues 
10. The fragmented nature of the Pharma distribution sector, working capital issues- credit 
industry, issues handling temperature controlled substances 
 
5.5: Section C - Discussions of the Delphi Results 
5.5.1: Delphi objective DSO1 - To identify the level of outbound supply chain 
outsourcing in the last decade in Nigeria. 
 
The first objective of the Delphi study was to identify the level of outsourcing of the outbound 
pharmaceutical value chains in Nigeria.  The focal services of the study were the logistic services 
of long distance transportation, off-site warehousing, distribution (also called secondary 
distribution), cold chain & reverse logistics. 
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As reflected in the results of the feedback/responses of the expert panelists, there was a very strong 
consensus about the high level of outsourcing of transportation, followed by distribution, 
warehousing, reverse logistics & cold chain services in decreasing order. These outbound logistics 
services are part of the value chain primary activities that Porter (1985) says must be performed 
more efficiently by an organization if it hopes to achieve competitiveness in the marketplace. The 
import of Porter’s model is that organizations must conduct a reality assessment of every activities 
in the outbound segment of the value chain and consider if they have competitiveness, keeping the 
activity internally performed.  Otherwise, he recommended that such activity should be given to a 
third party who can provide both the cost and value advantages that can give the organization an 
edge in the marketplace.  This is widely acknowledged as one of the early drivers of the practice 
of outsourcing which is now a widely-practiced management principle in almost every industry 
and sector today. 
 
According to Christopher (2011:24) “Whilst there is often a strong economic logic underpinning 
the decision to outsource activities that may previously have been performed in-house, such 
decisions may add to the complexity of the supply chain. Because there are by definition more 
interfaces to be managed as a result of outsourcing, the need for a much higher level of 
relationship management increases” A critical and significant component of the outbound 
logistics services currently being outsourced by the pharmaceutical companies is the mobile 
segment of transport & distribution. Transportation is a major enabler in the movement of products 
to the final customers. As most finished products are rarely consumed at the same location of 
origin, transport costs account for significant SC costs (Aniki et al., 2014; Meindl & Chopra, 
2009).  Studies have shown that manufacturing companies outsource their outbound transportation 
services at a significant level fast pace (Mubarik et al., 2012) to achieve overall costs reduction, 
effectiveness and agility in their supply chains and customer satisfaction (Mubarik et al., 2012; 
Hwang et al., 2016; Somuyiwa et al., 2015).  According to annual survey on third party logistics, 
“the most outsourced logistics processes are local (domestic) transportation (80%), warehousing 
(66%), international transportation (60%), freight forwarding (48%), customs brokerage (45%) 
and reverse logistics (34%)”. (Langley & Capgemini, 2016; Bulgurcu & Nakiboglu, 2018). 
Transportation enhances the efficiencies and effectiveness of many companies, helping most 
importantly, flow of finished products, reducing the lead times production and the final customer, 
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on one hand, and order-delivery cycle time on the other hand. This accounts for the growing 
requirement for transport services even if, in the assessment of most companies, a non-core 
competence (Ciesla, 2015).  
 
The low degree of outsourcing of cold chain services recorded in this study is not a reflection of 
an alternative in-house management system for theses specialized services, but a reflection of the 
few companies that are engaged in the manufacturing and/or sales & distribution of vaccines and 
cold chain products in the private sector, from which the expert panelists were drawn.  All over 
the world, vaccines cold chain management are largely public sector-driven.  Nevertheless, 
outsourcing of the storage and distribution services have been on the increase and successful in 
the last two decades. Before 2008, the vaccine cold chain of the US was ineffective until the 
government outsourced the management to the private sector (WHO/PATH, 2012).  Similar 
success stories have been recorded in Thailand, South Africa and Nigeria (WHO/PATH, 2011; 
WHO, 2011).  
 
5.5.2: Delphi objective DSO2 - To determine the age of the outsourcing relationships 
 
This objective was to determine the average length of time the pharmaceutical companies in 
Nigeria have been outsourcing their outbound pharmaceutical value chains with particular 
reference to the logistics services of transportation (both haulage and distribution), warehousing, 
cold chain and reverse logistics services.  The mean ages for the outsourced relationships were as 
follows: 
 Transport  - 12 years  
 Warehousing  - 9 years  
 Distribution  - 11 years  
 Cold chain  - 6 years  
 Reverse logistics - 10 years  
 
The mobile components of the value chain (transport, distribution & reverse logistics) are the 
oldest outsourced services by these companies. A closer look at the individual responses and ages 
of these relationships showed the oldest relationship at 23 years and the newest at just one year 
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old.  This indicates that outsourcing these services started more than two decades ago and is still 
an industry practice and preference with more companies outsourcing these functions over the 
years. This reflects the practice by most companies in the private sector, the pharmaceutical sector 
inclusive (Meindl & Chopra, 2009; Ciesla, 2015; Bulgurcu & Nakiboglu, 2018). The outsourcing 
of the warehousing and cold chain functions are relatively more recent than those of the transport-
based ones. 
 
5.5.3: Delphi objective DSO3 - To identify the main factors influencing the decision 
to outsource outbound pharmaceutical value chains 
 
This objective was to identify the main factors influencing the decision by pharmaceutical 
companies to outsource their outbound value chains. In results shown in Table 5.11, of the twelve 
reasons (12) compiled from extant literature on studies in other countries and industries/sectors, 
the panelists had a very strong consensus and ranked focus on core competence & reduction of 
costs as the most significant reasons while they outsource their outbound value chains comprising 
the logistic functions under consideration in this study with mean scores of 9 on each 
variable/reason. In the last two and half decades, outsourcing has developed into one of the most 
significant strategies organizations use to manage their supply chains (Akbari, 2018; Akbari & 
Hopkins, 2016).  
 
Due to the complexities and speed of service delivery in businesses nowadays, outbound logistics 
is crucial to achieving organizational competitiveness. (Konig and Spinler, 2016). Furthermore, 
and as confirmed in this study, organizations have progressively focused on their core 
competencies and give this as one of one the underlying reasons while they outsource their non-
core outbound value chain activities to third-party providers (Paltriccia, & Tiacci, 2016; Konig 
and Zhao et al., 2014; Spinler, 2016; Marasco, 2008; Awe et al., 2018;  Gazley, & Simmonds, 
2018). According to Awe et al. (2018:371), “most global firms are outsourcing various functions 
of their firms to save time, cost, and intellectual resources, thus utilize their core competencies 
for their primary competitive strategies. Outsourcing secondary activities have primarily enabled 
companies into rechanneling their energies toward focusing on the primary value chain activities 
and strengthening their core strategies”.  Cost reduction as reflected in this study, is a popular 
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reason while organizations outsource their supply chains. According to various studies, there are 
other several drivers and reasons behind outsourcing by organizations, but cost optimization is 
one of the most considered (Iqbal & Dad, 2013; Ndubisi & Nygaard, 2018).  Other reasons given 
in this study while the pharmaceutical companies outsource their value chain is flexibility, market 
expansion and customer service with mean values of 8. Whether in operations or in staffing, 
outsourcing has been found to accord organizations some degree of flexibility as it provides the 
outsourcing companies the flexibility to hire only when the need arises, in addition to avoiding 
the payment of expensive employees’ benefits (Jiang et al., 2006).  Furthermore, several studies 
reports that outsourcing can also provide greater flexibility in the ability of the outsourcing 
company to cope with the various dynamics in the marketplace (Power et al., 2006; Somuyiwa et 
al., 2015; Gazley, & Simmonds, 2018). Flexibility seems to be a major driver in terms of scope 
and nature of product or service. Hrušecká et al. (2015) noted that while organizations outsourcing 
at the international level have achieving cost advantages as a key rational, those outsourcing 
domestically, have as a key motivation, capacity flexibility. Companies need quicker ways of 
addressing customers’ needs and one of the ways of accomplishing this is through outsourcing. 
Viewed from another angle, outsourcing may also be regarded as a means of reducing the risks of 
the company through sharing them with the 3rd parties and in the process, attain the positive 
elements of the third party suppliers (Kremic et al., 2006). Some regard the improvement in their 
operational and supply chain flexibility as a rationale for outsourcing (Gobble, 2013; Yeo, & 
Saboori-Deilami, 2017; Gazley, & Simmonds, 2018). One of the pros of outsourcing, which also 
drives the process as reflected in this study, is customer service. Gazley and Simmonds (2018) 
noted that the access to 24/7 customer service for a fraction of the price is an incentive for 
outsourcing by organizations.   
 
Nigeria, like many other African countries has undergone several difficulties and instabilities 
arising from political and social changes. However, reforms in the economies with the attendant 
increase in development and direct foreign investments have had positive impact on these 
economies. As a result, market expansion and improvement in their attractiveness to foreign 
investors have been recorded (African Economic Outlook, 2015; El Baz et al., 2019). The positive 
side of this development is that for both local and international companies, outsourcing their 
outbound value chains has been a means of achieving the expansion of their markets.  This has 
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also been confirmed from the results of this study. To a lesser extent, the other reasons the 
pharmaceutical companies outsource their outbound value chain in addition to the ones already 
discussed are lack of capacity and in-house expertise. This is the practice in many countries and 
companies as validated by earlier studies (Hrušecká et al., 2015).  This is often the case with most 
sectors including the pharmaceutical as enormous capital will have to be deployed if the 
companies acquires the requisite capacity to deliver on its outbound value chain execution 
strategies.  Furthermore, the expert panelists gave corporate strategy as another reason while they 
outsource their outbound value chain.  Even though this reason doesn’t rate as high as the earlier 
ones, it has been established that the decision to outsource the value chains is neither operational, 
tactical nor functional but strategic. Nowadays, companies do not compete directly, but through 
their supply chains (Christopher, 2011).  On account of this, most companies take the decisions 
on outsourcing as a strategic one which derives from the overall corporate strategy of the 
organization.   
 
Finally, in this study, the expert panelists rated lowly and with a lesser consensus (mean valued 
of 7), other factors and reasons driving their outsourcing decisions as industry best practice, 
technological advancement, access to specialised skills, and transfer of risks to 3PL. These 
reasons though important, do not count as very critical and most of them are embedded and 
accommodated in the earlier most critical reasons while these organizations outsource their 
outbound pharmaceutical value chains. 
 
5.5.4: Delphi objective DSO4 - To identify the level of satisfaction of the outbound 
supply chain services currently being outsourced by the Pharmaceutical companies 
 
This objective was to determine from the user’s perspective, the level of satisfaction experienced 
by those who outsource their outbound pharmaceutical value chains. The specific services being 
surveyed here are the logistics functions of Transport - both long-distance haulage and distribution 
and reverse (logistics) services, warehousing and cold chain services. The results showed a higher 
satisfaction level from warehousing services higher than those of the mobile elements (transport) 
and cold chain services.  This is a reversal of the degree of outsourcing of these services especially 
between transport and warehousing services which showed transportation as the most outsourced 
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services. In all, they expressed satisfaction with the outsourced services, albeit to a varying 
degrees and levels.  
 
Positive satisfaction levels by users of outsourced service in developed economies like the US 
and Australia have been reported in other studies (Bhatnagar et al., 1999; Lieb, 1992). 
Comparative studies on logistics outsourcing in Mexico, Europe and the US showed a difference 
between the status in these countries with the firms in Mexico placing more emphasis on focus 
on core competency and customer service while those in US and Europe were more concerned 
with the tactical and integration of the logistics services (Arroyo et al., 2006). Only few studies 
have been carried out in developing countries on the degree/usage of 3PL services from the 
perspectives of the user as is being done in this study. The results of studies in Ghana and South 
Africa showed that the logistics services in these countries are less integrated like those obtainable 
in US & Europe but more operational in nature (Cilliers & Nagel, 1994; Sohail et al., 2004).  
Studies in Malaysia by Sohail and Sohal (2003) concluded that users of 3PL services in that 
country were generally satisfied. Rahman (2011) found a high level (86%) of satisfaction among 
users of 3PL services in Australia. 
 
5.5.5: Delphi objective DSO5 - To determine the underlying risk factors in the 
outsourcing relationship 
 
This objective was to access the level of risks associated with the outsourcing of outbound 
pharmaceutical value chains. From the results of this study, out of the total of fifteen (15) possible 
risks compiled from literature, the top two (2) identified by the expert panelists as the most critical 
are 3PL underperformance and service level not achieved. This reflects the fears these companies 
express in their outsourced relationship as these risks have the potentials of causing the strategic 
decision to outsource fail with negative consequences on the companies’ performance.   Inspite 
of  the benefits in outsourcing, there are potential risks associated with it.  According to El Mokrini 
et al. (2016:1239), “Outsourcing functions such as logistics has become an industry trend towards 
cost-effectiveness and high service level performance. Many firms have acknowledged the 
benefits of relying on external experts in a need to empower their abilities. The pharmaceutical 
industry in particular is challenged by constant evolution of their development and manufacturing 
processes. Outsourcing logistics becomes then an attractive option for firms to focus on their core 
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competencies. However, alongside the numerous benefits of outsourcing, various risks arise with 
the implementation of this option”.  Enyinda et al. (2009) in their study classified the risks 
associated with outsourcing pharmaceutical supply chains into four - regulatory, operational, 
technical and corporate social responsibility risks.  Later study by Li-Jun (2012) five types of risks 
to include: contract risk, associated with the inability of the 3PL to fulfil its contractual 
obligations; management risk, which arises from differences in management styles of the two 
organizations; information risk, arising from poor information management by the 3PL; market 
risk from changes in market dynamics and financial risk when the financial deliverables from the 
outsourcing process are unmet. Furthermore, other risks that have been reported include 
relationship, asset and competence risks (Hrušecká et al., 2015).  
 
Other risks from this study with moderate to high level of impact and consensus among the expert 
panelists are corporate governance structure of the 3PL organization, value misalignment, loss of 
confidentiality and loss of operational flexibility. These are potential risks associated with the 
structure and operating system and culture of the 3PL organizations that will impact on their ability 
and capacity to deliver on their contractual obligations.  Given that most of these outsourcing 
companies are multinational and publicly quoted companies with high ethical, corporate 
governance and value systems, the rating and ranking assigned to them by the expert panelists is 
understandable.  As shown and confirmed in this result, data security, increased compliance risk 
and loss of control are risks that have been reported in other studies involving pharmaceutical 
supply chain outsourcing (Kamath et al., 2014). Relph & Parker (2014) in their studies identified 
the loss of direct customer interface as obtainable in the outsourcing of transportation of products 
to the final customers and competency gap by the outsourcing companies as potential risks that 
are associated with outsourcing. This study ranks loss of flexibility as a moderate risk. Conferment 
of flexibility or lack of it are opposite sides of an attribute that can manifest as either a benefit (as 
has been reported in this and other studies) or a risk. Sandhu et al. (2018) report that outsourcing 
diminishes the overall flexibility of an organization especially when there is fixed-time contract to 
be executed.  They opine that the architecture of an outsourced relationship will not be quick 
enough to address the requirements of such contracts and engagement.  
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Other risk factors with lower consensus/impact in this study are vendor employee turnover, 
undertrained vendor’s employees, obsolete technology, loss of confidentiality, 3PL internal HR 
issues.  At the lowest rating of the risks considered by the panel members are the risks of loss of 
expertise and control over the outsourced function. The low ranking of these risks are probably 
due to the mitigating policies that the outsourcing companies have in place and the probable impact 
on their organizations. In a similar dimension analogous to loss of expertise, Sandhu et al. (2018) 
reported in their study, diminishing innovation as a major with the outsourcing organization’s 
dependency on the 3PL service provider with the consequence of their inability to address ever-
increasing requirements of customers (Min et al., 2013).  
 
There is a level of risk associated with every form of business tasks but the risk increases with 
outsourced tasks due to the complexity involved with SC and the increasing number of 
stakeholders in the chains (Gandhi et al., 2012). In summary, there is no outsourcing relationship 
that is risk-free. A careful and comprehensive cost-benefit analysis is recommended before the 
strategic decision to outsource a customer-facing part of the company’s supply chain like the 
outbound value chain (Schmeisser, 2013) 
 
 
5.5.6: Delphi objective DSO6 - To determine the criteria to a successful selection and 
outsourcing relationship with a 3rd Party Service Provider 
 
This objective was to determine which criteria the outsourcing organizations use to select their 
service providers. The decision to outsource outbound SC activities to 3PL service provider who 
will deliver effective and efficient service is regarded as a strategic one. Hence, a decision to 
undertake outsourcing without due consideration to the overall strategic objectives of the 
outsourcing company cannot produce the expected benefits of the decision (Alkhatib, 2017).  
Unlike the classical outsourcing process which is short-term and restricted in scope and outlook 
(Ho et al., 2015), SC outsourcing is strategic, long-term and multi-dimensional (Chai & Ngai, 
2015; Ho et al., 2015). Different selection criteria and methods have been employed by several 
organizations and are the subject of various studies (Alkhatib, 2017).  
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In this study, sixteen (16) selection criteria were investigated and considered by the expert 
panelists. Of this list of criteria, two – speed of service delivery and service reliability were 
considered very critical and rated very high with a perfect consensus and mean of 10. This is in 
sync with the earlier consensus on the anticipated benefits from the outsourcing in their responses 
for the rationale behind the outsourcing decision.  Diverse criteria have been used for 3PL service 
providers’ selection (Jian-Jun et al., 2015). Over time and from different studies and literature, 
the most prominent of them are price, quality, flexibility and services. (Alkhatib, 2017).   In this 
study, other criteria with very strong agreement among the expert panelists are financial strength, 
operational flexibility, pedigree/history of performance, quality policies/procedures and 
geographical spread.  All except geographical spread have been reported as selection criteria in 
many studies. Studies show variances in the criteria used by companies from different industries 
to select their 3PL service providers (Hwang et al., 2016). The inclusion of geographical spread 
in this study as a criterion instead of geographical location (Sandhu et al., 2018) brings a unique 
dimension to the peculiarity of the operating environment. In Nigeria, unlike some other countries, 
the road infrastructure imposes a constraint in the delivery of products across the country and 
hence the physical presence of a 3PL service provider as seen in network of warehouses and 
depots is a unique selling proposition and competitive advantage.  Every organization should set 
benchmarks for the selection of their 3PL service providers to guarantee present and future 
requirements (Humphreys et al., 2011; Kumar et al., 2011; Min et al., 2013). Sandhu et al. (2018) 
report that, before selecting a 3PL partner, it is necessary for organizations to first determine the 
critical success factors for the outsourced relationship.  These factors will contribute significantly 
to the selection process. Coming out from this study as the selection of least importance are 
availability of latest ICT tools, corporate values, flexible payment regimen and indemnity. These 
criteria though important, but not as critical as the ones earlier listed and discussed given the roles 
they play in the delivery of service by 3rd parties, vis-à-vis the other more critical selection criteria. 
 
Selecting service providers is multidimensional and more systematic than just scanning a list of 
prices and quotes from potential partners.  It involves several factors which impact on the selection 
process in different ways (Ho et al. 2012). Conventionally, the selection process has often relied 
on the knowledge and understanding (though sometimes limited) by the decision-makers and the 
subjective judgment that emanate from such understanding.  More often than not, such 
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understanding lacks the depth of system consideration and the theoretical support it requires to 
make a rationale decision and conclusion on the selection process (Xu, 2000). The outcome of 
this approach may not produce optimal decisions in the selection process. Traditional approaches 
for the selection of 3PL service providers have been predominated by the consideration of costs 
elements (Robinson et al., 2013; Weber et al., 1991). Nowadays, as more organizations engage 
in strategic relationships with 3PL service providers and treat them as strategic partners with long-
term contracts, a set of more wide-ranging quantitative and qualitative selection criteria have been 
adopted.  Some of these criteria include dimensions that incorporate customer satisfaction, 
political and social elements apart from the traditional and conventional costs, service delivery 
and quality considerations (Liu & Wang, 2009; Robinson et al., 2013). 
 
5.5.7: Delphi objective DS07 - To evaluate the vital pre-selection activities by the 
outsourcing organizations. 
 
This objective was to evaluate different activities engaged by the outsourcing organizations prior 
to selecting a 3PL service provider.  This is a further step in the selection process. It contains 
activities compiled from previous studies and the researcher that the expert panelists responded 
to, giving an indication of the type and scale of the activities listed here. Out of the 15 listed 
activities, the experts rated and ranked highest, 5 activities - analysing present costs of function(s), 
contract preparation & preparation, adequate due diligence and visiting 3PLs’ locations. These 
activities are the most critical steps taken by the organizations to assure themselves that every 
caution has been taken to enter into a well-thought relationship with the right partner, considering 
the strategic nature of these relationships.  
 
These activities contain two major initiatives: the internal - to ascertain the “as is” position of the 
company with respect to the costs and other dynamics of the logistics functions being outsourced,  
and the external – to conduct a comprehensive due diligence, including physical visits to the 
potential 3PL service providers’ locations with a view to confirming the facts and claims that may 
have been made by them in responding to the advertised  RFQ (request for quotes) for the logistics 
services.  Studies have shown that outsourcing companies go through these rigorous activities and 
steps, painstakingly and sometimes spending about 6 to 12 months in the whole process, 
engaging/involving different cadres of people in the organization (Bhattacharya et al., 2013). 
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These activities are proactive in nature, designed to mitigate the outsourcing risks before the final 
decision is made (Andersson & Norrman, 2003). 
 
One of the most comprehensive articles on the framework for pre-selection activities and steps 
for pharmaceutical logistics outsourcing is that by USAID (2014). Even though the framework 
was developed for use by the public sector, it nonetheless contains useful steps that are applicable 
to the private sector. After the preliminary internal assessment of the organization’s internal 
strength, capabilities and regulatory environment, the framework lists the following critical pre-
selection activities prior to the final outsourcing decision: 
I. Identification of the organization’s core competencies 
II. Conducting a cost-benefit analysis that is realistic. 
III. Design and negotiate a balanced contract with the requisite partners’ alignment and 
provision for transition to the new relationship 
IV. Establishing a project implementation group saddled with the responsibility of managing 
the service procurement 
V. Building or hiring the capacity to manage contract  
VI. Recruiting the 3PL service provider. 
 
It is obvious that the pre-selection activities for selection of pharmaceutical 3PL service providers 
is more rigorous than for other sectors, on account of the nature of the products (medicines) and 
the regulatory issues around them. Following the above most critical pre-selection activities, the 
expert panelists also had a high consensus (8) on the these activities below, even though they rank 
lower in terms of importance and criticality than the earlier discussed ones.  They include: 
I. Developing service levels agreement (SLA) 
II. Preparing an exit plans/provisions 
III. Developing a back-up plan 
IV. Engaging present clients of potential 3PL partner 
V. Corporate governance checks 
Once again, a look at the above activities puts them into two main categories, internal tasks – 
designed to develop some proactive risk mitigation and back-up plans and the external tasks – to 
conduct a deeper due diligence on the potential 3PL service provider. 
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The next set of activities are actually very close to the earlier ones.  The expert panelists ranked 
and rated them very close to the last set of activities and hence can be accorded the about the same 
degree of importance and materiality to the outsourcing process and decision.  This list contains 
three (3) activities: appointing a relationship manager; developing critical proactive corrective & 
preventive action (CAPA) plans and verification of listed references.  These activities are 
designed to establish the internal capabilities for managing the transition and on the side of the 
potential 3PL partner, go a step further to conduct another due diligence about their innate ability 
to deliver their services from the experiences testimony and references from their present credible 
(and sometimes, past) service users/customers. 
 
The last set of pre-selection activities - developing a transition plan and advertising a request for 
proposal (RFP) were ranked/rated least by the expert panelists. The first activity (developing a 
transition plan) was probably rated least because of their earlier high ranking of appointing a 
relationship manager who for most organizations will be saddled with the responsibility of birthing 
a comprehensive transition plan.  Concerning the issue of RFP, some respondents may have 
alternative  means of contacting potential 3PL partners such as referral from home countries, since 
many are multi-nationals for already exiting outsourced relationship by the parent companies and 
referrals from other organizations attesting to their service delivery and quality.  This may be an 
indication of how controlled, the costs for outsourcing may be for these organizations.   
 
5.5.8: Delphi objective DSO8 - To determine the challenges in the pharmaceutical 
outbound value chains 
This objective, unlike the earlier ones on the outsourcing of the outbound pharmaceutical value 
chains was to determine the challenges facing the outbound pharmaceutical value chains.  
 
From the results shown in Table 5.17, the expert panelists rated and ranked the challenges 
associated with infrastructure (Road & Power) as the most critical challenges of the outbound 
pharmaceutical value chains in Nigeria. Given the nature of the products in this sector/industry, 
it is not surprising to see these challenges, especially power supply as the most critical.  
Throughout the supply chain, steady and adequate power is very important in a highly-regulated 
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sector with temperature-sensitive products like drugs.  Nigeria like some most other sub-Saharan 
African countries still struggles with steady and adequate power supply and good road 
infrastructure needed to accelerate the country’s development. Notwithstanding the efforts made 
and the various economic developmental strides and growth that have been recorded by in many 
Sub-Saharan African countries, persistent infrastructure deficits still pose a number of challenges. 
(Arewa, 2016). This is particularly worrisome in the supply chains of pharmaceuticals where 
steady, uninterrupted electricity is required for the storage and potency of thermolabile products 
like vaccines and antibiotics.  The absence of a stable source of power also negatively affects 
certain aspects of the pharmaceutical supply chains especially the cold chains (Yakum et al., 
2015).  
 
This infrastructural deficit has been acknowledged as a plague to the productive sector and 
businesses generally and one of the most substantial structural barriers in the health systems of sub 
Saharan African countries (Fowkes et al., 2016; Ettah, 2017). In comparison with other economies 
like the middle- and high-income countries, the sub-region has one of the least-developed road 
networks with approximately 200 metres of roads per km2 paved compared to 1400 metres in high-
income countries (Schürenberg-Frosch, 2014).  Delivering pharmaceutical products across these 
decrepit and sometimes, almost impossible to navigate roads, over hundreds of kilometer is an 
exogenous one which, far beyond the purview and control of the pharmaceutical companies 
continues to impact negatively on the efficiency of their outbound value chains.   Next to the 
challenges of road & power infrastructure, the expert panelists ranked/rated another external 
problem –inadequate policy/regulation and absence of competent 3PL service providers. The 
pharmaceutical sector is one of the most regulated sectors in any country, Nigeria inclusive, on 
account of the object (drugs) and subject (human) of the products.  The most stringent requirements 
and standards are imposed on organizations involved with the handling of these products 
throughout the chain. Despite the foregoing, a lot of lapses exist in the regulatory framework of 
the sector.  From policy formation and/or enforcement of existing policies and laws, gaps exist, 
which have been capitalized by unscrupulous elements who make merchandize of the system for 
their selfish, financial gains. In Nigeria and some other sub-Saharan African countries, weak 
regulatory structure impact negatively on the pharmaceutical supply chains. Several of these 
national regulatory bodies and agencies in these countries lack adequate resources needed to 
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control the origin and inflow of medicines being pushed into the outbound supply chains (Preston 
et al., 2012). This is not only a challenge in itself, it also gives rise to a critical problem of poor 
quality medicines in the pharmaceutical supply chains (Giralt et al., 2017). It has been reported 
that as high as 90% of national drug regulatory bodies in SSA are unable to effectively discharge 
their basic regulatory functions (Giralt et al., 2017). Absence of competent 3PL service providers 
is also a challenge to effective management of outbound pharmaceutical supply chains in Nigeria. 
The 3PL Industry in Nigeria is still underdeveloped and dominated by some of the competent 3PL 
service providers like DHL & UPS who are multinational companies. The industry is very 
fragmented with many small privately-owned firms serving mostly in other sectors like Consumer 
Packaged Goods and Telecoms, where regulatory requirements are not as stringent as those 
obtainable in the Pharmaceutical sector. Other organized players like MDS Logistics (a partnership 
between UAC of Nigeria & Imperial Logistics of South Africa) are also prominent in the sector 
and in the last decade have been serving the sector. There is still however a gap of scale and 
competence in the 3PL sector in Nigeria, accounting in part, to the opinions expressed by the expert 
panelists.   
 
The least ranked set of challenges by the expert panelists are the somewhat-related issues that are 
associated with human resources and skill set - lack of skilled personnel and pilferages along the 
chain.  Of the two, pilferages along the vain was ranted the least critical challenge as in the opinion 
of the expert panelists, indemnity and other forms of product insurance are in place to mitigate this 
challenge. 
 
5.5.9: Delphi objective DSO9 - To identify the desired outcomes of outsourcing 
outbound pharmaceutical value chains 
 
This objective was to identify the outcomes and/or benefits these organizations desire to derive 
from outsourcing their outbound pharmaceutical value chains. In their responses, the expert 
panelists rated highest with a very strong consensus, the focus on core competence as the most 
desired outcome.  This is in sync with the results for the rationale behind their outsourcing and 
studies from other economies and sectors. As already established and acknowledged, these 
logistics services are considered non-core to the organizations and hence the decision to outsource 
them to free from the organization, valuable management time to focus on other critical core 
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activities (Paltriccia, & Tiacci, 2016; Konig and Zhao et al., 2014; Spinler, 2016; Marasco, 2008; 
Awe et al., 2018;  Gazley & Simmonds, 2018). According to Awe et al. (2018), besides core 
competencies’ focus, organizations regard reduction in costs as another critical reason while they 
outsource.  Consequently, it would seem logical that, just like the strong consensus and rating the 
expert panelists gave for focus on core competency as the most significant role of outsourcing in 
their organizations, they will also rate and rank reduction in cost as another significant outcome of 
outsourcing. Conversely, in this study, the expert panelists think otherwise and accordingly, have 
strong consensus about and rank geographical representation, reduced capital expenditure, 
improvement in customer service, and speed & agility as other significant benefits and desired 
outcomes of outsourcing in their organizations.  
 
The outcome of reduced costs is rated at a lower consensus. These results reflect the practical 
realities in the priorities of most companies operating in Nigeria where speed and agility are critical 
imperatives for excellent customer service and competitive advantage in the marketplace.  With 
most of these companies based in Lagos, these factors will be very critical in the execution of their 
channel strategy and quest to get their finished products from their points of origin in Lagos, South 
West, Nigeria to other locations and regions in the country with some as far as hundreds of 
kilometers away from Lagos. This is more so in a country with vast population of about 190million 
and a geography spanning about 1million square kilometers. Outsourcing delivers value in these 
firms’ ability to serve well and fast, the customers, their geographical locations notwithstanding. 
Value is created through the speed of service delivery at an affordable price point (Banerjee & 
Williams, 2009). This rating and ranking of this benefit/desired outcome that displaces “reduction 
in costs” also shows where the operational cost drivers of their organizations lie – in the cost of 
capital.  This cost in Nigeria is on the average, higher than those obtainable in other regions and 
continents of the world. Survey data (Iarossi, G/The World Bank, 2010:3), confirm this 
disadvantaged position stating that “firms in Africa pay, on average, an interest rate of 15 
percent—close to 5 percentage points more than firms in East Asia and 2 percentage points more 
than those in South Asia, in nominal terms”. However, given the strategic role outsourced logistics 
plays, for most organizations, the benefits of outbound value chains outsourcing transcend cost 
savings alone (Min, 2013). However, the expert panelists agreed that there is a moderate cost 
saving from the outsourcing of outbound pharmaceutical value chains. Also from this study, at a 
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lower level of benefits and ranking are efficiency, access to specialised skills, market share and 
indigenous expertise as the other roles the panelists listed outsourcing can play. Relph & Parker 
(2014:23) affirms that “the rapid growth of outsourcing suggests that both public and private 
organizations expect benefit from outsourcing. Naturally, different organizations in varying 
circumstances will expect different benefits”. The benefits and outcomes of outsourcing far 
outweigh the risks and challenges.  Accordingly, logistics outsourcing has witnessed growth, with 
attendant growth in the 3PL industry in the last two decades (Min, 2013).  
 
5.5.10: Delphi objective DSO10 - To determine the future pivotal context of the 
pharmaceutical distribution in Nigeria 
  
Following the responses and opinions of the expert panelists to the challenges of the outbound 
pharmaceutical supply chains as discussed in DS09, they were asked this open-ended question: 
“What do you envisage will be the pivotal context of the pharmaceutical distribution policy in the 
next 10 years?”.  10 of the experts responded as reproduced in verbatim below: 
 
1. Control of access & implementation of good distribution practice. 
2. The current chaotic drug distribution system needs to be sanitized with long lasting 
solution. 
3. Enforcement & implementation of the National Drug Distribution policy 
4. Provision of infrastructure & enforcement of policies towards a structured and 
better regulated distribution system that will include operations of wholesale 
outlets in the distribution chain. 
5. Government-driven national distribution centres, FDI increase, completion and 
erosion of margins, improvement of governance.  
6. More integrated approach with greater government oversight   
7. Mega drug distribution centers and closure of open drug markets 
8. There will be specialization in line with the new drug distribution guidelines 
9. Full implementation of the National Drug Distribution Guidelines (NDDG) 
integrated with an IT platform. This will lead to emergence of specialised and 
definitely resourced distribution companies with capacity to provide demand 
fulfilment on behalf of  its clients  (importers & manufacturers) 
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10. To streamline the chaotic drug distribution and have medicines delivered to 
consumers with intact integrity 
11. Professional and ethical access to quality, safe and affordable medicines to all. 
As earlier described under methodology, these responses were analysed with the Qualitative 
Content Analysis (QCA) technique (Forman & Damschroder, 2015).  Accordingly, the following 
thematic summative constructs were deducted from their responses as the pivotal of future 
pharmaceutical distribution policy in Nigeria 
1. Effective IT-driven,  integrated pharmaceutical distribution system 
2. Controlled access to affordable and quality medicines 
3. Improved public sector corporate governance and regulatory structure 
4. Provision of enabling infrastructure and enhanced policy enforcement framework 
 
5.5.11: Other Critical Issues affecting Pharmaceutical Supply Chains & outsourcing 
in Nigeria 
As earlier listed, in the second open-ended question, the expert panelists were requested to identify 
other issues affecting pharmaceutical outbound supply chains and outsourcing that may have been 
omitted from the questions above. They listed the following: 
 
1. Lack of credible industry data for planning & accurate forecasting to help implementing 
of outsourced services 
2. Enhanced regulation of the distribution system to a more regulated structure 
3. Few reliable and structured 3PL service providers (may be one). There is need for healthier 
competition to lift up/expand the industry. 
4. Soft infrastructure (human resource) , insurance, unregulated markets, financing 
5. Sustainability/Environmental considerations 
6. Law enforcement agencies e.g. the National Drug Laws Enforcement Agency (NDLEA) 
and the Police cause unnecessary harassment/ delays. 
7. Regulatory compliance by the outsourcing company 
8. Compliance by the 3PL staff to our business ethics, need for training and retraining of 
staff in the face of high staff attrition, know-how/control of products, getting through the 
last mile in good condition. 
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9. Multiple taxation on roads by various states local government, insecurity issues 
10. The fragmented nature of the Pharma distribution sector, working capital issues- credit 
industry, issues handling temperature controlled substances 
 
Utilizing the QCA technique similarly, the following were the summative thematic constructs 
deducted from their responses as critical issues associated with outbound pharmaceutical supply 
chains and the outsourcing in Nigeria: 
 
1. Dearth of capable and well-structured 3PL service providers with credible ethical and 
regulatory compliance systems 
2. Burdens of multiple taxation and law enforcement agents/agencies along the supply chains 
3. Unstructured and poorly-regulated outbound pharmaceutical distribution system 
4. Lack of skilled personnel and reliable industry data for effective planning and 
management of outsourced relationships. 
 
5.6: Conclusion  
Chapter five presented the results and discussions of the Delphi study. Calculations for the 
impact/influence level was done for the responses to all the questions by the expert panelists as 
they relate to the question groups addressing different aspects of outsourcing outbound 
pharmaceutical supply  Chains in Nigeria. The age, degree and rationale of outsourcing were 
considered. Also considered were the satisfaction level, critical success/risk factors, selection 
criteria and pre-selection activities relating to the outsourcing process.   
 
The responses of the expert panelists to the two open-ended questions were analysed and 
summarized thematically using the qualitative content analysis technique. Furthermore, the 
discussions of the findings were made under the various objectives earlier set. The findings from 
the expert panelists revealed consensus and coherence on the various issues relating to the Nigerian 
pharmaceutical supply chains and the outsourcing of the outbound segment with distinct patterns 
of peculiar constructs that will be valuable inputs to development the conceptual framework for 
the outsourcing of outbound pharmaceutical value chains in Nigeria.  
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CHAPTER 6 
 
RESULTS OF QUANTITATIVE STUDY 
 
6.1: Introduction  
 
In this chapter, the results of the data obtained from the distributed questionnaires are presented.  
A total of 103 respondents drawn from all the categories of the pharmaceutical sector of Lagos 
State, Nigeria completed the questionnaires out of 133 administered. With three invalid responses, 
this represents 77% response rate.  The respondents were mainly Pharmacists and other relevant 
professionals (supply chain, Finance, Sales & Marketing & Operations) working in the various 
organizations of both private and public sectors of the industry who had knowledge and 
involvement in the outbound supply chains of the organization.  The questionnaire had three main 
sections – A, containing key information about the respondents’ organization, B, containing the 
main body of the questionnaire which had nine (9) main questions (independent variables) and 76 
sub-questions (latent variables) and C, which had the personal information of the respondents. 
 
6.2: Section A – Preliminary information about respondents & organizations 
This section contains key information about the respondents and their respective organizations. 
This information include the gender distribution, academic qualification, professional 
qualification, years of experience, pharmaceutical sector categories of employers, employers’ 
employee number and annual turnover or value of products handled. 
 
6.2.1: Respondents’ gender  
 
The respondents’ gender distribution is presented in Table 6.1. It shows 44 males and 56 females 
responded to the questionnaire. This also represents 44 and 56% of the respondents respectively. 
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Table 6. 1: Gender distribution of respondents 
Gender No % 
Male 44 44 
Female 56 56 
Total 100 100 
 
 
6.2.2: Educational Qualification of Respondents 
From the results shown in Table 6.2, the respondents were all University degree holders with 65 (65%) 
and 35 (35%) holding Bachelor’s and Master’s degrees respectively. 
 
Table 6. 2: Educational qualification of respondents 
Qualification No % 
Bachelor 65 65 
Masters 35 35 
Ph.D 0 0 
Total 100 100 
 
6.2.3: Years of experience of Respondents 
 
Table 6.3 shows the years of relevant professional experience of the respondents.  They averaged 
12 years. 
Table 6. 3: Years of experience of Respondents 
Years of experience No % 
0 – 5 19 19 
6 – 10 22 22 
11 – 15 32 32 
16 – 20 17 17 
21 – 25 6 6 
26 – 30 4 4 
above 30 0 0 
Total 100 100 
  Mean 12.12 
  SD 6.3 
 
6.2.4: Areas of specialization of respondents 
As shown in table 6.4, the respondents were mainly pharmacists rendering pharmaceutical services and 
supply-chain related services (55%). Others were specialists in supply chain management (11%), 
Accountants (6%), operations management (7%). Others (engineering, etc.) accounted for 8%. 
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Table 6. 4: Areas of specialization of respondents 
Area of 
Specialization No % 
Pharmacy 55 55 
Supply Chain 11 11 
Accounting 6 6 
Operations 7 7 
Sales & Marketing 13 13 
Others 8 8 
Total 100 100 
 
 
6.2.5: Categories of Respondents’ Organizations 
The respondents were drawn from all the categories in the Pharmaceutical sector.  As shown in 
Table 6.5, the categories and the respondent from them are multinational manufacturing - 12 
(10.3%), overseas’ manufacturers’ representatives - 8 (6.8%), indigenous manufacturers - 16 
(13.7), importers/distributors - 17 (14.5%), State pharmaceutical services - 30 (25.6%), Local 
government pharmaceutical services – 23 (19.7%) and large pharmacy chains – 11 (9.4%) 
Table 6. 5: Categories of Respondents’ Organizations 
No. Category Responses % 
1 Multinational Manufacturing 12 10.3 
2 Overseas’ Manufacturer’s Representatives 8 6.8 
3 Indigenous Manufacturer 16 13.7 
4 Importer/Distributor 17 14.5 
5 State Pharmaceutical Services 30 25.6 
6 Local Government Pharmaceutical Services 23 19.7 
7 Large Pharmacy Chain 11 9.4 
 
 
6.2.6: Employees’ number of respondents’ organizations 
Table 6.6 shows the employees’ number of the respondents’ organizations. 53 (53%) had less than 
50, 19 (19%) had between 51 – 200 employees, 19 (19%) had between 201 – 500 employees while 
the largest of the organizations - 9 of them had between 501 – 1000 employees.  None of the 
organizations had more than 1000 employees.  
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Table 6. 6: Employee number of respondents’ organizations 
 
Number 
 
Frequency 
 
Percent 
Valid 
Percent 
Cumulative 
Percent 
501 – 1000 9 9.0 9.0 9.0 
201 – 500 19 19.0 19.0 28.0 
51 – 200 19 19.0 19.0 47.0 
Less than 50 53 53.0 53.0 100.0 
 
 
6.2.7: Turnover/value of products handled by respondents’ organizations 
In Table 6.7, the values of the annual turnover or products handled by the respondents’ 
organizations are presented.  As shown in the table, 29 (29%) had less than N100m, 24 (24%) had 
between N100m – N500m, 29 (29%) had between N1b – N5b while 18 (18%) had more than N5b 
as annual turnover or value of products handled. 
Table 6. 7: Turnover/value of products handled by respondents’ organizations 
 
Value (Naira) 
 
Frequency 
 
Percent 
Valid 
Percent 
Cumulative 
Percent 
More than N5b per annum 18 18.0 18.0 18.0 
N1b - N5b per annum 29 29.0 29.0 47.0 
N100m - 500m 24 24.0 24.0 71.0 
Less than N100m 29 29.0 29.0 100.0 
 
6.3: Section B - Results from the responses to the questionnaire  
In this section, the results of the analyses of the responses to the different questions in the 
questionnaire are presented. The software used for all analyses was the statistical analytical 
software - SPSS version 25. On account of the nature of the constructs and questions, Questions 
1to 3 were analysed using descriptive and inferential statistical techniques while exploratory factor 
analytical (EFA) technique was used for questions 4 to 9.  In both instances, the final output/results 
were exported into the tables that are now presented hereunder.    
6.3.1:  Degree of Outsourcing  
This question was intended to determine on the Likert scale of 1 – 5 that was used, the extent to 
which the earlier-listed outbound supply chain functions were outsourced by the responding 
organizations, with 1 representing a very low degree and 5, a very high degree. N represents the 
number of respondents who gave answers/responses to the status of their outsourcing of the 
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services. Some, whose organizations do not outsource the respective functions left the boxes 
unticked as to them, it was not applicable to them.  This explains why N in all cases was not equal 
to 100, which was the total number of the respondents. 
Table 6. 8: Degree of Outsourcing 
   
Transportation 
 
Warehousing 
 
Distribution 
Cold 
Chain 
Reverse 
Logistics 
Mean 3.38 2.74 2.65 2.54 2.63 
N 92 66 63 56 42 
Std. Dev. 1.27 1.49 1.52 1.51 1.43 
 
Accordingly, and as shown in Table 6.8, of the total number of respondents, 92  (92%) responded 
that they outsource transportation to an extent denoted by the mean value of 3.38, which represents 
about 64% outsourcing level. Likewise, 66 (66%) outsource warehousing with just above average 
degree of 2.74 (about 55%), 63 (63%) outsource distribution with mean value of 2.65; 56 (56%) 
outsource cold chain at a mean level of 2.54 (about 51%) while the least number of respondents 
(42) said they outsource reverse logistics at a mean level     
6.3.2:  Age of Outsourcing 
In question 2 of the questionnaire, the respondents were asked to state how long they have 
outsourced the different outbound supply chain functions with the 5 age brackets provided (1 – 3, 
4 – 6, 7 – 9, 10 – 12 and above 12).  
Table 6. 9: Age of Outsourcing - Transportation 
Age 
(years) Frequency Percent 
Cumulative 
Percent 
> 12 24 26.1 26.1 
10 – 12 10 10.9 37.0 
7 – 9 16 17.4 54.3 
4 – 6 23 25.0 79.3 
1 – 3 19 20.7 100.0 
Total 92 100.0   
 
Table 6.9 presents the age of transportation outsourcing with the practice starting more than 12 
years ago with rapid acceptance with 24 (26.1%) of the 92 respondents’ organizations commencing 
outsourcing more 12 years ago.  Lower numbers were recorded at the same time for warehousing, 
distribution, cold chain and reverse logistics as presented in Tables 6.10 for warehousing; Table 
6.11 for distribution; Table 6.12 for cold chain and Table 6.13 for reverse logistics respectively 
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Table 6. 10: Age of Outsourcing - Warehousing 
Age 
(years) Frequency Percent 
Cumulative 
Percent 
> 12 9 13.6 13.6 
10 - 12 12 18.2 31.8 
7 – 9 18 27.3 59.1 
4 – 6 10 15.2 74.2 
1 – 3 17 25.8 100.0 
Total 66 100.0   
 
Table 6. 11: Age of Outsourcing – Distribution 
Age 
(years) Frequency Percent 
Cumulative 
Percent 
> 12 5 7.9 0.0 
10 – 12 8 12.7 12.7 
7 – 9 12 19.0 31.7 
4 – 6 17 27.0 58.7 
1 – 3 21 33.3 92.1 
Total 63 100.0   
 
Table 6. 12: Age of Outsourcing – Cold Chain 
Age 
(years) Frequency Percent 
Cumulative 
Percent 
> 12 8 14.3 14.3 
10 – 12 5 8.9 23.2 
7 – 9 12 21.4 44.6 
4 – 6 8 14.3 58.9 
1 – 3 23 41.1 100.0 
Total 56 100.0   
 
 
Table 6. 13: Age of Outsourcing – Reverse Logistics 
Age 
(years) Frequency Percent 
Cumulative 
Percent 
> 12 4 9.5 9.5 
10 – 12 8 19.0 28.6 
7 – 9 10 23.8 52.4 
4 – 6 6 14.3 66.7 
1 – 3 14 33.3 100.0 
Total 42 100.0   
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6.3.3: Satisfaction from outsourcing 
The levels of satisfaction from the outsourcing of the functions with mean values showing above 
average satisfaction levels as shown in Table 6.14. 
Table 6. 14: Level of satisfaction from outsourced relationships 
   
Transportation 
 
Warehousing 
 
Distribution 
Cold 
Chain 
Reverse 
Logistics 
Mean 3.38 3.25 3.12 3.32 2.98 
N 92 66 63 56 42 
Std. Dev. 1.162 1.321 1.181 1.298 1.352 
 
6.3.4: The rationale for outsourcing 
This section presents the results of the responses on the rational for outsourcing. The items 
descriptive statistics (mean item scores, with their ranking) as well as the results for the exploratory 
factor analysis (EFA) using principal component analysis (PCA) are presented. Prior to the 
commencement of the analyses, a comprehensive definition of all the latent variables was done 
and the results are also provided. 
Table 6.15 shows the dictionary of definition of the latent variables used in question number 4 of 
the questionnaire. 
Table 6. 15: Definition of Latent Variables under rationale for outsourcing 
Code Variable Name Definition 
Q4.1 Cost savings Amount of costs saved from outsourcing 
Q4.2 
Industry best practice Substantive practices obtainable among the leading 
pharmaceutical organizations 
Q4.3 
Technological 
advancement 
Improvement in processes & operations through the use 
of latest technologies 
Q4.4 Flexibility Willingness to accede  to request for process changes 
Q4.5 Lack of Capacity Inability to perform a given task 
Q4.6 
Focus on core competence Concentration on distinctive know-how and ability by the 
organization 
Q4.7 Corporate Strategy Overall & overriding organizational policy and goal 
Q4.8 
Access to Specialised 
skills 
Avenue to acquire abilities to perform technical supply 
chain functions 
Q4.9 Transfer of risks to 3PL Handover of inherent supply chain risks to Third parties 
Q4.10 
Lack of in-house expertise Absence of internal skills to perform supply chain 
function 
Q4.11 
Market expansion Extension of the presence and placement of the 
company’s products in the marketplace  
Q4.12 
Improvement in Customer 
service 
Enhancement in the level and speed of service to 
customers 
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Table 6.16 shows the descriptive statistics for the latent variables and their ranking. 
 
Table 6. 16: Descriptive Statistics 
 
Latent Variables 
 
Mean 
Cronbach's 
Alpha 
 
Ranking 
Cost savings 3.43 0.859 1 
Focus on core competence 3.23 0.821 2 
Improvement in Customer service 3.17 0.839 3 
Flexibility 2.85 0.827 4 
Corporate Strategy 2.79 0.828 5 
Market expansion 2.78 0.821 6 
Lack of Capacity 2.72 0.865 7 
Lack of in-house expertise 2.06 0.844 8 
 
The ranking shows cost savings at the number 1 in the ranking, while focus on core competence, 
number 2, Improvement in Customer service is ranked number 3, while Flexibility is ranked 
number 4. Number 5 in the ranking is Corporate Strategy, while Market expansion, Lack of 
Capacity and Lack of in-house expertise were ranked 6, 7 and 8 respectively. 
Exploratory factor analysis (EFA) is helpful in statistical analysis of data for reduction of variables 
and to show the inter-relationships between the variables (Pallant, 2007).  In this study, EFA was 
conducted using the statistical software, SPSS version 25. Prior to conducting the factor analysis, 
the suitability and adequacy of the data for the analysis was determined. The correlation matrix 
showed many coefficient values of more than 0.30, showing a strong correlation between the 
factors (see Table 6.17). The internal reliability of the scale and composite scores was adequate 
with the Kaiser-Meyer-Olkin (KMO)’s value of 0.83, above the recommended minimum value of 
0.6.  Furthermore, as shown in Table 6.18, the Bartlett’s test of sphericity was statistically 
significant at 0.00 (less than 0.05), thus supporting the factorability of the data. 
The results for the factor analysis are presented in Tables 6.15 to 6.21 and Figure 6.1. The scree 
plot presented in Figure 6.1 shows the point of inflection of the Eigen values and the factors 
extracted and those excluded. 
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Table 6. 17: Correlation Matrix 
  Q4.1 Cost 
savings 
Q4.4 
Flexibility 
Q4.5 
Lack of 
Capacity 
Q4.6 Focus 
on core 
competence 
Q4.7 
Corporate 
Strategy 
Q4.10 
Lack of 
in-house 
expertise 
Q4.11 
Market 
expansion 
Q4.12 
Improvement 
in Customer 
service 
Q4.1 Cost 
savings 
1.000 0.422 0.045 0.438 0.414 0.138 0.245 0.380 
Q4.4 
Flexibility 
0.422 1.000 0.271 0.529 0.595 0.420 0.605 0.556 
Q4.5 Lack of 
Capacity 
0.045 0.271 1.000 0.352 0.312 0.527 0.324 0.047 
Q4.6 Focus 
on core 
competence 
 
0.438 
 
0.529 
 
0.352 
 
1.000 
 
0.638 
 
0.470 
 
0.662 
 
0.508 
Q4.7 
Corporate 
Strategy 
 
0.414 
 
0.595 
 
0.312 
 
0.638 
 
1.000 
 
0.378 
 
0.531 
 
0.492 
Q4.10 Lack 
of in-house 
expertise 
 
0.138 
 
0.420 
 
0.527 
0.470 0.378 1.000 0.541 0.332 
Q4.11 
Market 
expansion 
 
0.245 
 
0.605 
 
0.324 
 
0.662 
 
0.531 
 
0.541 
 
1.000 
 
0.655 
Q4.12 
Improvement 
in Customer 
service 
 
0.380 
 
0.556 
 
0.047 
 
0.508 
 
0.492 
 
0.332 
 
0.655 
 
1.000 
 
Table 6. 18: KMO and Bartlett's Test of Reliability 
Kaiser-Meyer-Olkin Measure of Sampling 
Adequacy. 
 
0.830 
Bartlett's Test of 
Sphericity 
 
Approx. Chi-Square 
 
344.719 
Df 28 
Sig. 0.000 
 
Table 6. 19: Total Variance Explained 
 
 
 
 
 
 
Factor 
 
 
Initial Eigenvalues 
 
Extraction Sums of Squared Loadings 
Rotation 
Sums of 
Squared 
Loadingsa 
 
 
Total 
 
% of 
Variance 
 
Cumulative 
% 
 
 
Total 
 
% of 
Variance 
 
Cumulative % 
 
 
Total 
1 4.073 50.914 50.914 3.649 45.613 45.613 3.410 
2 1.241 15.512 66.426 0.794 9.929 55.541 1.886 
3 0.774 9.673 76.098         
4 0.511 6.387 82.485         
5 0.471 5.885 88.370         
6 0.373 4.663 93.033         
7 0.337 4.217 97.250         
8 0.220 2.750 100.000         
Extraction Method: Principal Axis Factoring. 
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As shown in Table 6.19, the eigenvalue value was set at the conventional 1.00 and factor analysis 
was conducted with principal axis factoring with oblimin rotation. Of the 12 initial latent variables 
listed for the rationale for outsourcing, 2 factors were extracted with 6 and 2 variables each, leaving 
out 4 latent variables with the least impact factor.  The 2 factors extracted accounted for 55% of 
the total variance explained. With Factor 1 accounting for 45.6% and the second factor accounting 
for 9.9% 
 
Table 6.20 shows the communalities values of the latent variables. 
 
 
Table 6. 20: Communalities 
Latent Variables Initial Extraction 
Q4.1 Cost savings 0.319 0.285 
Q4.4 Flexibility 0.523 0.577 
Q4.5 Lack of Capacity 0.360 0.633 
Q4.6 Focus on core competence 0.601 0.632 
Q4.7 Corporate Strategy 0.519 0.549 
Q4.10 Lack of in-house expertise 0.444 0.531 
Q4.11 Market expansion 0.658 0.646 
Q4.12 Improvement in Customer service 0.540 0.590 
                      Extraction Method: Principal Axis Factoring 
 
 
Figure 6. 1: Scree Plot 
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Table 6. 21: Pattern Matrix 
 
Latent Variable  
Factor 
1 2 
Improvement in Customer service 0.807   
Flexibility 0.715   
Focus on core competence 0.683   
Market expansion 0.681   
Corporate Strategy 0.676   
Cost savings 0.570   
Lack of Capacity   0.815 
Lack of in-house expertise   0.587 
 
The Pattern matrix shown in Table 6.21 shows the factors are comprised of the following latent 
variables. Factor 1: Improvement in Customer service, Flexibility, Focus on core competence, 
Market expansion, Corporate Strategy and Cost savings. Factor 2: Lack of Capacity and Lack of 
in-house expertise.  From the relationships between these variables listed above, Factor 1 was 
termed organizational agility & competitiveness while Factor 2 was called lack of internal 
capability 
6.3.5: The critical criteria for selection of 3PL service providers  
This section presents the results of the responses on the critical criteria/factors for the selection of 
third party logistics (3PL) service providers. The items descriptive statistics (mean item scores, 
with their ranking) as well as the results for the exploratory factor analysis (EFA) using principal 
component analysis (PCA) are presented. Prior to the commencement of the analyses, a 
comprehensive definition of all the latent variables was done and the results are also provided. 
Table 6.22 shows the dictionary of definition of the latent variables used in question number 6 of 
the questionnaire. 
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Table 6. 22: Definition of Latent Variables 
Code Variable Name Definition 
Q5.1 
National/geographical 
spread 
Operational/physical presence of 3PL service provider 
in other locations/regions of the country 
Q5.2 Innovation 
Ability to invent and introduce new & better operational 
techniques 
Q5.3 Organizational culture 
Value and cultural system, including modus operandi of 
the organization 
Q5.4 
Customer orientation How the organization positions itself and delivers 
service to the customers 
Q5.5 
Service reliability Consistency and dependability of the organization’s 
services to its customers  
Q5.6 Financial strength Financial assets and structural base of the organization 
Q5.7 
Operational flexibility 3PL’s willingness to accede  to request for operational 
process/policy changes by the customer  
Q5.8 
Pedigree/history of 
performance 
Past history and testimonial of similar services offered 
by the organization 
Q5.9 
Stable industrial relations Consistency in operations in peaceful harmony with 
employees & stakeholders 
Q5.10 
Corporate values The core values and ethics that drive the way the 
organization operates  
Q5.11 
Availability of latest ICT 
tools 
Use of newest communication tools and technology in 
operations by the 3PL 
Q5.12 
Quality policies and 
procedures 
Local acquisition of supply chain management skills 
through outsourcing 
Q5.13 
Management structure & 
expertise 
The skill-set, experience and organogram of the 
organization’s management 
Q5.14 
Speed of service delivery The speed at which customers are served by the 
organization  
Q5.15 
Flexible payment regimen Non-rigid, concessional policy in payment for services 
rendered  
Q5.16 
Indemnity Financial & operational guarantee against losses by the 
outsourced organization 
 
 
Table 6.23 shows the mean item scores for the latent variables and their ranking.   
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Table 6. 23: Descriptive Statistics 
 
Latent Variables 
 
Mean 
Cronbach's 
Alpha 
 
Ranking 
Speed of service delivery 4.12 0.968 1 
Service reliability 4.05 0.968 2 
National/geographical spread 3.88 0.968 3 
Operational flexibility 3.82 0.967 4 
Pedigree/history of performance 3.82 0.965 5 
Financial strength 3.81 0.967 6 
Management structure & expertise 3.78 0.967 7 
Stable industrial relations 3.73 0.967 8 
Corporate values 3.71 0.966 9 
Quality policies and procedures 3.70 0.967 10 
Flexible payment regimen 3.70 0.968 11 
Availability of latest ICT tools 3.68 0.966 12 
Indemnity 3.64 0.968 13 
Customer orientation 3.64 0.967 14 
Innovation 3.47 0.965 15 
Organizational culture 3.38 0.966 16 
 
The ranking shows speed of service delivery as the number 1 in the ranking, while service 
reliability is number 2, national/geographical spread is ranked number 3, while Operational 
flexibility is ranked number 4. Number 5 in the ranking is pedigree/history of performance, while 
financial strength, management structure/expertise and Stable industrial relations were ranked 6, 
7 and 8 respectively. Number 9 is corporate values, while number 10 is Quality policies and 
procedures. Flexible payment regimen, Availability of latest ICT tools, Indemnity, Customer 
orientation, Innovation and Organizational culture completer the ranking at numbers 11, 12, 13, 
14, 15 and 16 respectively.  
As previously explained, EFA was conducted, and prior to conducting the factor analysis, the 
suitability and adequacy of the data for the analysis was determined. The correlation matrix 
showed many coefficient values of more than 0.30, showing a strong correlation between the 
factors (see Table 6.24). The internal reliability of the scale and composite scores was adequate 
with the Cronbach's Alpha value of 0.96, above the recommended minimum value of 0.6.  The 
results for the factor analysis are presented in Tables 6.22 to 6.28 and Figure 6.2. The scree plot 
presented in Figure 6.2 shows the point of inflection of the Eigen values and the factors extracted. 
 
Table 6. 24: Correlation Matrix 
 Latent Variables National
/geogra
phical 
spread 
Innova
tion 
Organizatio
nal culture 
Customer 
orientation 
Service 
reliability 
Financi
al 
strengt
h 
Operation
al 
flexibility 
Pedigree & 
history of 
performan
ce 
Stable 
industri
al 
relations 
Corporat
e values 
Availabilit
y of latest 
ICT tools 
Quality 
policies and 
procedures 
Mgt 
structure 
& expertise 
Speed 
of 
service 
delivery 
Flexible 
paymen
t 
regimen 
Indemnity 
National/geographi
cal spread 
1.000 0.715 0.632 0.542 0.556 0.562 0.519 0.592 0.538 0.534 0.504 0.484 0.426 0.640 0.344 0.413 
Innovation 0.715 1.000 0.782 0.668 0.592 0.554 0.644 0.683 0.663 0.618 0.713 0.612 0.525 0.528 0.548 0.571 
Organizational 
culture 
0.632 0.782 1.000 0.688 0.578 0.396 0.646 0.602 0.667 0.590 0.650 0.614 0.491 0.408 0.484 0.474 
Customer 
orientation 
0.542 0.668 0.688 1.000 0.588 0.502 0.690 0.645 0.546 0.620 0.647 0.529 0.456 0.551 0.327 0.368 
Service reliability 0.556 0.592 0.578 0.588 1.000 0.541 0.762 0.619 0.711 0.639 0.457 0.401 0.404 0.653 0.386 0.353 
Financial strength 0.562 0.554 0.396 0.502 0.541 1.000 0.674 0.661 0.502 0.686 0.486 0.371 0.476 0.652 0.603 0.500 
Operational 
flexibility 
0.519 0.644 0.646 0.690 0.762 0.674 1.000 0.708 0.756 0.677 0.583 0.436 0.416 0.624 0.524 0.481 
Pedigree/history of 
performance 
0.592 0.683 0.602 0.645 0.619 0.661 0.708 1.000 0.651 0.759 0.594 0.511 0.547 0.625 0.546 0.493 
Stable industrial 
relations 
0.538 0.663 0.667 0.546 0.711 0.502 0.756 0.651 1.000 0.699 0.603 0.466 0.557 0.494 0.593 0.518 
Corporate values 0.534 0.618 0.590 0.620 0.639 0.686 0.677 0.759 0.699 1.000 0.594 0.521 0.597 0.569 0.581 0.662 
Availability of 
latest ICT tools 
0.504 0.713 0.650 0.647 0.457 0.486 0.583 0.594 0.603 0.594 1.000 0.697 0.709 0.482 0.554 0.468 
Quality policies 
and procedures 
0.484 0.612 0.614 0.529 0.401 0.371 0.436 0.511 0.466 0.521 0.697 1.000 0.664 0.401 0.425 0.430 
Management 
structure & 
expertise 
0.426 0.525 0.491 0.456 0.404 0.476 0.416 0.547 0.557 0.597 0.709 0.664 1.000 0.490 0.611 0.537 
Speed of service 
delivery 
0.640 0.528 0.408 0.551 0.653 0.652 0.624 0.625 0.494 0.569 0.482 0.401 0.490 1.000 0.466 0.390 
Flexible payment 
regimen 
0.344 0.548 0.484 0.327 0.386 0.603 0.524 0.546 0.593 0.581 0.554 0.425 0.611 0.466 1.000 0.679 
Indemnity 0.413 0.571 0.474 0.368 0.353 0.500 0.481 0.493 0.518 0.662 0.468 0.430 0.537 0.390 0.679 1.000 
Table 6. 25: Test of Reliability 
Cronbach's Alpha N of 
Items 
0.957 16 
 
Table 6. 26: Total Variance Explained 
 
 
Component 
Initial Eigenvalues Extraction Sums of Squared 
Loadings 
Rotation Sums of Squared 
Loadings 
 
Total 
% of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative 
% 
1 9.471 59.192 59.192 9.471 59.192 59.192 4.927 30.796 30.796 
2 1.217 7.607 66.799 1.217 7.607 66.799 3.752 23.453 54.250 
3 1.087 6.795 73.594 1.087 6.795 73.594 3.095 19.344 73.594 
4 0.740 4.628 78.221             
5 0.625 3.906 82.128             
6 0.504 3.153 85.280             
7 0.425 2.654 87.934             
8 0.355 2.221 90.155             
9 0.316 1.978 92.133             
10 0.279 1.742 93.874             
11 0.237 1.483 95.358             
12 0.203 1.272 96.630             
13 0.180 1.128 97.757             
14 0.156 0.978 98.735             
15 0.122 0.765 99.500             
16 0.080 0.500 100.000             
Extraction Method: Principal component analysis. 
 
In Table 6.26, the factor analysis was with principal component analysis with varimax rotation. 
Three (3) factors with eigenvalue of more than 1 were extracted. The 3 factors extracted accounted 
for 73.6% of the total variance explained. Factor 1 accounted for 59.2%, Factor 2, 7.6% and the 
third factor accounted for 6.8% respectively of the total variance explained. 
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Table 6. 27: Communalities 
Latent variables  Initial Extraction 
National/geographical spread 1.000 0.613 
Innovation 1.000 0.774 
Organizational culture 1.000 0.775 
Customer orientation 1.000 0.729 
Service reliability 1.000 0.757 
Financial strength 1.000 0.745 
Operational flexibility 1.000 0.792 
Pedigree/history of performance 1.000 0.724 
Stable industrial relations 1.000 0.669 
Corporate values 1.000 0.755 
Availability of latest ICT tools 1.000 0.780 
Quality policies and procedures 1.000 0.756 
Management structure & expertise 1.000 0.734 
Speed of service delivery 1.000 0.657 
Flexible payment regimen 1.000 0.806 
Indemnity 1.000 0.709 
 
 
Figure 6. 2: Scree Plot 
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Table 6. 28: Rotated Component Matrix 
  
Latent Variables 
Component 
1 2 3 
Service reliability 0.821     
Operational flexibility 0.793     
Speed of service delivery 0.737     
Financial strength 
 
  0.536 
Pedigree/history of performance 0.666     
National/geographical spread 0.622    
Customer orientation 0.611    
Stable industrial relations 0.594    
Corporate values 
 
  0.545 
Quality policies and procedures   0.801   
Availability of latest ICT tools   0.742   
Organizational culture 
 
0.739   
Innovation 
 
0.655   
Flexible payment regimen     0.831 
Indemnity     0.767 
Management structure & expertise   
 
0.630 
Extraction Method: Principal component analysis. 
The rotated component matrix in Table 6.28 shows the factors are comprised of the following 
latent variables: 
Factor 1: Service reliability, Operational flexibility, Speed of service delivery, Pedigree/history of 
performance, National/geographical spread, Customer orientation and Stable industrial relations. 
Factor 2: Quality policies and procedures, Availability of latest ICT tools, Organizational culture 
and Innovation.   
Factor 3: Financial strength, Corporate values, flexible payment regimen, Indemnity and 
Management structure & expertise 
From the relationships between these variables listed above, Factor 1 was termed service 
excellence while Factor 2 was called Technical capability, while Factor 3 was named strong 
financial & corporate governance. 
6.3.6: The critical risks factors for outsourcing  
In this section, the results of the responses for the critical risk factors for outsourcing are presented. 
As in previous sections, the items descriptive statistics (mean item scores, with their ranking) as 
well as the results for the exploratory factor analysis (EFA) using principal component analysis 
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(PCA) are presented. Prior to the commencement of the analyses, a comprehensive definition of 
all the latent variables was done and the results are also provided. 
Table 6.29 shows the dictionary of definition of the latent variables used in question number 7 of 
the questionnaire. 
 
Table 6. 29: Definition of Latent Variables 
Code Variable Name Definition 
Q6.1 3PL Underperformance Delivery of less-than-expected service level by the 3PL 
service provider 
Q6.2 Loss of control of 
outsourced function 
Forfeiture of the ability to control the management of 
supply chain function due to outsourcing 
Q6.3 Loss of expertise Loss of technical know-how and skills in managing 
supply chains due to outsourcing 
Q6.4 Hidden costs New costs hitherto unseen prior to commencement of 
outsourced relationship 
Q6.5 Corporate governance  The system of rules, practices and processes by which 
the 3PL is directed and controlled  
Q6.6 Vendor employee 
turnover 
The rate at which the 3PL loses its employees, 
especially the strategic ones 
Q6.7 Undertrained vendor’s 
employees 
Use of unskilled, undertrained employees by the 3PL to 
execute the outsourced contract  
Q6.8 Obsolete Technology Use of outdated technology by the employees 
Q6.9 Loss of confidentiality Loss of access or restrictions on certain types of 
information due to outsourcing  
Q6.10 Internal HR issues Problems associated employees’ engagement by the 3PL 
service provider  
Q6.11 Cost reduction not 
realised 
Non-realization of the cost savings agreed to/promised 
by the 3PL prior to outsourcing 
Q6.12 Service levels not 
achieved 
Non-attainment of the service levels agreed to/promised 
by the 3PL prior to outsourcing 
Q6.13 Loss of flexibility Loss of ease of changes to supply chain processes after 
outsourcing 
Q6.14 No continuous 
improvement by 3PL 
Lack of sustained enhancement in operations & service 
levels by the 3PL service provider  
Q6.15 Value misalignment Irreconcilable differences in ethics and value systems by 
the 3PL and outsourcing organizations  
 
 
 
 
 
 
 
 
 
 
 
 
 
119 
 
Table 6.30 shows the mean item scores for the latent variables and their ranking. 
 
Table 6. 30: Descriptive Statistics 
 
Latent Variable 
 
Mean 
Cronbach's 
Alpha 
 
Ranking 
Obsolete Technology 3.13 0.950 1 
Undertrained vendor’s employees 3.13 0.949 2 
Service levels not achieved 3.05 0.952 3 
Hidden costs 2.94 0.955 4 
Cost reduction not realised 2.92 0.951 5 
Value misalignment 2.91 0.951 6 
No continuous improvement by 3PL 2.85 0.951 7 
Loss of control of outsourced function 2.85 0.954 8 
Loss of flexibility 2.82 0.952 9 
Vendor employee turnover 2.78 0.951 10 
Loss of expertise 2.77 0.951 11 
Corporate governance 2.75 0.952 12 
Internal HR issues 2.65 0.953 13 
 
The ranking shows Obsolete Technology as the number 1 in the ranking, while Undertrained 
vendor’s employees is number 2, Service levels not achieved is ranked number 3, while Hidden 
costs is ranked number 4. Number 5 in the ranking is Cost reduction not realised, while Value 
misalignment, No continuous improvement by 3PL and Loss of control of outsourced function were 
ranked 6, 7 and 8 respectively. Number 9 is Loss of flexibility, while number 10 is Quality policies 
and procedures. Loss of expertise, corporate governance and Internal HR issues complete the 
ranking at numbers 11, 12 and 13 respectively 
As previously explained, EFA was conducted, and prior to conducting the factor analysis, the 
suitability and adequacy of the data for the analysis was determined. The correlation matrix 
showed many coefficient values of more than 0.30, showing a strong correlation between the 
factors. The internal reliability of the scale and composite scores was adequate with the Cronbach's 
Alpha value of 0.95, above the recommended minimum value of 0.6, thus supporting the 
factorability of the data as shown in Table 6.31. The results for the factor analysis are presented in 
Tables 6.29 to 6.35 and Figure 6.3. The scree plot presented in Figure 6.3 shows the point of 
inflection of the Eigen values and the factors extracted. 
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Table 6. 31: Test of Reliability 
 
Cronbach's Alpha 
Cronbach's Alpha 
Based on 
Standardized Items 
N of Items 
0.953 0.953 15 
 
Table 6. 32: Total Variance Explained 
 
 
 
 
Factor 
 
 
 
Initial Eigenvalues 
 
 
 
Extraction Sums of Squared Loadings 
Rotation 
Sums of 
Squared 
Loadingsa 
Total % of 
Variance 
 
Cumulative % 
 
Total 
 
% of Variance 
 
Cumulative % 
 
Total 
1 7.874 60.569 61 7.523 57.868 57.868 7.154 
2 1.066 8.198 69 0.745 5.734 63.602 5.776 
3 0.807 6.207 75 
    
4 0.671 5.160 80 
    
5 0.472 3.632 84 
    
6 0.391 3.008 87 
    
7 0.353 2.717 89 
    
8 0.322 2.477 92 
    
9 0.296 2.276 94 
    
10 0.275 2.113 96 
    
11 0.238 1.832 98 
    
12 0.146 1.127 99 
    
13 0.089 0.685 100 
    
Extraction Method: Principal Axis factoring. 
 
In Table 6.32, the factor analysis was with principal axis factoring with oblimin rotation. Two (2) 
factors with eigenvalue of more than 1 were extracted. The 2 factors extracted accounted for 63.6% 
of the total variance explained. Factor 1 accounted for 57.8.2% while Factor 2 accounted for 5.7% 
of the total variance explained. 
Table 6. 33: Correlation Matrix 
Latent 
Variables 
Loss of 
control 
of 
outsourc
ed 
function 
 Loss of 
expertise  
Hidde
n costs 
Corporate 
governanc
e 
Vendor 
employe
e 
turnover 
Undertraine
d vendor’s 
employees 
Obsolete 
Technolog
y 
Interna
l HR 
issues 
Cost 
reductio
n not 
realised 
Service 
levels not 
achieved 
Loss of 
flexibility 
No 
continuous 
improv.by 
3PL 
Value 
misalignment 
Loss of 
control of 
outsourced 
function 
1.000              1  0.382 0.588 0.558 0.521 0.566 0.483 0.514 0.485 0.434 0.531 0.454 
Loss of 
expertise 
0.702              1  0.421 0.606 0.647 0.605 0.652 0.539 0.558 0.452 0.555 0.609 0.557 
Hidden costs 0.382              0  1.000 0.385 0.434 0.510 0.423 0.510 0.649 0.599 0.529 0.363 0.333 
Corporate 
governance 
0.588              1  0.385 1.000 0.669 0.583 0.654 0.488 0.518 0.445 0.513 0.546 0.539 
Vendor 
employee 
turnover 
0.558              1  0.434 0.669 1.000 0.793 0.728 0.655 0.590 0.446 0.511 0.632 0.595 
Undertrained 
vendor’s 
employees 
0.521              1  0.510 0.583 0.793 1.000 0.809 0.646 0.597 0.590 0.611 0.634 0.664 
Obsolete 
Technology 
0.566              1  0.423 0.654 0.728 0.809 1.000 0.719 0.603 0.515 0.553 0.738 0.620 
Internal HR 
issues 
0.483              1  0.510 0.488 0.655 0.646 0.719 1.000 0.657 0.586 0.583 0.595 0.524 
Cost reduction 
not realised 
0.514              1  0.649 0.518 0.590 0.597 0.603 0.657 1.000 0.660 0.538 0.549 0.450 
Service levels 
not achieved 
0.485              0  0.599 0.445 0.446 0.590 0.515 0.586 0.660 1.000 0.759 0.621 0.592 
Loss of 
flexibility 
0.434              1  0.529 0.513 0.511 0.611 0.553 0.583 0.538 0.759 1.000 0.655 0.602 
No continuous 
improvement 
by 3PL  
0.531              1  0.363 0.546 0.632 0.634 0.738 0.595 0.549 0.621 0.655 1.000 0.700 
Value 
misalignment 
0.454              1  0.333 0.539 0.595 0.664 0.620 0.524 0.450 0.592 0.602 0.700 1.000 
Table 6. 34: Communalities 
 Latent Variables Initial Extraction 
Loss of control of outsourced 
function 
0.578 0.480 
Loss of expertise 0.662 0.617 
Hidden costs 0.519 0.460 
Corporate governance 0.593 0.562 
Vendor employee turnover 0.757 0.745 
Undertrained vendor’s 
employees 
0.807 0.723 
Obsolete Technology 0.815 0.783 
Internal HR issues 0.653 0.595 
Cost reduction not realised 0.657 0.604 
Service levels not achieved 0.745 0.883 
Loss of flexibility 0.694 0.649 
No continuous improvement by 
3PL  
0.717 0.633 
Value misalignment 0.617 0.535 
 
 
Figure 6. 3: Scree Plot 
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Table 6. 35: Pattern Matrix 
  
Latent Variables 
Factor 
1 2 
Vendor employee turnover 0.949   
Obsolete Technology 0.916   
Loss of expertise 0.796   
Corporate governance 0.783   
Undertrained vendor’s employees 0.751   
Loss of control of outsourced 
function 
0.666   
 No continuous improvement by 
3PL  Provider 
0.634   
Value misalignment 0.585   
Internal HR issues 0.510   
Service levels not achieved   0.914 
Loss of flexibility   0.636 
Hidden costs   0.630 
Cost reduction not realised   0.510 
                                          Extraction Method: Principal axis factoring. 
 
The pattern matrix in Table 6.35 shows the factors are comprised of the following latent variables: 
Factor 1: Vendor employee turnover, obsolete technology, loss of expertise, corporate 
governance, undertrained vendor’s employees, Loss of control of outsourced function, no 
continuous improvement by 3PL service provider, value misalignment and internal HR issues 
Factor 2: Service levels not achieved, loss of flexibility, hidden costs and cost reduction not 
realised 
From the relationships between these variables listed above, Factor 1 was termed Institutional 
inadequacy while Factor 2 was called goals under-realizations. 
6.3.7: Pre-selection activities by outsourcing organizations  
In this section, the results of the responses for the activities undertaken by the outsourcing 
organizations before selecting their 3PL service providers are presented. As in previous sections, 
the items descriptive statistics (mean item scores, with their ranking) as well as the results for the 
exploratory factor analysis (EFA) using principal component analysis (PCA) are presented. Prior 
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to the commencement of the analyses, a comprehensive definition of all the latent variables was 
done and the results are also provided.  
Table 6.36 shows the dictionary of definition of the latent variables used in question number 8 of the 
questionnaire. 
Table 6. 36: Definition of latent variables 
Code Variable Name Definition 
Q7.1 Analysing present costs of function(s) Determination of the costs of supply chain functions by the 
organization prior to outsourcing 
Q7.2 Adequate due diligence Comprehensive appraisal of the 3PL, especially to establish its 
assets and liabilities and evaluate its potentials, structure and 
capability to deliver advertised service(s) 
Q7.3 Advertising a Request for proposal  
(RFP) 
Putting out an advert to solicit for proposals, by the 
outsourcing company for interested 3PL organizations to 
submit theirs business proposals to provide supply chain 
services 
Q7.4 Engaging present clients of potential 
3PL partner 
Discussions with current customers of potential 3PL by the 
outsourcing organizations find out more about their capacity  
to provide advertised services  
Q7.5 Verification of listed references Confirmatory visits to/contacts with people/organizations 
listed by potential 3PL as references   
Q7.6 Developing service levels agreement 
(SLA) 
Developing an agreement to spell out reciprocal service 
levels, commitments and obligations between the organization 
and service provider 
Q7.7 Preparing an exit plans/provisions Making a proactive, contingency plans to exit the outsourced 
relationship should it fail 
Q7.8 Developing a transition plan Developing a plan for seamless transfer of management of 
supply chain functions to a newly contracted 3PL service 
provider  
Q7.9 Developing a back-up plan Developing a fallback position to the management of 
outsourced supply chains function should the need arise  
Q7.10 Contract negotiation A take-and-give discussion of the various provisions and 
obligations of the contract with 3PL service provider  
Q7.11 Contract preparation Preparing the legal document to formalize the engagement of 
the potential 3PL service provider 
Q7.12 Visiting 3PLs’ locations Physical visits to operational locations of 3PL service 
providers to verify claims made in their submission of 
proposal 
Q7.13 Corporate governance checks Confirmatory investigation on the system of rules, practices 
and processes by which the 3PL is directed as stated in their 
response to the RFP 
Q7.14 Appointing a relationship manager The appointment of a manager by the outsourcing 
organization to act as the point of contact (POC) between it 
and the potential 3PL service provider  
Q7.15 Developing critical proactive 
Corrective And Preventive Action 
(CAPA) plans 
A proactive process document for corrective and preventive 
action consisting of improvements to an organization's 
processes taken to eliminate causes of non-conformities or 
other undesirable situations that may arise in the outsourced 
relationship. 
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Table 6.37 shows the mean item scores for the latent variables and their ranking. 
Table 6. 37: Descriptive Statistics 
 
Latent Variables 
 
Mean 
Cronbach's 
Alpha 
 
Ranking 
Adequate due diligence 3.39 0.956 1 
Analysing present costs of function(s) 3.38 0.957 2 
Developing service levels agreement 
(SLA) 
2.82 0.955 3 
Developing a back-up plan 2.81 0.956 4 
Contract preparation 2.77 0.957 5 
Verification of listed references 2.77 0.954 6 
Developing a transition plan 2.66 0.954 7 
Developing critical proactive Corrective 
And Preventive Action (CAPA) plans 
2.55 0.955 8 
Visiting 3PLs’ locations 2.54 0.955 9 
Preparing an exit plans/provisions 2.47 0.954 10 
Appointing a relationship manager 2.40 0.956 11 
Corporate governance checks 2.38 0.955 12 
Advertising a Request for proposal  (RFP) 2.24 0.956 13 
 
The ranking shows Adequate due diligence as the number 1 in the ranking, while Analysing present costs 
of function(s) is number 2, Developing service levels agreement (SLA) is ranked number 3, while 
Developing a back-up plan is ranked number 4. Number 5 in the ranking is Contract preparation, while 
verification of listed references, developing a transition plan and developing critical proactive Corrective 
and Preventive Action (CAPA) plans were ranked 6, 7 and 8 respectively. Number 9 is visiting 3PLs’ 
locations, while number 10 is preparing an exit plans/provisions. Appointing a relationship manager, 
corporate governance checks and advertising a Request for proposal (RFP) complete the ranking at 
numbers 11, 12 and 13 respectively 
The EFA was conducted, and prior to conducting the factor analysis, the suitability and adequacy 
of the data for the analysis was determined. The correlation matrix showed many coefficient values 
of more than 0.30, showing a strong correlation between the factors (see Table 6.37). The internal 
reliability of the scale and composite scores was adequate with the Cronbach's Alpha value of 0.95, 
above the recommended minimum value of 0.6, thus supporting the factorability of the data as 
shown in Table 6.39. The results for the factor analysis are presented below in Tables 6.36 to 6.42 
and Figure 6.4 The scree plot presented in Figure 6.4 shows the point of inflection of the Eigen 
values and the factors extracted. 
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Table 6. 38: Correlation Matrix 
Latent 
Variables 
Analysin
g present 
costs of 
functions 
Adequate 
due 
diligence 
Advertising 
a Request 
for proposal  
(RFP) 
Verification 
of listed 
references 
Dev. 
service 
levels 
agreemen
t (SLA) 
Preparing 
an exit 
plans & 
provisions 
Developi
ng a 
transition 
plan 
Developing a 
back-up plan 
Contract 
preparatio
n 
Visiting 
3PLs’ 
locations 
Corporate 
governanc
e checks 
Appointing 
a 
relationshi
p manager 
Developing 
critical 
CAPA) 
plans 
Analysing 
present costs 
of function(s) 
1.000 0.845 0.540 0.700 0.663 0.586 0.606 0.651 0.632 0.546 0.494 0.499 0.555 
Adequate due 
diligence 
0.845 1.000 0.578 0.625 0.695 0.658 0.701 0.615 0.582 0.547 0.552 0.516 0.590 
Advertising a 
Request for 
proposal  
(RFP) 
0.540 0.578 1.000 0.691 0.659 0.811 0.741 0.575 0.482 0.590 0.607 0.567 0.537 
Verification of 
listed 
references 
0.700 0.625 0.691 1.000 0.721 0.770 0.716 0.795 0.618 0.668 0.557 0.608 0.585 
Developing 
service levels 
agreement 
(SLA) 
0.663 0.695 0.659 0.721 1.000 0.717 0.689 0.566 0.627 0.677 0.646 0.586 0.648 
Preparing an 
exit 
plans/provisio
ns 
0.586 0.658 0.811 0.770 0.717 1.000 0.870 0.718 0.585 0.651 0.692 0.606 0.705 
Developing a 
transition plan 
0.606 0.701 0.741 0.716 0.689 0.870 1.000 0.771 0.575 0.594 0.669 0.638 0.672 
Developing a 
back-up plan 
0.651 0.615 0.575 0.795 0.566 0.718 0.771 1.000 0.547 0.574 0.536 0.575 0.595 
Contract 
preparation 
0.632 0.582 0.482 0.618 0.627 0.585 0.575 0.547 1.000 0.754 0.678 0.582 0.624 
Visiting 3PLs’ 
locations 
0.546 0.547 0.590 0.668 0.677 0.651 0.594 0.574 0.754 1.000 0.799 0.718 0.726 
Corporate 
governance 
checks 
0.494 0.552 0.607 0.557 0.646 0.692 0.669 0.536 0.678 0.799 1.000 0.730 0.868 
Appointing a 
relationship 
manager 
0.499 0.516 0.567 0.608 0.586 0.606 0.638 0.575 0.582 0.718 0.730 1.000 0.721 
Developing  
(CAPA) plans 
0.555 0.590 0.537 0.585 0.648 0.705 0.672 0.595 0.624 0.726 0.868 0.721 1.000 
Table 6. 39: Test of Reliability 
Cronbach's Alpha N of Items 
0.959 13 
 
Table 6. 40: Total Variance Explained 
 
 
 
Component 
 
Initial Eigenvalues 
Extraction Sums of Squared 
Loadings 
Rotation Sums of Squared 
Loadings 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative % Total % of 
Variance 
Cumulative 
% 
1 8.738 67.217 67.217 8.738 67.217 67.217 5.280 40.616 40.616 
2 1.020 7.847 75.065 1.020 7.847 75.065 4.478 34.449 75.065 
3 0.756 5.817 80.881             
4 0.511 3.928 84.809             
5 0.471 3.621 88.430             
6 0.356 2.740 91.169             
7 0.301 2.317 93.486             
8 0.244 1.875 95.362             
9 0.183 1.410 96.772             
10 0.142 1.090 97.862             
11 0.104 0.797 98.659             
12 0.096 0.741 99.400             
13 0.078 0.600 100.000             
Extraction Method: Principal component analysis. 
 
In Table 6.40, the factor analysis was with principal axis factoring with oblimin rotation. Two (2) 
factors with eigenvalue of more than 1 were extracted. The 2 factors extracted accounted for 
75.06% of the total variance explained. Factor 1 accounted for 67.2% while Factor 2 accounted 
for 7.8% of the total variance explained. 
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Table 6. 41: Communalities 
Latent Variables  Initial Extraction 
Analysing present costs of function(s) 1.000 0.728 
Adequate due diligence 1.000 0.735 
Advertising a Request for proposal  
(RFP) 
1.000 0.644 
Verification of listed references 1.000 0.782 
Developing service levels agreement 
(SLA) 
1.000 0.704 
Preparing an exit plans/provisions 1.000 0.794 
Developing a transition plan 1.000 0.785 
Developing a back-up plan 1.000 0.709 
Contract preparation 1.000 0.639 
Visiting 3PLs’ locations 1.000 0.816 
Corporate governance checks 1.000 0.889 
Appointing a relationship manager 1.000 0.723 
Developing critical proactive 
Corrective And Preventive Action 
(CAPA) plans 
 
1.000 
 
0.811 
 
 
Figure 6. 4: Scree Plot 
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Table 6. 42: Rotated Component Matrix 
  
Latent Variables 
Component 
1 2 
Analysing present costs of 
function(s) 
0.812   
Adequate due diligence 0.804   
Verification of listed references 0.793   
Developing a back-up plan 0.770   
Developing a transition plan 0.759   
Preparing an exit plans/provisions 0.736   
Advertising a Request for proposal  
(RFP) 
0.688   
Developing service levels agreement 
(SLA) 
 
0.507 
Corporate governance checks   0.888 
Visiting 3PLs’ locations   0.821 
Developing critical proactive 
Corrective And Preventive Action 
(CAPA) plans 
  0.816 
Appointing a relationship manager   0.771 
Contract preparation   0.664 
                                          Extraction Method: Principal component analysis. 
The pattern matrix shown in Table 6.42 shows the factors are comprised of the following latent 
variables: 
Factor 1: Analysing present costs of function(s), adequate due diligence, verification of listed -
references, developing a back-up plan, developing a transition plan, preparing an exit 
plans/provisions and advertising a Request for proposal (RFP) 
Factor 2: Developing service levels agreement (SLA), corporate governance checks, visiting 
3PLs’ locations, developing critical proactive Corrective & Preventive Action (CAPA) plans, 
appointing a relationship manager and contract preparation 
From the relationships between these variables listed above, Factor 1 was termed internal 
preparedness while Factor 2 was called Proactive & authentication initiatives 
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6.3.8: Challenges of outbound pharmaceutical value chain in Nigeria & its 
outsourcing  
In this section, the results of the responses for the challenges of the outbound pharmaceutical 
supply chains are presented. As in previous sections, the items descriptive statistics (mean item 
scores, with their ranking) as well as the results for the exploratory factor analysis (EFA) using 
principal component analysis (PCA) are presented. Prior to the commencement of the analyses, a 
comprehensive definition of all the latent variables was done and the results are also provided. 
Table 6.43 shows the dictionary of definition of the latent variables used in question number 9 of 
the questionnaire. 
Table 6. 43: Definition of latent variables 
Code Variable Name Definition 
Q8.1 Road Infrastructure The condition and adequacy of road network in the country 
Q8.2 
Power Infrastructure The state, regularity and adequacy of the electricity power supply 
in the country 
Q8.3 
 
Inadequate Policy & Regulation 
The insufficiency and ineffectiveness in the various laws and 
policies governing the pharmaceutical supply chains in the 
country  
Q8.4 
 
Absence of competent 3rd Party 
Service Providers 
Lack of reliable and competent third party organizations to 
manage the outbound pharmaceutical supply chains if outsourced 
to them   
Q8.5 
Lack of skilled personnel Dearth of trained professionals to manage pharmaceutical supply 
chains   
Q8.6 Pilferages along the chain In-transit theft of products along the outbound pharmaceutical 
supply chains 
 
Table 6.44 shows the mean item scores for the latent variables and their ranking 
Table 6. 44:  Descriptive Statistics 
 
Latent Variables  
 
Mean 
Cronbach's 
Alpha  
 
Ranking 
Road Infrastructure 4.09 0.739 1 
Power Infrastructure 3.65 0.757 2 
Inadequate Policy & 
Regulation 
3.63 0.699 3 
Absence of competent 
3PL Service Providers 
2.97 0.665 4 
Lack of skilled 
personnel 
3.06 0.673 5 
Pilferages along the 
chain 
2.88 0.707 6 
 
The ranking shows road infrastructure as the number 1 in the ranking, while power infrastructure 
is number 2, Inadequate Policy & Regulation is ranked number 3, while Absence of competent 
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3PL Service Providers is ranked number 4. Number 5 in the ranking is Lack of skilled personnel, 
while Pilferages along the chain sits as the last in the ranking at number 6 
As previously explained, EFA was conducted, and prior to conducting the factor analysis, the 
suitability and adequacy of the data for the analysis was determined. The correlation matrix 
showed many coefficient values of more than 0.30, showing a strong correlation between the 
factors (see Table 6.45). The internal reliability of the scale and composite scores was adequate 
with the Cronbach's Alpha value of 0.745, above the recommended minimum value of 0.6, thus 
supporting the factorability of the data as shown in Table 6.46. The results for the factor analysis 
are presented in Tables 6.43 to 6.49 and Figure 6.3.8.1. The scree plot presented in Figure 6.3.8.1 
shows the point of inflection of the Eigen values and the factors extracted. 
 
Table 6. 45: Correlation Matrix 
  
 
 
 
Latent Variables 
Road 
Infrastructure 
Power 
Infrastructure 
Inadequate 
Policy & 
Regulation 
Absence of 
competent 
3rd Party 
Service 
Providers 
 
Lack of 
skilled 
personnel 
 
Pilferages 
along the 
chain 
Road Infrastructure 1.000 0.525 0.395 0.266 0.117 0.095 
Power Infrastructure 0.525 1.000 0.396 0.137 0.069 0.023 
Inadequate Policy & 
Regulation 
0.395 0.396 1.000 0.448 0.340 0.244 
Absence of 
competent 3rd Party 
Service Providers 
0.266 0.137 0.448 1.000 0.643 0.581 
Lack of skilled 
personnel 
0.117 0.069 0.340 0.643 1.000 0.700 
Pilferages along the 
chain 
0.095 0.023 0.244 0.581 0.700 1.000 
 
 
Table 6. 46: Test of Reliability 
 
Cronbach's Alpha 
Cronbach's Alpha 
Based on 
Standardized Items 
 
N of Items 
0.745 0.747 6 
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Table 6. 47: Total Variance Explained 
 
 
 
Component 
 
Initial Eigenvalues 
Extraction Sums of Squared 
Loadings 
Rotation Sums of Squared 
Loadings 
Total % of 
Variance 
Cumulativ
e % 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative 
% 
1 2.726 45.438 45.438 2.726 45.438 45.438 2.388 39.800 39.800 
2 1.556 25.937 71.375 1.556 25.937 71.375 1.894 31.575 71.375 
3 0.587 9.777 81.152             
4 0.490 8.161 89.313             
5 0.357 5.947 95.260             
6 0.284 4.740 100.000             
Extraction Method: Principal Axis factoring. 
 
In Table 6.47, the factor analysis was with principal axis factoring with oblimin rotation. Two (2) 
factors with eigenvalue of more than 1 were extracted. The 2 factors extracted accounted for 63.6% 
of the total variance explained. Factor 1 accounted for 57.8.2% while Factor 2 accounted for 5.7% 
of the total variance explained. 
Table 6. 48: Communalities 
Latent Variables  Initial Extraction 
Road Infrastructure 1.000 0.687 
Power Infrastructure 1.000 0.716 
Inadequate Policy & Regulation 1.000 0.583 
Absence of competent 3rd Party Service Providers 1.000 0.733 
Lack of skilled personnel 1.000 0.803 
Pilferages along the chain 1.000 0.760 
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Figure 6. 5: Scree Plot 
 
 
Table 6. 49: Rotated component Matrix 
 
Latent Variables 
Component 
1 2 
Lack of skilled personnel 0.894   
Pilferages along the chain 0.872   
Absence of competent 3rd 
Party Service Providers 
0.817   
Power Infrastructure   0.845 
Road Infrastructure   0.826 
Inadequate Policy & 
Regulation 
  0.655 
Extraction Method: Principal component analysis. 
The rotated component matrix shown in Table 6.49 shows the factors are comprised of the 
following latent variables: 
Factor 1: Lack of skilled personnel, pilferages along the chain and absence of competent 3rd Party 
Service Providers 
Factor 2: Power Infrastructure, road Infrastructure and inadequate Policy & Regulation 
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From the relationships between these variables listed above, Factor 1 was termed People & 
competency issues while Factor 2 was called infrastructural & regulatory inadequacies 
 
6.3.9: The desired outcomes of outsourcing  
This section presents the results of the responses on the desired outcomes of outsourcing. The 
items descriptive statistics (mean item scores, with their ranking) as well as the results for the 
exploratory factor analysis (EFA) using principal component analysis (PCA) are presented. Prior 
to the commencement of the analyses, a comprehensive definition of all the latent variables was 
done and the results are also provided. 
Table 6. 50 Definition of Latent Variables 
Code Variable Name Definition 
Q9.1 Cost advantage/benefit Actual costs saved from outsourcing decision 
Q9.2 Reduced manpower Reduction in personnel after outsourcing decision 
Q9.3 
Focus on core 
competency 
More time to concentrate on distinctive know-how and 
ability by the organization after outsourcing 
Q9.4 
Reduced Capital 
expenditure 
Reduction in spend on capital-intensive assets due to 
outsourcing 
Q9.5 
Geographical 
representation 
Presence in other locations and regions of the country 
through representation by the 3PL partner  
Q9.6 
Efficiency Ability and proficiency in managing the outbound value 
chain in the right way  
Q9.7 
Access to Specialised 
skills 
Acquisition of supply chain management skills through 
outsourced partner/relationship  
Q9.8 
Market expansion Increase in marketplace presence and placement of the 
company’s products through outsourcing 
Q9.9 
Improvement in Customer 
service 
Enhancement in the level and speed of service to 
customers 
Q9.10 Speed & Agility Increased speed of response to marketplace dynamics 
Q9.11 
Market share Increase in company’s share (in value & volume) of the  
Market, presence and placement of it’s products in the 
marketplace  
Q9.12 
Indigenous expertise Local acquisition of supply chain management skills 
through outsourcing 
 
Table 6.50 shows the dictionary of definition of the latent variables used in question number 5 of 
the questionnaire. 
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Table 6. 51  - Descriptive Statistics 
 
Latent Variable 
 
Mean 
Cronbach's 
Alpha 
 
Ranking 
Focus on core competency 4.01 0.935 1 
Reduced Capital expenditure 3.74 0.934 2 
Cost advantage/benefit 3.72 0.938 3 
Improvement in Customer service 3.71 0.932 4 
Efficiency 3.66 0.936 5 
Speed & Agility 3.65 0.934 6 
Geographical representation 3.52 0.933 7 
Market expansion 3.48 0.933 8 
Reduced manpower 3.45 0.938 9 
Market share 3.38 0.931 10 
Access to Specialised skills 3.27 0.934 11 
Indigenous expertise 3.18 0.932 12 
 
Table 6.51 shows the mean item scores for the latent variables and their ranking.  The ranking 
shows focus on core competency as the number 1 in the ranking, while reduced capital expenditure 
is number 2, cost advantage/benefit is ranked number 3, while improvement in customer service 
is ranked number 4. Number 5 in the ranking is efficiency, while speed & agility geographical 
representation, and market expansion were ranked 6, 7 and 8 respectively. Number 9 is reduced 
manpower, while number 10 is market share.  Access to specialized skills and indigenous expertise 
complete the ranking at numbers 11 and 12 
As previously explained, EFA was conducted, and prior to conducting the factor analysis, the 
suitability and adequacy of the data for the analysis was determined. The correlation matrix 
showed many coefficient values of more than 0.30, showing a strong correlation between the 
factors (see Table 6.52). The internal reliability of the scale and composite scores was adequate 
with the Kaiser-Meyer-Olkin (KMO)’s value of 0.86, above the recommended minimum value of 
0.6.  Furthermore, as shown in Table 6.53, the Bartlett’s test of sphericity was statistically 
significant at 0.00 (less than 0.05), thus supporting the factorability of the data. 
The results for the factor analysis are presented in Tables 6.50 to 6.56 and Figure 6.6. The scree 
plot presented in Figure 6.6 shows the point of inflection of the Eigen values and the factors 
extracted. 
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Table 6. 52: Correlation Matrix 
  Cost 
advantage 
Reduced 
manpower 
Focus on 
core 
competency 
Reduced 
Capital 
expenditure 
Geograph. 
representio
n 
 
Efficiency 
Access to 
Specialised 
skills 
Market 
expansion 
Improvement 
in Customer 
service 
Speed 
& 
Agility 
Market 
share 
Indigenous 
expertise 
Cost  
advantage 
1.000 0.427 0.587 0.526 0.480 0.552 0.562 0.233 0.500 0.480 0.487 0.424 
Reduced 
manpower 
0.427 1.000 0.590 0.767 0.467 0.350 0.378 0.528 0.321 0.312 0.518 0.544 
Focus on core 
competency 
0.587 0.590 1.000 0.661 0.630 0.529 0.523 0.523 0.513 0.575 0.609 0.455 
Reduced 
Capital 
expenditure 
0.526 0.767 0.661 1.000 0.557 0.462 0.418 0.528 0.381 0.453 0.499 0.462 
Geograph. 
representatn 
0.480 0.467 0.630 0.557 1.000 0.612 0.546 0.728 0.648 0.579 0.805 0.593 
Efficiency 0.552 0.350 0.529 0.462 0.612 1.000 0.558 0.418 0.590 0.716 0.517 0.490 
Access to 
Specialised 
skills 
0.562 0.378 0.523 0.418 0.546 0.558 1.000 0.309 0.476 0.478 0.625 0.655 
Market 
expansion 
0.233 0.528 0.523 0.528 0.728 0.418 0.309 1.000 0.612 0.605 0.617 0.503 
Improvement 
in Customer 
service 
0.500 0.321 0.513 0.381 0.648 0.590 0.476 0.612 1.000 0.761 0.652 0.584 
Speed & Agility 0.480 0.312 0.575 0.453 0.579 0.716 0.478 0.605 0.761 1.000 0.565 0.521 
Market share 0.487 0.518 0.609 0.499 0.805 0.517 0.625 0.617 0.652 0.565 1.000 0.701 
Indigenous 
expertise 
0.424 0.544 0.455 0.462 0.593 0.490 0.655 0.503 0.584 0.521 0.701 1.000 
 
 
Table 6. 53: KMO and Bartlett's Test of Reliability 
Kaiser-Meyer-Olkin Measure of Sampling 
Adequacy. 
 
0.860 
Bartlett's Test of 
Sphericity 
 
Approx. Chi-Square 
 
505.560 
Df 66 
Sig. 0.000 
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Table 6. 54: Total Variance Explained 
Initial Eigenvalues Extraction Sums of Squared 
Loadings 
Rotation Sums of Squared 
Loadings 
Total % of 
Variance 
Cumulative 
% 
 
Total 
% of 
Variance 
Cumulative 
% 
 
Total 
% of 
Variance 
Cumulative 
% 
6.911 57.590 57.590 6.911 57.590 57.590 4.830 40.247 40.247 
1.151 9.590 67.180 1.151 9.590 67.180 3.232 26.933 67.180 
0.977 8.144 75.323             
0.776 6.467 81.791             
0.487 4.062 85.853             
0.419 3.492 89.345             
0.347 2.890 92.236             
0.258 2.152 94.388             
0.209 1.741 96.129             
0.192 1.599 97.728             
0.179 1.492 99.219             
0.094 0.781 100.000             
Extraction Method: Principal component analysis. 
As shown in Table 6.54, the eigenvalue value set at the conventional 1.00 and factor analysis was 
conducted with principal component factoring with varimax rotation. Of the latent variables listed 
for the role (benefits) of outsourcing, 2 factors were extracted with 6 and 2 variables each, leaving 
out 4 latent variables with the least impact factor.  The 2 factors extracted accounted for 67.2% of 
the total variance explained. With Factor 1 accounting for 40.2% and the second factor accounting 
for 26.9% 
Table 6. 55: Communalities 
Latent Variables  Initial Extraction 
Cost advantage/benefit 1.000 0.465 
Reduced manpower 1.000 0.862 
Focus on core competency 1.000 0.675 
Reduced Capital expenditure 1.000 0.820 
Geographical representation 1.000 0.725 
Efficiency 1.000 0.642 
Access to Specialised skills 1.000 0.528 
Market expansion 1.000 0.535 
Improvement in Customer service 1.000 0.766 
Speed & Agility 1.000 0.746 
Market share 1.000 0.714 
Indigenous expertise 1.000 0.584 
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Figure 6. 6: Scree Plot 
 
Table 6. 56: Rotated Component Matrix 
 
Latent Variables 
Component 
1 2 
Improvement in Customer service 0.862 
 
Speed & Agility 0.847 
 
Efficiency 0.770 
 
Geographical representation 0.721 
 
Market share 0.710 
 
Access to Specialised skills 0.647 
 
Indigenous expertise 0.634 
 
Market expansion 0.561 
 
Cost advantage/benefit 
 
0.437 
Reduced manpower 
 
0.915 
Reduced Capital expenditure 
 
0.866 
Focus on core competency 
 
0.653 
Extraction Method: Principal component analysis. 
The rotated component matrix shown in Table 6.56 shows the factors are comprised of the 
following latent variables. Factor 1: Improvement in Customer service, Speed & Agility, 
Efficiency, Geographical representation, market share, Access to Specialised skills, Indigenous 
expertise and Market expansion.  
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Factor 2: Cost advantage/benefit, reduced manpower, reduced capital expenditure and focus on 
core competency.  From the relationships between these variables listed above, Factor 1 was 
termed marketplace dominance while Factor 2 was called operational efficiency. 
6.4: Summary of Factors 
The tables below show the summary of all the 13 factors extracted and their component latent variables 
Table 6. 57: Factors for rationale for outsourcing 
QUESTION FACTOR LATENT VARIABLE 1 2 
4
 (
R
a
ti
o
n
a
le
 f
o
r 
o
u
ts
o
u
rc
in
g
) 
1
 -
 O
rg
a
n
iz
a
ti
o
n
a
l 
a
g
il
it
y
 &
 
co
m
p
et
it
iv
en
es
s 
Improvement in Customer service 0.807 
  
Flexibility 0.715 
  
Focus on core competence 0.683 
  
Market expansion 0.681 
  
Corporate Strategy 0.676 
  
Cost savings 0.570 
  
2
 -
 L
a
ck
 o
f 
in
te
rn
a
l 
ca
p
a
b
il
it
y
 
Lack of Capacity   0.815 
Lack of in-house expertise   0.587 
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Table 6. 58: Critical criteria/factors for 3PL selection 
QUESTION FACTOR LATENT VARIABLE 1 2 3 
5
 (
C
ri
ti
ca
l 
c
ri
te
r
ia
/f
a
ct
o
rs
 f
o
r 
3
P
L
 s
el
ec
ti
o
n
) 
1
 -
 S
er
v
ic
e 
ex
ce
ll
en
ce
 
Service reliability 0.821     
Operational flexibility 0.793     
Speed of service delivery 0.737     
Pedigree/history of performance 0.666     
National/geographical spread 0.622     
Customer orientation 0.611     
Stable industrial relations 0.594     
2
 -
 T
ec
h
n
ic
a
l 
ca
p
a
b
il
it
y
 
Quality policies and procedures   0.801   
Availability of latest ICT tools   0.742   
Organizational culture 
  
0.739   
Innovation   0.655   
3
 -
 F
in
a
n
ci
a
l 
&
 
co
rp
o
ra
te
 g
o
v
er
n
a
n
ce
 
Flexible payment regimen     0.831 
Indemnity     0.767 
Management structure & expertise     0.63 
Financial strength     0.536 
Corporate values 
  
  0.545 
 
 
 
 
Table 6. 59: Factors for Critical risk factors of outsourcing 
QUESTION FACTOR LATENT VARIABLE 1 2 
6
 (
C
ri
ti
ca
l 
r
is
k
 f
a
ct
o
rs
 o
f 
o
u
ts
o
u
rc
in
g
) 
1
 -
 I
n
st
it
u
ti
o
n
a
l 
In
a
d
eq
u
a
cy
 Vendor employee turnover 0.949   
Obsolete Technology 0.916   
Loss of expertise 0.796   
Corporate governance 0.783   
Undertrained vendor’s employees 0.751   
Loss of control of outsourced function 0.666   
 No continuous improvement by 3PL  
Provider 
0.634 
  
Value misalignment 0.585   
Internal HR issues 0.51   
2
 -
 G
o
a
ls
 u
n
d
er
-
re
a
li
za
ti
o
n
 Service levels not achieved 
  0.914 
Loss of flexibility   0.636 
Hidden costs   0.63 
Cost reduction not realized   0.51 
 
 
 
 
142 
 
 
Table 6. 60: Factors for Pre-selection activities 
QUESTION FACTOR LATENT VARIABLE 1 2 
7
 (
P
re
-s
el
ec
ti
o
n
 a
ct
iv
it
ie
s)
 
1
 -
 I
n
te
rn
a
l 
p
re
p
a
re
d
n
es
s Analysing present costs of function(s) 0.812   
Adequate due diligence 0.804   
Verification of listed references 0.793   
Developing a back-up plan 0.77   
Developing a transition plan 0.759   
Preparing an exit plans/provisions 0.736   
Advertising a Request for proposal  
(RFP) 
0.688 
  
2
 -
 P
ro
a
ct
iv
e 
&
 a
u
th
en
ti
ca
ti
o
n
 
in
it
ia
ti
v
es
 
Developing service levels agreement 
(SLA) 
  
0.507 
Corporate governance checks 
  
0.888 
Visiting 3PLs’ locations 
  
0.821 
Developing critical proactive Corrective 
And Preventive Action (CAPA) plans 
  
0.816 
Appointing a relationship manager 
  
0.771 
Contract preparation   0.664 
 
 
Table 6. 61: Factors for Challenges to outbound supply chains/outsourcing 
QUESTION FACTOR LATENT VARIABLE 1 2 
8
 (
C
h
a
ll
en
g
es
 t
o
 o
u
tb
o
u
n
d
 s
u
p
p
ly
 
ch
a
in
s/
o
u
ts
o
u
rc
in
g
) 
1
 -
 P
eo
p
le
 &
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o
m
p
et
en
cy
 
is
su
e
s 
 
Lack of skilled personnel 0.894 
  
Pilferages along the chain 0.872 
  
Absence of competent 3rd Party Service 
Providers 
0.817 
  
2
 -
 I
n
fr
a
st
ru
ct
u
ra
l 
&
 
re
g
u
la
to
ry
 i
n
a
d
eq
u
a
ci
es
 
Power Infrastructure 
  
0.845 
Road Infrastructure 
  
0.826 
Inadequate Policy & Regulation 
  
0.655 
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Table 6. 62: Factors for desire outcomes of outbound supply chains/outsourcing 
QUESTION FACTOR LATENT VARIABLE 1 2 
9
 (
D
es
ir
ed
 o
u
tc
o
m
es
 o
f 
o
u
ts
o
u
rc
in
g
) 
1
 -
 M
a
rk
et
p
la
ce
 
d
o
m
in
a
n
ce
 
Improvement in Customer service 0.862   
Speed & Agility 0.847   
Efficiency 0.77   
Geographical representation 0.721   
Market share 0.71   
Access to Specialised skills 0.647   
Indigenous expertise 0.634   
Market expansion 0.561   
2
 -
 O
p
er
a
ti
o
n
a
l 
ef
fi
ci
en
cy
 
Cost advantage/benefit   0.437 
Reduced manpower   0.915 
Reduced Capital expenditure 
  
0.866 
Focus on core competency 
  
0.653 
 
6.5: Conclusion 
In this chapter, the results of the quantitative survey have been presented.  They include key 
background information about the respondents and their organizations, the analyses of the 
responses to the different questions (latent variables) under the nine (9) major groups of 
independent variables and focus of investigation.  As appropriate, the analytical methods employed 
range from descriptive, inferential and exploratory factor analysis (ETA) statistical techniques 
using SPSS version 25 software.  The interpretation of the results has been done using extracted 
tables from the software where applicable and explanatory notes on them.  The discussions on the 
results are presented in chapter seven. 
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CHAPTER 7 
 
DISCUSSIONS OF THE QUANTITATIVE STUDY 
 
7.1: Introduction  
Chapter six presented the results of the quantitative study with analyses of the responses to contents 
of the questionnaire. Also, exploratory factor analyses for questions 4 – 9 were conducted and out 
of the 76 latent variables, thirteen (13) factors were extracted as the critical ones with influences 
on the different questions/dependent variables of outsourcing outbound value chains by 
pharmaceutical organizations in Nigeria; namely: the rationale (reasons) for outsourcing, the 
critical risk factors, 3PL service providers’ selection criteria, the pre-selection activities, the 
challenges to the outbound pharmaceutical value chain/its outsourcing and the desired outcomes 
of outsourcing. This chapter discusses the survey results in two sections – section A will focus on 
questions Q1 – Q3 with descriptive analysis, while section B will focus on the results of the EFA 
conducted on questions Q 4 – Q9.  
 
7.2: Section A – Discussions on the questionnaire survey results  
This section discusses the responses to questions 1 to 3 of the questionnaire. The results have been 
presented in descriptive statistics, considering the nature of the responses and hence the 
discussions on them will focus on this format.  Accordingly, in the Likert scale of 1 – 5 used, 1 
represents very low level, impact or degree; 2 represents low; 3 represents moderate, 4 represents 
high while 5 represents very high level, impact or degree respectively. 
 
7.2.1: Degree of outsourcing  
As shown in Table 6.8 in the previous chapter, of the total number of respondents, 92% responded 
that they outsource transportation to an extent denoted by the mean value of 3.38  (SD 1.27). Of 
the 5 outbound value chain functions investigated, this represented the function with the highest 
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degree of outsourcing at above moderate to high level with a mean value of 3.38 (SD 1.27). 
Likewise, although in decreasing order 66% of the respondents outsource warehousing with just 
about moderate degree of 2.74 (SD 1.49); 63% outsource distribution with mean value of 2.65(SD 
1.52); 56% outsource cold chain at between low to moderate level with a mean value of 2.54 (SD 
1.51), while the least number of respondents 42 (42%) said they outsource reverse logistics at 
between low to moderate level with a mean value of 2.54 (SD 1.43).  The high standard deviation 
of these mean values shows diversity and heterogeneity in the degree/level of outsourcing from 
low to high by these respondents’ organizations. These agree with findings from previous studies 
on outsourced logistics.  Domestic transportation (haulage & distribution) and warehousing are 
some of the most outsourced supply chain functions. Globally, the degree of outsourcing of 
domestic transport has been found to be as high as 80%, with warehousing (66%) and reverse 
logistics (34%) also featuring to a lesser degree ((Langley & Capgemini, 2016; Bulgurcu & 
Nakiboglu, 2018). These figures represent a significant growth in the degree of outsourcing of 
these functions reported in early studies which put the levels of outsourcing at transportation 
(53.3%), reverse logistics (26.9%) and warehousing (23.4%) (Xiaofeng & Jianhua, 2006).   
Recent study in South Africa confirm the steady rise in the outsourcing of outbound value chain 
functions in the last decade. In a survey by Karrapan et al. (2017), the leading outsourced functions 
are: transportation (99%), customs clearance (83.5%), freight forwarding (83.5%), freight billing 
(70.9%) and warehousing (37.9%). Efficiency in inventory management and accuracy in supply 
and warehousing practices have been long recognized by the healthcare professionals, influencing  
the adoption of outsourcing by the pharmaceutical organizations (Azzi et al., 2013). The relatively 
low degree of cold chain outsourcing is largely attributable to the historical practice in developing 
countries like Nigeria where a lot of vaccine and cold chain management is done internally by both 
the public and private organizations on account of the specialized skills required for their handling 
and the dearth of competent third party service providers.  
Despite the foregoing, outsourcing of the storage and distribution services have been on the 
increase and successful in the last few decades (Transaid, 2009; WHO/PATH, 2012; Zhao et al., 
2014).  The outbound pharmaceutical value chain is part of the larger healthcare system for which 
outsourcing has now become a strategic tool for increasing overall effectiveness and efficiency of 
the system (Chiara & Lorenzo, 2016) 
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7.2.2: Age of outsourcing 
Tables 6.9 - 6.13 present the results of the ages of outsourced relationships with providers of the 
value chain services (Transportation, Distribution, Warehousing, Reverse Logistics and Cold 
chain) by the pharmaceutical organizations studied.  The age brackets used in this study were 
designed not necessarily to determine the actual individual ages of these outsourced relationships, 
but to study the growth in the outsourcing practices in the last decade. 
As shown in these tables, 24 (26.1%) of the respondents had commenced the outsourcing of 
transportation more than 12 years ago,  the figures for other functions are warehousing, 9 (13.6%); 
distribution 5 (7.9%), cold chain, 8 (14.3%) and reverse logistics, 4 (9.5%). These figures show 
that apart from transportation services, more than 80% of the outsourced relationships for the other 
serviced were contracted in the last 12 years, showing a period of tremendous growth and adoption 
of the practice during this period.  
General/informal outsourcing has been practiced in Nigeria for some decades now (Kolawole & 
Agha, 2015). However, strategic outsourcing as a practice in the Nigerian pharmaceutical sector 
is relatively new with the early relationships mainly tactical and on peripheral services such as 
catering, cleaning, security, etc. The earliest scholarly study on outsourcing in Nigeria in 1998 had 
a poor response with only 29% of the 70 companies investigated responding (Okolie, 1999). Of 
the few companies investigated, only 2 were pharmaceutical, and the only outbound value chain 
functions outsourced were transport (17.7%) and warehousing (5.9%). The growth trend observed 
in this study in the last decade corroborates findings reported in studies in other sectors in Nigeria 
and sub-Saharan Africa (Acti & Abigail, 2014; Ikegwuru & Ihunwo, 2018; Kolawole & Agha, 
2015; Muogboh & Ojadi, 2018). 
 
7.2.3: Satisfaction from outsourced relationships  
The level of satisfaction derived from the outsourced services was measured here for all the five 
(5) outbound value chain functions under investigation in this study.  As presented in Table 6.14; 
among the respectively respondents for the different functions – Transportation, 92; Warehousing, 
66; Distribution, 63; Cold chain, 56 and Reverse logistics, 42; the mean levels of satisfaction were: 
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Transportation, 3.38 (SD, 1.16); Warehousing, 3.25 (SD, 1.32); Distribution, 3.12 (SD, 1.18); Cold 
chain, 3.32 (SD, 1.30) and Reverse logistics, 2.98 (SD, 1.35).  Translated into percentages, these 
come to 67.6%, 65%, 62.4%, 66.4% and 59.6% satisfaction levels respectively.  These are 
moderate, above-average level satisfaction across all the functions, albeit less than high - very high 
levels of satisfaction. In the earliest scholarly article on outsourcing in Nigeria, the level of 
satisfaction by the companies investigated was 50% (Okolie, 1999). 
Some scholars have used customer satisfaction level by users of outsourced services as one of the 
indirect indicators (or soft measures as they are also called) of the success of outsourcing and 
performance by third party service providers (Grover et al., 1996; Cho et al., 2008; Lahiri, 2016). 
According to Hansemark and Albinson (2004), the satisfaction that a customer derives from a 
service is a wholesome one which involves both the attitude of the customer towards the service 
provider and the emotional fulfillment attached to the service. Generally, satisfaction is achieved 
when a customer’s expectation about a service is either met or exceeded (Fornell et al., 1996; Ali 
& Kaur, 2018). 
Since the 1990s, which witnessed a rapid growth of the practice and research into outsourcing, the 
satisfaction and experiences of the users of 3PL services have been mixed, with reports of 
dissatisfaction (Currie & Willcocks, 1997; Kakabadse & Kakabadse, 2000) and satisfaction 
reported in various sectors in both developed (Lieb & Miller, 2002) and emerging economies 
including Ghana, South Africa and Nigeria (Sohail & Sohal, 2003; Sohail et al., 2004; Cilliers & 
Nagel, 1994; Rahman, 2011).  
As reported in this study, satisfaction in outsourcing relationships has been investigated from the 
angle of the service users (Gopalakrishnan et al., 2017).  Customer satisfaction from outsourcing 
relationship is a product of the service quality or contractual factors/obligations (Juga et al., 2010) 
and what has been called “relational factors” such as communication, trust, among others (Ojha, 
2002; Rai et al., 2012).  The other factors that affect the satisfaction level experienced by users are 
the experience of the organization in outsourcing arrangements (Waug & Luke, 2011; Hanna, 
2009); the 3PL human resources deployed and their skills in service delivery (Sanchis-Pedregosa 
et al., 2018) and the capability for service recovery (in cases of failures) and processes of the 3PL 
services provider (Gazley & Simmonds, 2018). In pharmaceutical outbound value chain 
outsourcing, in addition to the factors enumerated above as drivers of customer satisfaction, total 
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visibility of the inventory (pharmaceutical products) all throughout the chain until they get to the 
final consumer (the patient) from real-time data contributes to satisfaction by 3PL service users 
(Bhavana, 2018). 
 
7.3: Section B – Discussions on the questionnaire survey results (Q4 – Q9) 
The section discusses the results of the responses to questionnaires questions 4 to 9 which contain 
the latent variables associated with different aspects of the outsourcing process.  As previously 
presented in chapter 6, for each question, both the descriptive and exploratory factor analysis was 
done, with the final outputs being the ranking (for the descriptives) and extracted factors (for the 
EFA) of the latent variables.  Therefore, the discussions of these results will focus on the ranking 
status and the identified/extracted factors. 
7.3.1: The rationale for outsourcing  
This section presents the results of the responses on the rational for outsourcing. The items 
descriptive statistics (mean item scores, with their ranking), as well as the results for the 
exploratory factor analysis (EFA) using principal component analysis (PCA) are presented. Prior 
to the commencement of the analyses, a comprehensive definition of all the latent variables was 
done and the results are also provided. Table 6.16 shows the mean item scores for the latent 
variables and their ranking.  The ranking shows cost savings at the number 1 in the ranking, while 
focus on core competence, number 2, Improvement in customer service is ranked number 3, while 
flexibility is ranked number 4. Number 5 in the ranking is corporate Strategy, while market 
expansion, lack of capacity and lack of in-house expertise were ranked 6, 7 and 8 respectively.  
During the factor analysis, four latent variables (Q4.2: Industry best practice; Q4.3: Technological 
advancement; Q4.8: Access to Specialised skills & Q4.9: Transfer of risks to 3PL) with low 
coefficients and/or showing cross loading on the factors were excluded. From the ranking of the 
latent variables, top four variables are cost savings, focus on core competence, improvement in 
Customer service and flexibility. These variables will be discussed under the 1st Factor extracted 
in the next section. 
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7.3.1.1: Factor 1 – Organizational agility and competitiveness 
This extracted factor contains 6 latent variables - improvement in Customer service, flexibility, 
focus on core competence, market expansion, corporate strategy and cost savings and is discussed 
as the first factor influencing the decision of the pharmaceutical organizations to outsource their 
outbound value chains. 
As the operating environment becomes more competitive and challenging, many organizations 
have been evolving, redefining their operating strategies and devising ways of gaining competitive 
advantage in the marketplace to reach out to their customers faster than others. The outbound value 
chain is one key area where focus has been placed by many organizations to become agile and 
accordingly, acquire competitiveness. Organizational agility refers to the ability of an organization 
to swiftly respond to the changes in the environment through changes in their products and 
services. This ability has been very critical for organizations not just to gain competitiveness, but 
also to attain sustainability in it (Singh et al., 2013). This concept has been traced to the erstwhile 
CEO of General Electric, Jack Welch, who emphasized “speed, agility, and simplicity” as 
important (Tichy & Charan, 1989:3; Baškarada & Koronios, 2018). Likewise, agility in supply 
chain refers to the ability of organizations to master the turbulence in the market (van Hoek et al., 
2001; Yusuf et al., 2014). 
Agility in the value chain which in turn confers agility to the organization and its speedy 
responsiveness to its customers, is viewed as a virile source of competitiveness nowadays, even 
though its development is slower than expected (Jain, et al., 2008).  Value chain agility is a vital 
operational capability in view of the critical factors of cost and speed in products delivery (Ngai 
et al., 2011; Overby et al., 2006). This capability derives from efficiency and the ability of the 
organization to integrate and coordinate with external partners in the value chain like 3PL service 
providers. (Brusset, 2016). Previous studies on organizational agility have concentrated on the 
nature and features of the organization, without any focus on the unique abilities and attributes on 
the practices that confer agility and competitiveness on such organizations. (Appelbaum et al., 
2017a;  2017b).  Even though there is no global consensus in academic literature on these attributes 
that confer organizational agility and competitiveness (Brusset, 2016), an effective supply/value 
chain has been identified as key (Porter, 1985, Christopher, 2000).  The outsourcing of the 
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outbound segment of the value chain as confirmed by this study has been identified as one of the 
ways to acquire organizational agility and competitiveness. 
7.3.1.2: Factor 2 – Lack of capacity 
The second factor influencing the outsourcing of outbound value chain by pharmaceutical 
organizations in Nigeria is the lack of capacity to undertake the ownership and management of the 
value chain. Outbound pharmaceutical value chains are unlike other value chains with regards to 
the requirements to the management and nature of the products being managed. Due to the 
sensitive, thermolabile and high-regulated products along these chains, a lot of investment on 
capacities is required to effectively manage the value chains.  These capacities are not only limited 
to the physical assets like vehicles (both ambient and cold-chain) and storage facilities like 
warehouses, but also include human capacities in the effective management of the processes. To 
achieve competitive edge and effective product delivery, pharmaceutical organizations outsource 
their outbound value chain management to: acquire additional capacity (Somuyiwa, 2015; 
Christopher), to reduce capital expenditure on acquisition of assets (Somuyiwa, 2015); gain access 
to the 3PL service providers’ automation, leverage on their process maturity and reduce 
operational risks (Sandhu et al., 2018) and acquire innovative capacities from their association 
with the 3PL service providers (Sanchis-Pedregosa et al., 2018). Deepen et al. (2008) posit that 
organizations who outsource service are actually acquiring value-adding capacities like skills and 
knowledge. 
Grossler et al. (2013) report that while the focus of organizations who outsource internationally is 
on cost saving, those who outsource locally, like the ones investigated in this study do so to achieve 
flexibility in their capacities.  In doing so, these organizations often outsource such outbound value 
chain functions like transportation and warehousing where they lack capacity (Denisa et al., 2015).  
In Nigeria, like many developing countries, the gap in outbound value chain management 
capacities transcends beyond the facilities and infrastructure, but also include the human capacity 
to manage effectively, the entire process (Jahree et al., 2012; Kolawole & Agha, 2015) 
7.3.2: The critical criteria for 3PL selection  
This section discusses the results for the criteria the organizations use in selecting their 3PL service 
providers. The ranking of the 16 latent variables has been done from the descriptive statistical 
analysis as explained in the previous chapter. Table 6.23 shows the mean item scores for the latent 
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variables and their ranking.  The ranking shows speed of service delivery as the number 1 in the 
ranking, while service reliability is number 2, national/geographical spread is ranked number 3, 
while Operational flexibility is ranked number 4. Number 5 in the ranking is pedigree/history of 
performance, while financial strength, management structure/expertise and Stable industrial 
relations were ranked 6, 7 and 8 respectively. Number 9 is corporate values, while number 10 is 
Quality policies and procedures. 
Flexible payment regimen, Availability of latest ICT tools, Indemnity, Customer orientation, 
Innovation and Organizational culture completer the ranking at numbers 11, 12, 13, 14, 15 and 16 
respectively. 
Furthermore, the rotated component matrix in Table 6.28 shows 3 factors were extracted, using all 
the 16 latent variables. The names of the factors and their latent variables are as follows:  
Factor 1: Service Quality (Service reliability, Operational flexibility, Speed of service delivery, 
Pedigree/history of performance, National/geographical spread, Customer orientation and Stable 
industrial relations). 
Factor 2: Technical capability (Quality policies and procedures, Availability of latest ICT tools, 
Organizational culture and Innovation).   
Factor 3: Financial Health & corporate governance (Financial strength, corporate values, 
flexible payment regimen, Indemnity and Management structure & expertise) 
7.3.2.1: Factor 1: Service quality 
The main objective behind any organization’s decision to outsource its customer-facing outbound 
value chain is to render service on behalf of the organizations to its customers. The service quality 
by a provider is therefore important in its selection and retention for the provision of the service(s). 
It is therefore not surprising that service attributes and capabilities are topmost criteria both in the 
descriptive statistics and in the number of latent variables loading on Factor 1 extracted.  
The top position occupied by service quality in this survey aligns with the ranking from various 
studies (Bayazit & Karpak, 2013; Menon et al., 1998; Qureshi et al., 2007; Karrapan et al., 2017; 
Fachao et al., 2012; Efendigil et al.; 2008; Alkhatib et al., 2015). 
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Service quality is a vital ingredient of organization’s strategy to differentiate itself and its services 
from competition and determine its competitive advantage (Ghobadian et al., 1994).  Sustainability 
in the delivery of quality service by any 3PL service providers is also vital for its long-term success 
and profitability (Owen et al., 2001; Stamenkov & Dika, 2015; Ghobadian et al., 1994) 
Many service users and even researchers ascribe their understanding of quality to different 
components of the service offering but will generally consider a service of good or high quality if 
it meets and /or exceeds the customer’s expectations (Ojasalo, 2018). From this study, the key 
indicators of service quality as ranked by the respondents are speed and service reliability, the 
geographical spread of their operations; their customer service orientation and the history/pedigree 
of service delivery. These attributes are topmost in the list of criteria the respondents/their 
organizations use to determine service quality and hence select their service providers. 
The revolutionary study by Parasuraman et al. (1985; 1988) extracted the 5 key components of 
service quality which are now popularly called by the acronym “RATER” as: reliability, assurance, 
tangibles, empathy, and responsiveness. These 5 key components are now acceptably used as the 
five dimensions in the evaluation of service quality and are altogether called SERVQUAL 
dimensions (Carr, 2007; Gandhi et al., 2018). Further studies of the components and dimensions 
of service quality in 3PL services put three dimensions to include dimensions of operational, 
personal and technical (Ojasalo, 2018).   
7.3.2.2: Factor 2: Technical capability 
This second factor of the selection of 3PL service providers contains as latent variables, quality 
policies and procedures, availability of latest ICT tools, organizational culture and Innovation.   
The management of the outbound value chains of the pharmaceutical sector poses a lot of unique 
challenges unlike other sectors.  The sensitive nature of life-saving drugs/medicaments and other 
pharmaceutical products for human use and the strict regulations of the handling of these products 
places a high demand on the pharmaceutical organizations and accordingly their service providers 
involved at different stages of the supply chains especially outbound value chains. Technical 
capability of the 3PL service providers is crucial in their selection for the provision of outbound 
value chain services as the focus of these organizations has over the years moved from routinized 
service provision to value creation by these service providers. 3PL service providers must seek to 
develop solutions that address specific customer’s requirements and market-sensing and technical 
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capability (Kindstrom et al., 2013; Raddats & Burton, 2014). The potential benefit of gaining value 
from these external partners is central in today’s competitive operating environment (Lintukangas 
et al., 2016).  
Capability is “the ability to implement and integrate resources to achieve corporate goals, as well 
as results acquired from long-term accumulation of interaction among various resources” (Tseng 
& Lee, 2014:159).  The technical capability of 3PL service providers as priotized by the 
respondents of this study contains vital capabilities such as quality policies and procedures, 
availability of latest ICT tools, organizational culture and Innovation all of which are prerequisites 
for effective and efficient management of the unique outbound pharmaceutical value chains. Over 
time, various dimensions and components of technical capability have been studied and identified.  
Information Technology (IT) capability (Maheshwari et al., 2012); innovation capability, 
critical for the introduction of new processes faster than competitors (Guan & Ma, 2003; Zawislak 
et al., 2018); operational capability, which involves the ability of the firm to coordinate multiple 
aspects of the service delivery in a cost-efficient, flexible and commercially-viable way (Zawislak 
et al., 2018). Managerial capability denotes the expertise skills and procedures for the 
coordination of the firm’s other activities in a way as to reduce internal organizational friction and 
complexities (Zawislak et al., 2018).  Other technical capabilities identified include transactional 
capability, for efficient transaction costs management, (Tello-Gamarra & Zawislak, 2013; 
Zawislak et al., 2018) 
Consignment tracking capability (Kumar & Singh, 2012) which is very critical especially in the 
outbound value chain management to ensure adequate inventory monitoring and visibility.  In a 
recent study, another capability, robust supply network/distribution network capability was 
found to be the most significant capability and factor in the selection of 3PL logistics service 
providers in Indian pharmaceutical sector (Gardas et al., 2019). 
7.3.2.3: Factor 3: Financial & corporate governance 
This last factor for the selection of 3PL service providers contains two sub-factors that have been 
grouped together on account of their common linkage and use in the selection process in being 
able to evaluate the overall structure and health of the 3PL company, thereby assessing its 
sustainability, business model and continuity status.  The selection is a multi-dimensional process 
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that transcends the pricing consideration (Ho et al., 2012). Earlier selection processes were 
subjective and resulting in sub-optimal outcomes and decisions (Xu, 2000; Wang et al., 2015).   
While Aguezzoul (2014) in her review reported similarities in the selection criteria of both goods 
and logistics service providers, with difference in their order of importance;  Bulgurcu and 
Nakiboglu (2018) report that financial measures like financial stability and viability are some of 
the most commonly used criteria. Apart from the spectrum of service offering, the financial 
structure and key indicators of the service providers are critical to their selection by the outsourcing 
organizations (Gotzamani et al., 2010; Hofmann & Lampe, 2013).  Different measures have been 
used to access the financial health of companies including ratings by credit rating organizations, 
even though credit rating may in itself not be totally objective and a true reflection of the health of 
a company, Griffin and Tang (2012), Ames et al. (2014) opine that a lot of information can still be 
accessed from such ratings. In few circumstances, there have been cases of the outsourcing 
organization with stronger financial might and higher credit rating assisting their 3PL providers 
with financial support to increase their service delivery capacities (Randall & Farris II, 2009).  
Other measures and indicators used to assess the financial health of a 3PL firm include companies’ 
market capitalization and stock exchange quotation for listed and publicly quoted firms and the 
revenue streams (Hofmann & Lampe, 2013). Some researchers like Bhandari (1988) have used the 
debt-to-equity ratio which is a key assessment data for financial risks. Hofmann & Lampe (2013) 
reported another financial measure - liquidity which is a useful indicator of the capacity of the 3PL 
firm to meet up with the various operational and contractual obligations especially in the 
pharmaceutical value chain management which involves the use of specialised, capital-intensive 
assets and facilities. 
On account of the widely-reported collapses of some major companies in the private sector, the 
issue of corporate governance in private companies has received close scrutiny globally 
(L’Huillier, 2014). 
The focus of corporate governance has been on the management structure and performance of 
companies and has been a critical component of the financial reporting and performance of these 
companies (Stuebs & 2015).  Srivastava et al. (2018:19) refer to corporate governance “as a set of 
predefined rules which guide the actions of mangers resulting in the best interest of investors”. In 
Nigeria, the national corporate governance code was revised in 2018 and now contains such 
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elements as: role of the board, board structure and composition, corporate governance evaluation, 
risk management, relationship with shareholders, protection of shareholders’ rights, business 
conduct/ethics and sustainability (FRCN, 2018). On account of the paucity of well-established 3PL 
providers from the organised private sector, a lot of family-controlled private 3PL firms abound in 
Nigeria with the attendant risks of ineffective boards even with independent directors who are 
unable to prevent poor corporate governance practices like financial misstatements and 
manipulations (Jaggi et al., 2010; Michael & Goo, 2015).  Given the foregoing, it’s imperative that 
outsourcing organizations must determine the most suitable criteria for selecting of their service 
providers to warrant that these firms have all it takes to meet their immediate and future value 
chain management needs (Kumar et al., 2011) and prevent the outsourcing risks (Handley, 2012; 
Zhang et al., 2013) 
7.3.3: The critical risks factors for outsourcing  
Table 6.30 shows the mean item scores for the latent variables on the critical risk factors and their 
ranking.  The ranking shows Obsolete Technology as the number 1 in the ranking, while 
Undertrained vendor’s employees is number 2, Service levels not achieved is ranked number 3, 
while Hidden costs is ranked number 4. Number 5 in the ranking is Cost reduction not realised, 
while Value misalignment, No continuous improvement by 3PL and Loss of control of outsourced 
function were ranked 6, 7 and 8 respectively. Number 9 is Loss of flexibility, while number 10 is 
Quality policies and procedures. Loss of expertise, corporate governance and Internal HR issues 
complete the ranking at numbers 11, 12 and 13 respectively. 
Upon factor analysis, two factors were extracted as follows: 
Factor 1: Vendor employee turnover, obsolete technology, loss of expertise, corporate 
governance, undertrained vendor’s employees, Loss of control of outsourced function, no 
continuous improvement by 3PL service provider, value misalignment and internal HR issues 
Factor 2: Service levels not achieved, loss of flexibility, hidden costs and cost reduction not 
realised 
From the relationships between these variables listed above, Factor 1 was termed Organizational 
inadequacies while Factor 2 was called goals under-realizations. 
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7.3.3.1: Factor 1 – Organizational inadequacies 
As listed above, this factor contains the following latent variables: Vendor employee turnover, 
obsolete technology, loss of expertise, corporate governance, undertrained vendor’s employees, 
Loss of control of outsourced function, no continuous improvement by 3PL service provider, value 
misalignment and internal HR issues. Despites the several advantages and benefits of outsourcing, 
like many other management practices and initiatives, there are some risks.  Gandhi et al. (2012) 
refers risk as the result of the probability of an untoward incident happening and its consequences 
or impact. According to Christopher (2001:202), “It can be argued that in today’s volatile business 
environment the biggest risks to business continuity lie in the wider supply chain” Various critical 
risk elements have been categorised into two major factors in this research.  In this first factor, 
organizational inadequacies, the elements are risks associated with the inadequacies of the two 
organizations involved – the outsourcer and service provider.   
The inadequacies of outsourcing organizations emanate from the impact of the process on the 
organization.  This impact is characterized by their inability to exhibit some attributes and or loss 
of some capacities and capabilities. Various researchers have reported the form of these losses to 
include loss of control of the innovative capacity (Aubert et al., 1998; Gandhi et al., 2012) loss of 
operational capabilities (Aron et al., 2005; Handley et al., 2012; Zhang et al., 2015;  Iqbal & Dad, 
2013); technical expertise or business process knowhow (Willcocks et al., 2004; Iqbal & Dad, 
2013); lack of control over the 3PL service provider (Quinn and Hilmer, 1994; Kakabadse & 
Kakabadse, 2000), loss of  cross functional expertise (Kakabadse & Kakabadse, 2000); loss of 
privacy /intellectual property (Herath and Kishore, 2009; Iqbal & Dad, 2013).  In this study, the 
potential risks associated with the outsourcing organization are loss of expertise and internal 
human resources issues.  The latter may manifest as decreased productivity and motivation of the 
employees resulting from job insecurity and satisfaction.   
On the side of the service providers, inadequacies identified result from their inability to match 
service delivery/expectations with actual expectations.  Some of the latent variables identified in 
this study leading to these inadequacies include obsolete technology, high employee turnover and 
lack of continuous improvement, amongst others.   These inadequacies and gap in performance 
have also been reported in various forms since the advent of researches into outsourcing practices 
and include: service disruption (Aubert et al., 1998; Gandhi et al., 2012), declining quality of 
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service (Beasley et al., 2004; Aron et al., 2005; Iqba & Dad, 2013), hidden costs (Aubert et al., 
1998; Gandhi et al., 2012).  Outsourcing risks have been grouped and categorised by other 
researchers.  While some of these categories relate to the nature, origin and impact factor; some 
are associated with the relationships, processes, whilst others cut across the two participating 
organizations. These categories that have emerged both generally and specific to the 
pharmaceutical industry include operational, strategic, regulatory, technical and corporate 
responsibility (Harland et al., 2003; Enyinda et al., 2009; El Mokrini et al., 2016).   
The type and impact of these risks depend on the outsourced relationships and number of 
stakeholders (Gandhi et al., 2012). It has been shown that one way of mitigating against these risks 
and prevent them from impacting negatively on the business is to have a back-up service provider 
or use more than one provider (Pratap, 2014; Colicchia et al., 2010; Bhattacharya et al., 2013). 
Other approaches in the mitigation and management of these risks which have been widely 
reported are risk retention, avoidance, reduction and transfer (Deloach, 2000; Wagner & Bode, 
2008; El Mokrini et al., 2016)  
The issues of risks and the management in outsourcing have become prominent in the last few 
decades.  These sources of uncertainties faced by the outsourcing pharmaceutical organizations 
have been critically investigated and considered when the strategic decision of outsourcing OPVC 
is being taken (Costa et al., 2006; Gandhi et al., 2012). 
7.3.3.2: Factor 2 - Goals under-realization 
The second factor comprising the risk elements of outsourcing OPVC relates to the under-
realization of the strategic goals of the outsourcing decision. In this study, the component latent 
variables of this risk factor are Service levels not achieved, loss of flexibility, hidden costs and 
cost reduction not realised.  All these risk elements are identified as possessing the potentials for 
non-attainment of the desired strategic goals the outsourcing organizations set out to achieve with 
the outsourcing initiative.  For every organization in or contemplating an outsourcing contract, 
these goals are very critical form the kernel of the contract and accordingly, are embedded in it.   
Gottschalk and Solli-Saether (2006: 201) capture the importance of the outsourcing goal in their 
definition of the outsourcing contract by referring to it as a “legally bound, institutional framework 
in which each party’s rights, duties, and responsibilities are codified and the goals, policies, and 
strategies are specified” The goals of outsourcing by most organizations are connected with the 
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rationales to outsource as has been extensively discussed in previous sections. Generally, most 
organizations, including the pharmaceutical ones studied in this research have as major 
components of their goals, focus on core competence, financial goals such cost reduction, service, 
amongst others.  Studies have shown that apart from some few organizations whose goals are 
beside financial measures, most of them focus on cost reduction as their main goal of outsourcing 
(Denisa et al., 2015; Mukherji & Ramachandran, 2007; Bustinza et al., 2010; Brewer et al., 2013). 
Few others consider financial goals as complementary to other non-financial strategic goals like 
efficiency and service targets (Wang et al., 2015).  No matter the content and intent of the goals, 
all organizations, irrespective of their size and sector have outsourcing goals (O’riodan & 
Sweeney, 2007). Suraju & Hamed (2013:26) opine that “outsourcing must be done carefully, 
systematically, and with explicit goals and expectations”. Consequently, a critical risk of the 
outsourcing decision and relationship is when these goals are not realised in the form and 
magnitude set out in the outsourcing strategy and contract.  Common manifestations of these risks 
if and when they materialize are service levels not achieved by the 3PL service provider and 
outright failure in service delivery and task performance (Alkhatib et al., 2015; Bulgurcu et al., 
2018).    
 
It is reported that outsourcing failures resulting from under or non-realization of goals are due to 
lack of alignment of the goals of the two organizations – the outsourcer and the 3PL service 
provider with reported cases of post-engagement complaints like payment of low prices by service 
providers and goals and objectives mismatch by outsourcers (Bhattacharya et al., 2013). Achieving 
short-term instead of long-term strategic goals has been reported as a risk of goals under-realization 
(Hupfeld, 1997; Kakabadse & Kakabadse, 2000). Tsay (2014) refers to goals mismatch and 
conflict in outsourcing relationship as a “moral hazard”.  A periodic review of the strategic fit 
between the outsourcer’s goals and that of the 3PL service provider has been recommended as a 
mitigation against goals’ mismatch in outsourcing relationship especially in the pharmaceutical 
sector (USAID/Deliver, 2014). While Vitasek and Manrodt (2012) report that organizations must 
become “vested,” or mutually dedicated to the attaining a successful long-term relationship 
founded or either party’s dedication to their mutually-beneficial goals, Suraju and Hamed (2013) 
report that even though most organizations attain some demonstrable success in their outsourcing 
relationship, the outcomes of such relationships still fall short of the strategic goals underpinning 
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the relationship. Outsourcing like many management and supply chain decisions are not free from 
risks. Despite these risks associated with outsourcing of outbound pharmaceutical value chain 
(OPVC); a lot of value can still be derived from the process and practice. Fundamental to this value 
extraction and maximisation is identifying these risks and their dimensions (El Mokrini et al., 
2016), understanding the interconnections between them and implementation mitigating strategies 
at the commencement of the outsourcing process (Gandhi et al., 2012; Gbadegesin et al., 2015). 
 
7.3.4: Pre-selection activities by outsourcing organizations  
Table 6.37 shows the mean item scores for the latent variables and their ranking.  The ranking 
shows Adequate due diligence as the number 1 in the ranking, while Analysing present costs of 
function(s) is number 2, Developing service levels agreement (SLA) is ranked number 3, while 
Developing a back-up plan is ranked number 4. Number 5 in the ranking is Contract preparation, 
while verification of listed references, developing a transition plan and developing critical 
proactive Corrective and Preventive Action (CAPA) plans were ranked 6, 7 and 8 respectively. 
Number 9 is visiting 3PLs’ locations, while number 10 is preparing an exit plans/provisions. 
Appointing a relationship manager, corporate governance checks and advertising a Request for 
proposal (RFP) complete the ranking at numbers 11, 12 and 13 respectively. From the EFA 
conducted, the two factors  extracted are comprised of the following latent variables: 
Factor 1: Analysing present costs of function(s), adequate due diligence, verification of listed 
references, developing a back-up plan, developing a transition plan, preparing an exit 
plans/provisions and advertising a Request for proposal (RFP) 
Factor 2: Developing service levels agreement (SLA), corporate governance checks, visiting 
3PLs’ locations, developing critical proactive Corrective & Preventive Action (CAPA) plans, 
appointing a relationship manager and contract preparation 
From the relationships between these variables listed above, Factor 1 was termed internal 
preparedness while Factor 2 was called Proactive & authentication initiatives 
7.3.4.1: Factor 1 - Internal preparedness 
Preparedness refers to a state of being ready.  In this first factor, the critical internal activities and 
processes that assist the outsourcing organization’s readiness for the strategic transition to the 
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outsourced relationship are discussed. The component variables as listed earlier address various 
aspect of the outsourcing project.  Fundamental to this factor and phase is the situational 
assessment of the organization, involving the comprehensive analysis of its current target outbound 
value chain functions to determine level of performance and the associated costs for internal 
management. Greaver (1999) considers this important step as exploring strategic implications of 
the outsourcing decision. It will be helpful and serve as a veritable tool in the tenure of the 
relationship for evaluation of the deliverables of the contract. The process also involves the 
benchmarking of the functions and comparative analysis of various dimensions of the functions 
with external alternatives (Franceschini et al., 2003; Sandhu et al., 2018).  The next activity in the 
internal preparedness factor is “the request for proposal”, RFP.  In this study, this step/activity was 
ranked low. This is probably because of the form in which the activity was captured in the 
questionnaire – “advert for RFP”.  
In Nigeria, except for some multinational and Foreign Donor organizations, not many 
organizations spend to advert for RFP. Instead, the outsourcing organizations use various means 
like professional groups, technical networks & associations, references, 3PL service providers’ 
websites and direct contacts to send out their RFPs. Howbeit, this is an activity that all the 
organizations conduct prior to the selection of their preferred service providers.  Other activities 
listed in this factor address additional areas of internal situational assessment and checks (adequate 
due diligence & verification of listed references) effective and seamless migration to the new 
business architecture (developing a transition plan) and advanced measures to guarantee against 
future gaps in the relationship and to provide a business continuity plan in the event of a failure 
(developing a back-up plan and preparing an exit plans/provisions).   
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Figure 7. 1: Framework for the outsourcing process (Perunovic et al., 2006) 
 
Perunovic et al. (2006) provide a framework for outsourcing process where they refer to the pre-
selection stage as “preparation”. As shown in Figure 7.1, the preparation stage sums the activities 
in five strategic questions they named whether? What? Where? When? and How?, with each 
question addressing the critical activity at this stage of the outsourcing process. 
Perunovic and Perderson (2007) list the key activities at the preparation to include screening of 
potential vendors, the outsourced process configuration, drafting of service level agreement (SLA) 
and determining preferred length of the outsourcing contract. Strategic transitions like the 
outsourcing transition is a critical one which needs to be properly managed hence an activity like 
“developing a transition plan” is embedded in the pre-selection stage to ensure a seamless non-
disruptive migration to the new business model of the organization. 
7.3.4.2: Factor 2 - Proactive & authentication initiatives 
This second factor containing other pre-selection activities by the outsourcing organizations are 
various proactive steps taken to: ensure potential sources of failures are identified and a template 
for their remediation developed (developing critical proactive Corrective & Preventive Action 
(CAPA) plans); have a cordial and mutually-beneficial relationship (appointing a relationship 
manager).  Furthermore, this factor helps in the verification of claims by the 3PL service provider 
in responding to the RFP (visiting 3PLs’ locations); confirm the firm’s modus operandi, 
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management, ownership structure and business continuity (corporate governance checks) and 
finally, to prepare the outsourcing contract with adequate provisions and clauses to accommodate 
various aspects of the future relationship and spell out obligations of both parties (developing 
service level agreement (SLA) and contract preparation).  The preparation phase and the pre-
selection activities help to design the future of the outsourcing relationship (Perunovic & 
Perderson, 2007) and to ensure that one of the strategic goals of outsourcing decision to be 
competitive is achieved (Sandhu et al., 2018) 
In a country like Nigeria with huge population and vast geography, visiting the 3PL locations is 
critical to confirming the capacity of the 3PL service provider to offer an advantage in the areas of 
lead-time reduction and reduced transportation costs that are distance-related (Sandhu et al., 2018).  
As the complexity of the outbound pharmaceutical value chains grows, it is vital for these 
outsourcing organizations to authenticate the resources at the disposal of their potential service 
providers not only to achieve execution of routine services but also to design optimal and 
innovative solutions to the benefit of their customers (Flint et al., 2005; Wallenburg et al., 2010).  
These solutions a go beyond the traditional tactical performance of efficiency and costs reduction 
to include capabilities to responding to the ever-changing dynamism in the operating environment 
(Zhang et al., 2013). 
The outsourcing contract is very critical in guiding the principles of the relationship and hence 
should reflect such components as the type, pricing, reward/penalty clauses and vital performance 
indicators and measures (Gunasekaran et al., 2015).  These terms and provisions are included in 
the contract to avoid future contractual disputes and relationship failures. Even though many 
criteria and pre-selection activities are and have been considered by the outsourcing organizations, 
over time and especially in the last decade, more attention has been focused on issues of 
performance pedigree, financial structure and control systems of the 3PL firms, thus providing a 
more robust framework for their assessment prior to engagement by the outsourcing organizations 
(Alkhatib et al., 2015)  
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7.3.5: Challenges of outbound pharmaceutical value chain in Nigeria & its 
outsourcing (Q8) 
In this section, the results for the challenges of outbound pharmaceutical value chain and its 
outsourcing are discussed. Table 6.44 shows the mean item scores for the latent variables and their 
ranking.  The ranking shows road infrastructure as the number 1 in the ranking, while power 
infrastructure is number 2, Inadequate Policy & Regulation is ranked number 3, while Absence of 
competent 3PL Service Providers is ranked number 4. Number 5 in the ranking is Lack of skilled 
personnel, while Pilferages along the chain sits as the last in the ranking at number 6.  Two factors 
were extracted - Factor 1 named People & competency issues  comprising of Lack of skilled 
personnel, pilferages along the chain and absence of competent 3rd Party Service Providers & 
Factor 2 named infrastructural & regulatory inadequacies and comprising Power 
Infrastructure, road Infrastructure and inadequate Policy & Regulation 
7.3.5.1: Factor 1 - People & competency issues 
The first factor of challenges to OPVC and its outsourcing in Nigeria is related to people issues.  
This factor, “people & competency issues” contains three latent variables - Lack of skilled 
personnel, pilferages along the chain and absence of competent 3rd Party Service Providers. 
Underlining every organization’s quest to undertake the strategic outsourcing of its OPVC is the 
desire to leverage on the specialized skills and knowledge of the 3PL service provider. (Zhang et 
al., 2013).  This skill-set and competencies are different from those deployed in traditional, tactical 
outsourcing (Ordoobadi, 2009). Studies have shown that these skills help in the competitiveness 
of the outsourcing organization (Ketchen & Hult, 2007; Brewer et al., 2013) as the 3PL service 
provider’s expertise, managerial capabilities  and competency are embedded in the knowledge and 
skill-set of its people (employees) deployed to manage the outsourced functions (Bhattacharya et 
al., 2013) . Lack of skills both in the outsourcing organization and the potential service provide is 
a critical challenge to the overall outsourcing process.   
The skill gaps identified among the human resources of the outsourcing organization manifest as 
inability to evaluate and or manage the outsourced functions (El Mokrini et al., 2016).  
Relationship management skills are also required during the tenure of the relationship.  Pilferages 
along the value chain speaks of both process monitoring gap and sometimes, the integrity of the 
personnel involved in the handling of these products. Even though both the outsourcing 
organizations and their service providers have mitigating plans like stock and goods in transit 
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insurance policies to indemnify them against financial losses resulting from these unwholesome 
practices, the negative impact of non-availability of the medicine to treat the target customer (sick 
patient) is a worrisome outcome of treatment failures in the healthcare delivery system. 
Absence of competent 3PL service providers as a challenge to outbound pharmaceutical supply 
chains in Nigeria relate to the country’s infrastructural and industrial development. The 3PL 
Industry in Nigeria is still underdeveloped and dominated by some of the competent 3PL service 
providers like DHL & UPS who are multinational companies. The industry is very fragmented 
with many small privately-owned firms playing mostly in other sectors like Consumer Packaged 
Goods and Telecoms, where regulatory requirements are not as stringent as those obtainable in the 
Pharmaceutical industry. Other organized players like MDS Logistics (a partnership between UAC 
of Nigeria & Imperial Logistics of South Africa) are also prominent in the sector and in the last 
decade have been serving the sector. There is still however a gap of scale and competence in the 
3PL sector in Nigeria. 
7.3.5.2: Factor 2 - Infrastructural & regulatory inadequacies 
This factor contains exogenous barriers and challenges facing the outbound pharmaceutical value 
chains and their outsourcing not just in Nigeria but across the sub-Saharan and other developing 
countries with poor infrastructure and regulatory structures. The latent variables in this factor - 
Power Infrastructure, road Infrastructure and inadequate Policy & Regulation have over the years 
impacted negatively on both the costs and efficiency of the value chains. 
Pharmaceutical products are not just thermolabile, requiring special handling techniques, the 
facilities deployed in their management have high asset intensity, reflecting the ratio of the fixed 
asset to current assets involved (Hofmann & Lampe, 2013). Power supply is a very critical 
requirement for the handling of these products.  Throughout the supply chain, steady and adequate 
power is very important in this highly-regulated sector.  Nigeria like some most other sub-Saharan 
African countries still struggles with steady and adequate power supply.  At national power output 
of 5,000 megawatts for its 180million citizens compared to South Africa, another African economy 
with an output of about 53,000 megawatts for its 57 million citizens, Nigeria is obviously 
“underpowered” with corresponding negative consequences to the industries generally and power-
intensive sectors like the pharmaceutical in particular. This is particularly worrisome in the supply 
chains of pharmaceuticals where steady, uninterrupted electricity is required for the storage and 
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potency of thermolabile products like vaccines and antibiotics.  The absence of a stable source of 
power also negatively affects certain aspects of the pharmaceutical supply chains especially the 
cold chains (Yakum et al., 2015).  
 
Nigeria has a very poor road infrastructure (Schürenberg-Frosch, 2014). Good road infrastructure 
is needed to accelerate enhance the management of the outbound pharmaceutical value chains and 
overall development of the country. Notwithstanding the efforts made and the various economic 
developmental strides and growth that have been recorded by the country, persistent infrastructure 
deficits still pose a number of challenges (Arewa, 2016). This infrastructural deficit has been 
acknowledged as a challenge to the management of OPVC and one of the most substantial 
structural barriers in the health systems of the country (Fowkes et al., 2016; Ettah, 2017).  
 
Delivering pharmaceutical products across these decrepit and sometimes, almost impossible to 
navigate roads, over hundreds of kilometer is an exogenous one which, far beyond the purview 
and control of the pharmaceutical companies continues to impact negatively on the efficiency of 
their outbound value chains. Included in this factor is another external challenge – that of 
inadequate policy/regulation and absence of competent 3PL service providers. The pharmaceutical 
sector is one of the most regulated sectors in any country, Nigeria inclusive, on account of the 
object (drugs) and subject (human) of the products.  The most stringent requirements and standards 
are imposed on organizations involved in the handling of these products. Despite the foregoing, a 
lot of lapses exist in the regulatory framework of the sector.  From policy formation and/or 
enforcement of existing policies and laws, gaps exist, which have been capitalized by unscrupulous 
elements who make merchandize of the system for their selfish, financial gains. In Nigeria and 
some other sub-Saharan African countries, Weak regulatory structure impact negatively on the 
pharmaceutical supply chains. Several of these national regulatory bodies and agencies in these 
countries lack adequate resources needed to control the origin and inflow of medicines being 
pushed into the outbound supply chains (Preston et al., 2012). This is not only a challenge in itself, 
it also gives rise to a critical problem of poor quality medicines in the pharmaceutical supply chains 
(Giralt et al., 2017). It has been reported that as high as 90% of national drug regulatory bodies in 
SSA are unable to effectively discharge their basic regulatory functions (Giralt et al., 2017).  
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7.3.6: The desired outcomes of outsourcing  
Table 6.51 shows the mean item scores for the latent variables and their ranking.  The ranking 
shows focus on core competency as the number 1 in the ranking, while reduced capital expenditure 
is number 2, cost advantage/benefit is ranked number 3, while improvement in customer service 
is ranked number 4. Number 5 in the ranking is efficiency, while speed & agility geographical 
representation, and market expansion were ranked 6, 7 and 8 respectively. Number 9 is reduced 
manpower, while number 10 is market share.  Access to specialized skills and indigenous expertise 
complete the ranking at numbers 11 and 12. The rotated component matrix shown in Table 6.56 
shows two factors extracted as given below with the component latent variables: 
Factor 1: Improvement in Customer service, Speed & Agility, Efficiency, Geographical 
representation, market share, Access to Specialised skills, Indigenous expertise and Market 
expansion.  
Factor 2: Cost advantage/benefit, reduced manpower, reduced capital expenditure and focus on 
core competency.  From the relationships between these variables listed above, Factor 1 was 
termed marketplace dominance while Factor 2 was called operational efficiency. 
7.3.6.1: Factor 1 - marketplace dominance 
At the core of every organization’s strategic decision to outsource its customer-facing process and 
functions like outbound value chains is a goal to achieve a desired outcome.  In this study, the one 
of the factors for these desired outcomes has been named “marketplace dominance”.  The factor 
contains various latent variables that are requisite for a superior performance and interface in the 
marketplace vis-à-vis other similar players. The component latent variables - improvement in 
customer service, speed & agility, efficiency, geographical representation, market share, access to 
specialised skills, indigenous expertise and market expansion are all attributes closely linked to 
gaining a competitive advantage and dominance in the marketplace. Until recently, most 
pharmaceutical organizations, especially in the private sector channeled their efforts and resources 
at discovery and development of new “blockbuster” drugs, sales and marketing activities which 
expectedly, should bring superior performance and competitiveness to them. (Gollu, 2017). 
However, real and sustained competitive advantage and dominance requires products’ access and 
availability to the patients which outbound value chain provides (Srai et al., 2015; Gollu, 2017).  
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One of the ways to achieve marketplace dominance in the pharmaceutical industry is via sustained 
outbound value chain strategy as part of a larger supply strategy for sustainability in the overall 
organizational development (Cervera & Flores, 2012; Gonzalez-Loureiro et al., 2015). This 
process is irreplicable by competitors and it is now the source of competitive advantage (Banerjee 
& Williams, 2009) in the ever-changing and intensely-competitive business environment. 
According to Slone (2004), competition between organizations has now moved from the traditional 
inter-organizational mode to between supply chains of the organizations.  The strategic initiatives 
that organizations deploy to achieve competitive advantage including the outsourcing of their 
outbound value chains has been a key focus of studies in the strategic management field (Grimm 
et al., 2015). Gaining marketplace dominance through the outsourcing of outbound value chains 
or other functions involves amongst others, risk sharing, relational strategies and the alignment of 
the various supply chain players (Gonzalez-Loureiro et al., 2015). 
Limited studies and extant literature exist in the field of marketplace dominance by pharmaceutical 
organizations.  Few have focused on the structure and component determinants of agility of the 
pharmaceutical supply chains like speed, flexibility, competence (Gollu, 2017; Yu et al., 2010; 
Mehralian et al., 2015).  Awe et al. (2018) report that there is no unanimity in studies on 
organizational performance and outsourcing as the results are still mixed.  Both outsourcing 
organizations and 3PL service have realized that beyond providing efficiency in operations and 
the value chains, sources of marketplace dominance and sustained competitive advantage have 
transformed to unique value-adding managerial and technical capabilities (Banerjee & Williams, 
2009). 
7.3.6.2: Factor 2 - operational efficiency 
This second factor (operational efficiency) for the desired outcomes of outsourcing outbound value 
chains by pharmaceutical organizations contains latent variables which have proved to be vital in 
the quest by various organizations – both public and private sectors in entrenching efficiency in 
their operations.  Operational efficiency is defined as “the difference between business inputs and 
the resulting outputs of goods and/or services” (Crumpton, 2013:21).  In the present competitive 
business environment, operational excellence is a vital tool for any successful organization (Abbasi 
& Kaviani, 2016).  According to Kanghwa (2010:138), “operational efficiency is what occurs 
when the right combination of people, process and technology come together to enhance the 
168 
 
productivity and value of any business operation, while driving down the cost of routine operations 
to a desired level”. Measuring the performance of the organization and the processes that impact 
on operational efficiency assists Managers in their definition of their overall business strategy. 
Many studies have been carried out which confirms outsourcing as one key strategy that 
organizations use to improve operational efficiency.   
Outbound value chain functions like most other supply chain functions involve enormous financial 
and human resources, hence a decision to outsource these functions will correspondingly have a 
very significant implication on costs (Min, 2013). This value-adding decision frees resources that 
can be channeled to other core areas (Sanders & Locke, 2005). Outsourcing outbound value chain 
activities to 3PL providers with the requisite expertise has evolved over the years, providing 
organizations a viable means of focusing on their core competencies (Wang et al., 2015).  Supply 
chain is regarded as essential to improvements in organizational efficiency (Mathur et al., 2018). 
To achieve the objective of outsourcing and operational efficiency in the face of keener 
competition and challenging business environment at a minimal cost, the efficient management of 
inventory, costs, human and other organizational resources is a pre-requisite (Mohanty et al., 
2018). In this study, the measures of operational efficiency are cost advantage/benefit, reduced 
manpower, reduced capital expenditure and focus on core competency. 
7.4: Overview of results from Delphi study & Quantitative survey 
In this study and as earlier explained in Chapter 4, a sequential mixed methodology was adopted, 
with the Delphi (qualitative) study preceding the quantitative survey.  The results from both studies 
have been presented and discussed in Chapters 5 to 7.  An overview of the results from both studies 
shows a congruity in the trend. In the scope and age of the outbound value chain functions 
outsourced, both studies show that Transportations was both the most frequently outsourced and 
the oldest among the five functions investigated.  Satisfaction levels were above average with 60 
– 80% levels obtained and following a similar trend. Rankings for the different variables listed in 
questionnaires questions showed also a similar trend. The five most critical variables as ranked 
from both studies for these variables are presented Tables 7.1 to 7.6 
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Table 7. 1: Rationale for outsourcing 
Function 
Ranking 
Delphi Quantitative 
Focus on core competence 1 2 
Cost savings 2 1 
Improvement in Customer service 3 3 
Flexibility 4 4 
Lack of Capacity 5 7 
 
Table 7. 2: Critical criteria/factors for 3PL selection 
Function 
Ranking 
Delphi Quantitative 
Speed of service delivery 1 1 
Service reliability 2 2 
Operational flexibility 3 4 
Pedigree/history of performance 4 5 
Financial strength 5 6 
 
Table 7. 3: Critical risk factors for outsourcing 
Function 
Ranking 
Delphi Quantitative 
3PL Underperformance 1 1 
Service levels not achieved 2 3 
Corporate governance  3 12 
Value misalignment 4 6 
Loss of confidentiality 5 7 
 
Table 7. 4: Pre-selection activities 
Function 
Ranking 
Delphi Quantitative 
Analysing present costs of function(s) 1 2 
Adequate due diligence 2 1 
Visiting 3PLs’ locations 3 9 
Developing SLA 4 4 
Contract preparation 5 5 
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Table 7. 5: Challenges of outbound pharmaceutical value chain in Nigeria  
Function 
Ranking 
Delphi Quantitative 
Road Infrastructure 1 1 
Power Infrastructure 2 2 
Absence of competent 3PL providers 3 4 
Inadequate Policy & Regulation 4 3 
Lack of skilled personnel 5 5 
  
Table 7. 6: Desired Outcomes of outsourcing 
Function 
Ranking 
Delphi Quantitative 
Focus on core competency 1 1 
Reduced Capital expenditure 2 2 
Geographical representation 3 6 
Speed & Agility 4 7 
Improvement in Customer service 5 4 
 
As shown in the six results presented in Tables 7.1 to 7.6, the quantitative study had a high degree 
of congruence with and validated the Delphi study. 
7.5: Developing the framework for outsourcing outbound pharmaceutical 
value chain in Nigeria  
In the development of the frameworks for outsourcing process, capability & relationships in the 
pharmaceutical industry, many of the existing frameworks focus on one aspect of the industry – 
either the public or the private sector, even though application can be generalized and the principles 
applied.  Another gap observed is the dearth of frameworks developed out of empirical studies in 
developing countries. This framework is proposed to fill these gaps by utilizing inputs from both 
sectors of the pharmaceutical industry in Nigeria in its development. It is developed for 
outsourcing outbound pharmaceutical value chains.   
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The model is presented below:   
 
 
Figure 7. 2: Framework for outsourcing pharmaceutical outbound value chain in Nigeria (Author)  
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7.5.1: Components of the framework 
The components of this framework are the various factors extracted from the quantitative survey 
results as have been extensively discussed in the earlier sections. This model is founded on the 
Porter’s value chain theory/model with a focus on one of the primary activities of the model – 
outbound logistics. 
As shown in Figure 7.2, the framework details the outsourcing process from the decision to 
outsource to the desired outcomes.  The components are: 
1. Lack of internal capacity & organizational agility and competitiveness: These two 
components are the factors which explains the rationales influencing the outsourcing 
decision 
2. Service quality, technical capacity and financial/corporate governance: These three 
components are the factors which form the vital criteria used by the outsourcing 
organization to select the value chain service provider.  
 
3. Internal preparedness and proactive and authentication initiatives: These two are the 
factors which detail the pre-selection activities the organization engages in prior to the final 
selection of the service provider. They contain activities that confirm the readiness of both 
the outsourcing organization and validate the readiness and capability of the potential 
service provider. As shown in the framework, these activities are in dynamic equilibrium 
with the factors for selection criteria on account of the interconnectivity between the two 
sets of factors and processes 
 
4. Organizational inadequacies and goals under-realization: These are the critical risk 
factors that envelope the entire outsourcing process which the both involved parties 
involved in the outsourcing process, especially the outsourcer should proactively plan a 
mitigating strategies for. 
 
5. Marketplace dominance and operational efficiency:  These two factors are the desired 
ultimate outcomes and deliverables of the outsourcing decision.  
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7.6: Conclusion 
In this chapter, the quantitative survey findings were discussed, leading to the extraction of 13 
factors addressing various aspects of the outsourcing process.  The comparative overview of the 
results of both quantitative survey and the Delphi study was done.  It showed a lot of communalities 
between the two study methods used and hence one can conclude that the quantitative survey 
validated the Delphi study results.  Finally, the factors extracted from the exploratory factor 
analysis (EFA) of the survey results were used to develop the framework for outsourcing 
pharmaceutical outbound value chains.   
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Chapter 8 
CONCLUSION 
8.1: Introduction 
The focus of this study was the Nigerian pharmaceutical supply chains management with emphasis 
on the outsourcing of the outbound value chains. In conducting the study, a review of literature on 
pharmaceutical supply chain management in Nigeria, overview of outsourcing and pharmaceutical 
supply chains was undertaken.  In this chapter, the summary of the results of the study, vis-à-vis 
the research objectives is presented. Also included in this chapter, are the contributions, value of 
the study and recommendations for methodology, policy implications and practice.  Finally, the 
recommendations for further studies and a final conclusion of the study are included in this chapter.  
8.1.1: Research objective RO1 
This first objective was to study the extent (degree) of outsourcing of outbound value chain 
activities in the Nigerian pharmaceutical industry. The findings show that all five outbound value 
chain functions investigated – transportation, warehousing, distribution, cold chain and reverse 
logistics are outsourced to varying degree.  The transport services (long-distance transportation & 
distribution) were outsourced to the highest degree while cold chain was least outsourced.  
Furthermore, it was observed that there has been a steady increase in the level of the outsourcing 
of these functions in the last decade.  The trend observed in the study was generally in tandem with 
earlier studies in other economies and sectors. 
8.1.2: Research objective RO2 
The second objective of this study was to investigate the rationale (reasons) for outsourcing 
outbound pharmaceutical value chains in Nigeria. In the study, latent variables identified from 
literature and some additional ones were investigated in both the Delphi and the quantitative 
studies.  From the common ranking of these variables, the most significant rationales given by the 
responding organizations are: focus on core competence, cost savings, improvement in customer 
service, flexibility and lack of capacity.  Furthermore, the factors as extracted from all the 
variables investigated are: organizational agility & competitiveness and lack of internal 
capacity.  Most literature reports focus on core competence and costs reductions as the main 
reasons while organizations outsource their outbound value chains. 
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8.1.3: Research objective RO3 
This objective was to study the critical criteria for a successful selection and outsourcing 
relationship with a 3rd Party Service Provider in the Nigerian pharma industry. Of the 16 criteria 
investigated, the most critical ones identified by the study are: speed of service delivery, service 
reliability, operational flexibility, pedigree/history of performance and financial strength. Of 
interesting note is the topmost ranking accorded speed of service delivery.  This is probably due 
to the vast geography of the country, the state of the road infrastructure since all but one 
(warehousing) of the outbound value chain functions studied are mobile services requiring one 
form of physical movement or the other.  Three factors – service quality, technical capacity and 
financial & corporate governance were identified as the most critical criteria ones for the selection 
process.  Furthermore, in this study and unlike what is reported by most other researches on the 
selection of 3PL services, a number of pre-selection activities engaged in by the outsourcing 
organizations were investigated. The most critical of these activities are: analyzing present costs 
of function(s), adequate due diligence, visiting 3PLs’ locations, developing SLA and contract 
preparation.  The factors identified are internal preparedness & proactive and authentication 
initiatives. 
 
8.1.4: Research objective RO4 
Many previous studies have reported that at the core of every organization’s decision to outsource 
its outbound value chain is to amongst others, to gain competitive advantage and focus on its core 
competencies.  This objective was to identify the desired outcomes of outsourcing outbound 
pharmaceutical value chains in Nigeria and to confirm if the results of other studies were 
obtainable in the Nigerian setting.  From this study, the desired outcomes of the outsourcing 
process by these organizations are: focus on core competency, reduced capital expenditure, 
geographical representation, speed & agility and improvement in customer service.  This result 
confirms earlier studies and additionally, it was observed that the organizations focus greatly on 
the issues of reduced capital expenditure and geographical representation on account on the 
comparative higher cost capital, vast geography and challenging transport infrastructure in 
Nigeria which makes the issues more critical. From these variables, operational efficiency and 
marketplace dominance were the factors extracted and identified as the desired outcomes of the 
outsourcing decision by these organizations. 
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8.1.5: Research objective RO5 
The last objective of this study was to develop a framework for outsourcing and improvement of 
outbound value chain activities in the Nigerian pharmaceutical industry. Figure 7.2 shows the 
framework developed using the output factors extracted from the various latent variables 
associated with different aspect of the outsourcing process.  The framework in itself and the 
summary of the recommendations of this study will be beneficial to the pharmaceutical industry 
in Nigeria in the area of outsourcing in particular and improvements in outbound value chains 
management in general. 
8.2: Research Value and Contributions 
The contribution and value of this study theoretically, methodologically and practically are 
discussed in the section.  The development of a conceptual framework for the outsourcing of 
outbound pharmaceutical value chain is a notable contribution of this study to the body of 
knowledge and the pharmaceutical industry.  
 
8.2.1: Framework for outsourcing pharmaceutical outbound value chain in 
Nigeria 
The most outstanding contribution of this study is developing a framework for outsourcing 
pharmaceutical outbound value chains in Nigeria. As shown in Figure 7.2, this framework 
incorporates in it, different factors which are critical and associated with the outsourcing of 
pharmaceutical outbound value chains. It contains the two factors (Lack of internal capacity & 
organizational agility and competitiveness) which explain the variable for assessing the rationale 
and decision to outsourcing.  After this stage, the framework leads to the selection stage where 
three factors (service quality, technical capacity and financial/corporate governance) containing 
the criteria for selection, guide the selection process. These two factors are in sync and dynamism 
with two other factors (Service quality, technical capacity and financial/corporate governance) 
which govern the process of conducting a series of pre-selection activities which the outsourcing 
organization should engage in to confirm the status of the potential partner before the final sign-
off.  Before and during the contract, the framework illustrates two critical risk factors 
(Organizational inadequacies and goals under-realization). These are the murky waters/critical risk 
factors that envelope the entire outsourcing process which the both involved parties involved in 
the outsourcing process, especially the outsourcer should proactively plan a mitigating strategies 
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for.  If well implemented, the framework leads to the desired outcomes of the entire outsourcing 
process.  These positive outcomes are founded on two significant factors -  Marketplace 
dominance and operational efficiency. The current study utilised a mixed method approach and 
extension of the value chain theory/model as developed by Porter (1985) as the underpinning 
model to investigate the outsourcing process and to develop the framework. 
8.2.2: Theoretical contribution and value 
The results of the exploratory factor analysis confirm that the outsourcing of pharmaceutical 
outbound value chain is a 13-factor framework.  From extensive literature, there is no evidence of 
any similar study conducted in the pharmaceutical industry of Nigeria. Although many latent 
variables are involved in the entire outsourcing process, this study is significant in providing the 
theoretical information about the most critical factors involved in each of the stages involved in 
the outsourcing processes. The place of latent variables like financial measures, pre-selection 
validation activities, geography and infrastructure which are prominent factors in the Nigeria 
setting will provide additional theoretical information about outsourcing processes in similar 
developing countries.  
8.2.3: Methodological contribution and value 
Many studies on outsourcing generally and on logistics and SC management in the Nigerian 
pharmaceutical industry in particular have been either theoretical, single-method or single-sector 
approach.  There is no evidence of any study that has used empirical, mixed-method and both 
sector approach in its methodology as has been used in this study.  This novel approach therefore 
will be a useful basis for other similar studies in and beyond the pharmaceutical industry in Nigeria 
and other countries with similar socio-economic features as Nigeria.  The approach used in this 
study will be a useful contribution to logistics and SC management researches in Nigeria. 
8.2.4: Practical contribution and value 
Outsourcing in the pharmaceutical industry in Nigeria is still a relatively new and growing practice.  
Given the nature of products handled in the outbound value chain and the myriad of infrastructural 
and systemic challenges confronting the sector, any outsourcing decision needs to be critically 
examined and carefully taken.  The developed framework will be useful in providing management 
of organizations, a handy tool in taking the outsourcing decision.  
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8.3: Recommendations 
The recommendations from this study as they relate to the methodology, policy implications and 
SC management and outsourcing practices are given in the next sections. 
8.3.1: Methodological  
It is recommended that the mixed method design used in this study be used in studies in supply 
chain management in Nigeria as opposed to the mostly-used current practice of a single 
methodology.  The use of Delphi method in the highly technical and regulated industry like the 
Pharmaceutical is also encouraged and recommended.  Conducting a similar study for other 
regions in Nigeria and other SSA is further recommended.  
8.3.2: Policy implications 
As has been reported in previous studies and confirmed by the contribution of the Delphi panelists 
used in this study, the pharmaceutical supply system in Nigeria is both chaotic and unorganized 
with a lot of regulatory and policy gaps giving rise to unprofessional practices. The current drug 
distribution system needs to be sanitized with long lasting solutions involving amongst others, the 
enforcement of the National Drug Distribution policy and provision of enabling infrastructure & 
environment for professionalism in the supply system of the pharmaceutical industry.  The public 
pharmaceutical sector needs to adopt the use of carefully-implemented outsourcing strategies to 
improve the outbound value chain management of products from centrally stored locations. 
8.3.3: Practice 
In practice, the outcomes from a strategic outsourcing decision may not always be desirable and 
positive.  It is recommended that any organization considering the outsourcing of its outbound 
value chain or any of its non-core functions and activities, conducts a comprehensive internal 
situational analysis.  The determination of the organization’s core and non-core activities, and 
benchmarking them in terms of costs, scope and efficiency is critical for this analysis. Also 
recommended is a thorough and objective process for service providers’ selection using relevant 
criteria and pre-selection activities.  A well-managed transition involving a focal or relationship 
manager will be a vital requirement for a seamless transition to an outsourced relationship. The 
development of a mitigation strategies for the identified outsourcing risks, back-up and CAPA 
(corrective and preventive action) plans is recommended for a successful outsourcing relationship. 
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8.4: Limitations 
This study was conducted in Lagos, one of the 36 states in Nigeria.  Even though it is the industrial 
hub of the country and was sufficient for the study, it would have been better if the scope of the 
study was expanded to include other States like the South Western States in the same geo-political 
region as Lagos. The absence of an embedded design to simultaneously compare both sectors of 
the pharmaceutical industry with its consequent useful insights is another limitation.  Finally, 
another limitation is the size of the sample used. Notwithstanding that the quantitative sample size 
of 100 was cross-sectional and adequate, a larger sample would have been more desirable, as with 
most empirical studies involving sampling from a population. Despite these limitations, this study 
has produced some outcomes that will be significant in the academia, strategic outsourcing policy 
development/management and the pharmaceutical industry at large.  
8.5: Further research suggestions 
The following are the areas identified and recommended for further research: 
 A study to investigate the various aspects of the outsourcing relationships like scope of 
services, challenges of service delivery and 3PL contracts is recommended. Many 
researches that have been carried out in the field of outsourcing have been conducted from 
the viewpoint of the outsourcing organizations.  Only few researches have been conducted 
from the perspective of the service provider. Case studies to investigate experiences of 
some selected organizations who have had outsourced relationships in the last decade in 
the pharmaceutical industry need to be carried. 
 A replica of this study needs to be conducted in other sectors and industries of the country, 
besides the pharmaceutical industry.   
 A similar study on the inbound value chain will be useful in gaining more insight into the 
outsourcing practices by these organizations. The outbound value chain was the focus of 
this study.  
8.6: Conclusion 
In this study, the pharmaceutical supply chains management in Nigeria with emphasis on the 
outsourcing of the outbound value chains was investigated. In conducting the study, an extensive 
review of literature on pharmaceutical SC management in Nigeria, overview of outsourcing in 
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general and pharmaceutical SC in particular was undertaken. A sequential exploratory mixed 
method approach with Delphi study preceding a quantitative survey was adopted.  The findings of 
quantitative survey were in congruence with the Delphi study, with exploratory factor analysis 
used in extracting factors which served as the inputs for the development of the conceptual 
framework for the outsourcing of outbound pharmaceutical value chains.  Valuable contributions 
to knowledge, research methodology and policies have been made from the results of this study. 
The framework developed for the outsourcing of the outbound value chains will be a valuable tool 
for policy and decision makers in the pharmaceutical industry in Nigeria and other resource-poor 
countries. 
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APPENDICES 
 
Appendix A: Delphi Study (Qualitative) Questionnaire 
 
INVITATION TO PARTICIPATE IN A STUDY 
 
 
 
 
 
 
April 23, 2018 
 
 
Dear Sir/Ma, 
 
 
Solomon Aigbavboa is registered for a Ph.D. in the Department of Quality & Operations Management at the University 
of Johannesburg under the supervision of Prof Charles Mbohwa 
 
The area of his research is on PHARMACEUTICAL SUPPLY CHAINS IN NIGERIA: FRAMEWORK FOR 
OUTSOURCING OUTBOUND VALUE CHAINS. He requires the participation of experts in the filed in the 
technique (Delphi) he will be adopting. Your consent to participate will be highly appreciated.  
 
Yours sincerely, 
 
Prof. Charles Mbohwa 
Dept. of Quality & Operations Management 
University of Johannesburg 
DEng: Mechanical Engineering, Tokyo metropolitan Inst of Technology 
   
Telephone: 011 559 1202/6361 
E-mail: cmbohwa@uj.ac.za  
Website: www.uj.ac.za  
Office: 198 Maropeng Building Doornfontein Campus/ A-Ring 
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BACKGROUND INFORMATION 
 
The Delphi Method  
You have been asked to participate in the Delphi process for a doctoral study on PHARMACEUTICAL SUPPLY 
CHAINS IN NIGERIA: A FRAMEWORK FOR OUTSOURCING OUTBOUND VALUE CHAINS.  The goal of 
this project is to study the outbound value chains of the Nigerian pharmaceutical sector with a view to identifying the 
extent, role of, and framework for outsourcing these distribution activities and to consider future improvement 
practices. 
 
 
 
DELPHI SURVEY – ROUND 1  
 
SECTION A – PRELIMINARY INFORMATION 
 
Kindly answer by marking “X”  
1. Which of the following is your organization’s main status? 
Category Mark “X” 
Multinational Manufacturing  
Overseas’ Manufacturer’s Representative  
Indigenous Manufacturer  
Importer/Distributor  
State Pharmaceutical Services  
Local Govt Pharmaceutical Services  
Large Pharmacy Chain  
 
2. Which of the following does your Organization manufacture, import, distribute or store?  
Category Mark “X” 
Over the Counter Products  
Ethical/Prescription Drugs  
Vaccines  
 
3. Indicate No. of employees & level of annual turnover or value of drugs handled (N’m/b) 
No. of employees & 
level of annual turnover(N’m/b) 
Less 
than 
50 
51-200 201-
500 
501-
1000 
1001-
5000 
More 
than 
5000 
Less than N100m        
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N100-500m       
N501m-N1b       
N1– N5b per annum       
More than N5b per annum       
 
 
SECTION B – DELPHI SURVEY – ROUND 1 
 
Q1. DEGREE OF OUTSOURCING: To identify the level of outbound supply chain outsourcing in the last decade 
 
 
 
Functions 
 
 
 
CODE 
What is the level of the listed outbound supply chain functions have 
you outsourced in the last 10 years? (1=low level, 10=high level) 
1 2 3 4 5 6 7 8 9 10 
Transportation Q1.1           
Warehousing  Q1.2           
Distribution Q1.3           
Cold Chain Q1.4           
Reverse Logistics Q1.5           
 
 
 
 
 
Q2. SATISFACTION LEVEL: To identify level of satisfaction from the outbound supply chain functions 
currently being outsourced  
 
 
 
Functions 
 
 
 
CODE 
What is the level of satisfaction you currently achieve from 
outsourcing the listed outbound supply chain functions?  
1 2 3 4 5 6 7 8 9 10 
Transportation Q2.1           
Warehousing  Q2.2           
Distribution Q2.3           
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Cold Chain Q2.4           
Reverse Logistics Q2.5           
 
Q3. AGE OF OUTSOURCING RELATIONSHIP:  This is to determine the age of the outsourcing relationships 
 
 
 
 
 
Functions 
 
 
 
 
 
CODE 
How long have you outsourced the following outbound supply chain 
functions? (indicate in the age brackets provided below) 
 
Age of relationship (years) 
1 2 3 4 5 6 7 8 9 10 Others 
Transportation Q3.1            
Warehousing  Q3.2            
Distribution Q3.3            
Cold Chain Q3.4            
Reverse Logistics Q3.5            
 
 
Q4. RATIONALE OF OUTSOURCING: To identify the main factors influencing the decision to outsource your 
outbound supply chains 
 
 
 What is the influence of the following factors in the decision to 
outsource your outbound supply chains? (1=low influence, 
10=high influence) 
Factors CODE 1 2 3 4 5 6 7 8 9 10  
Cost savings Q4.1            
Industry best practice Q4.2            
Technological advancement Q4.3            
Flexibility Q4.4            
Lack of Capacity Q4.5            
Focus on core competence  Q4.6            
Corporate Strategy Q4.7            
Access to Specialised skills Q4.8            
Transfer of risks to 3PL Q4.9            
Lack of in-house expertise Q4.10            
214 
 
Market expansion Q4.11            
Improvement in Customer service Q4.12            
 
Q5. CRITICAL 3PL SELECTION FACTORS: This refers to the factors that are critical to a successful selection 
and relationship with a 3rd Party Service Provider  
 
 
 
Factors 
 
 
 
CODE 
What is the Impact of each of the listed factors in 
determining the selection and successful relationship with 
3PL provider?  
1 2 3 4 5 6 7 8 9 10  
National/geographical spread Q5.1            
Innovation Q5.2            
Organizational culture Q5.3            
Customer orientation Q5.4            
Service reliability Q5.5            
Financial strength Q5.6            
Operational flexibility Q5.7            
Pedigree/history of performance Q5.8            
Stable industrial relations Q5.9            
Corporate values Q5.10            
Availability of latest ICT tools Q5.11            
Quality policies and procedures Q5.12            
Management structure & expertise Q5.13            
Speed of service delivery Q5.14            
Flexible payment regimen Q5.15            
Indemnity  Q5.16            
 
 
Q5. CRITICAL RISK FACTORS: This refers to the underlying risk factors in the outsourcing relationship  
 
 
 
Factors 
 
 
 
CODE 
What is the Level of potential risk that each of the listed 
factors presents in your outsourcing relationship? (1=very 
low, 10=very high) 
1 2 3 4 5 6 7 8 9 10  
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3PL Underperformance Q6.1            
Loss of control of outsourced 
function 
Q6.2            
Loss of expertise Q6.3            
Hidden costs Q6.4            
Corporate governance  Q6.5            
Vendor employee turnover Q6.6            
Undertrained vendor’s employees Q6.7            
Obsolete Technology  Q6.8            
Loss of confidentiality Q6.9            
Internal HR issues Q6.10            
Cost reduction not realised Q6.11            
Service levels not achieved Q6.12            
Loss of flexibility Q6.13            
No continuous improvement by 3PL Q6.14            
Value misalignment Q6.15            
 
 
Q7. PRE-SELECTION ACTIVITIES: This refers to the vital pre-engagement activities by the outsourcing 
organization  
 
 
 
Factors 
 
 
 
CODE 
To what Extent do you engage in the following pre-
selection activities? (1=very low, 10=very high) 
1 2 3 4 5 6 7 8 9 10  
Analysing present costs of function(s) Q7.1            
Adequate due diligence Q7.2            
Advertising a Request for proposal  
(RFP) 
Q7.3            
Engaging present clients of potential 
3PL partner 
Q7.4            
Verification of listed references Q7.5            
Developing service levels agreement 
(SLA) 
Q7.6            
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Preparing an exit plans/provisions Q7.7            
Developing a transition plan Q7.8            
Developing a back-up plan Q7.9            
Contract negotiation Q7.10            
Contract preparation Q7.11            
Visiting 3PLs’ locations Q7.12            
Corporate governance checks Q7.13            
Appointing a relationship manager Q7.14            
Developing critical proactive Corrective 
And Preventive Action (CAPA) plans 
 
Q7.15 
           
 
Q8. CHALLENGES OF THE OUTBOUND VALUE CHAIN: This refers to the present challenges in the 
pharmaceutical outbound value chains and their outsourcing  
 
 
 
Factors 
 
 
 
CODE 
How do you rate the impact of each of the listed factors 
on your outbound supply chains? (1= low, 10=very high) 
1 2 3 4 5 6 7 8 9 10  
Road Infrastructure Q8.1            
Power Infrastructure Q8.2            
Inadequate Policy & Regulation Q8.3            
Absence of competent 3rd Party Service 
Providers 
Q8.4            
Lack of skilled personnel Q8.5            
Pilferages along the chain Q8.6            
 
Q9. DESIRED OUTCOMES OF OUTSOURCING: To identify the desired outcomes of outsourcing your 
outbound value chains 
 
 
 
Role 
 
 
 
CODE 
To what extent have the following benefits accrued to your 
organization following the decision to outsource your outbound 
supply chains? (1=low, 10=high) 
1 2 3 4 5 6 7 8 9 10  
Cost advantage/benefit Q9.1            
Reduced manpower Q9.2            
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Focus on core competency Q9.3            
Reduced Capital expenditure Q9.4            
Geographical representation Q9.5            
Efficiency  Q9.6            
Access to Specialised skills Q9.7            
Market expansion Q9.8            
Improvement in Customer service Q9.9            
Speed & Agility Q9.10            
Market share Q9.11            
Indigenous expertise  Q9.12            
 
Q10. What do you envisage will be the future pivotal context of the pharmaceutical distribution in Nigeria? 
Q11. What are the critical issues facing pharmaceutical outbound supply chains and their outsourcing that have been omitted 
from the questions above.  
 
PERSONAL INFORMATION  
Title   
Qualification  
Specialisation  
Years of experience (pharma 
management etc.) 
 
Current employer  
Position  
 
Thank you for completing this survey.  
Should you have any questions relating to this study, please contact me or my supervisor, Professor Charles 
Mbohwa.  
 
Thank you. 
Solomon Aigbavboa. B.Pharm., M.Sc., MBA. 
Ph.D. Student, Dept. of Quality & Operations Management 
University of Johannesburg, South Africa 
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Appendix B: Quantitative Questionnaire 
 
INVITATION TO PARTICIPATE IN A QUANTITATIVE SURVEY 
 
 
 
 
 
 
 
 
Dear Sir/Ma,                 August 20, 2018 
 
LETTER OF INVITATION FOR RESEARCH SURVEY  
I am registered Ph.D. student in the Department of Quality & Operations Management at the University of 
Johannesburg under the supervision of Prof Charles Mbohwa. 
 
The area of my research is: PHARMACEUTICAL SUPPLY CHAINS IN NIGERIA: A FRAMEWORK FOR 
OUTSOURCING OUTBOUND VALUE CHAINS.  
I humbly request your assistance in completing the following questionnaire which will take approximately 15 minutes. 
 
Should you have any questions relating to this study, please contact me or my supervisor, Professor Charles 
Mbohwa.  
  
Thanking you in advance  
 
 
Solomon Aigbavboa. B.Pharm,. M.Sc., MBA. 
Ph.D. Student, Dept. of Quality & Operations Management 
University of Johannesburg, South Africa 
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QUESTIONNAIRE ON: PHARMACEUTICAL SUPPLY CHAINS IN NIGERIA: FRAMEWORK FOR 
OUTSOURCING OUTBOUND VALUE CHAINS. 
 
SECTION A – PRELIMINARY INFORMATION 
 
Please answer  by marking “X” 
 
1. Which of the following is your organization’s main status? 
Category Mark “X” 
Multinational Manufacturing  
Overseas’ Manufacturer’s Representative  
Indigenous Manufacturer  
Importer/Distributor  
State Pharmaceutical Services  
Local Govt Pharmaceutical Services  
Large Pharmacy Chain  
 
2. Which of the following does your Organization manufacture, import, distribute or store?  
Category Mark “X” 
Over the Counter Products  
Ethical/Prescription Drugs  
Vaccines  
 
4. Indicate No. of employees & level of annual turnover or value of drugs handled (N’m/b) 
No. of employees & 
level of annual turnover(N’m/b) 
Less 
than 
50 
51-200 201-
500 
501-
1000 
1001-
5000 
More 
than 
5000 
Less than N100m        
 
N100-500m       
N501m-N1b       
N1– N5b per annum       
More than N5b per annum       
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SECTION B - QUESTIONNAIRE   
 
Q1. DEGREE OF OUTSOURCING: What is the level of the listed outbound supply chain functions have you 
outsourced in the last 10 years? (1=low level, 5=high level) 
 
Functions 
 
CODE 
Degree of outsourcing 
1 2 3 4 5 
Transportation Q1.1      
Warehousing  Q1.2      
Distribution Q1.3      
Cold Chain Q1.4      
Reverse Logistics Q1.5      
 
Q2. AGE OF OUTSOURCING RELATIONSHIP:  How long have you outsourced the following outbound 
supply chain functions? (indicate in the age brackets provided below) 
 
Functions 
 
CODE 
Age of relationship (years) 
1 – 3 4 - 6 7 - 9 10 - 12 >12 
Transportation Q2.1      
Warehousing  Q2.2      
Distribution Q2.3      
Cold Chain Q2.4      
Reverse Logistics Q2.5      
 
Q3. SATISFACTION LEVEL: What is the level of satisfaction you currently achieve from outsourcing the listed 
outbound supply chain functions? (1=low satisfaction, 5=high satisfaction) 
 
Functions 
 
CODE 
Level of satisfaction 
1 2 3 4 5 
Transportation Q3.1      
Warehousing  Q3.2      
Distribution Q3.3      
Cold Chain Q3.4      
Reverse Logistics Q3.5      
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Q4. RATIONALE OF OUTSOURCING: What is the influence of the following factors in the decision to 
outsource your outbound supply chains? (1=low influence, 5=high influence) 
 
Factors 
 
CODE 
Level of influence 
1 2 3 4 5 
Cost savings Q4.1      
Industry best practice Q4.2      
Technological advancement Q4.3      
Flexibility Q4.4      
Lack of Capacity Q4.5      
Focus on core competence  Q4.6      
Corporate Strategy Q4.7      
Access to Specialised skills Q4.8      
Transfer of risks to 3rd Party Q4.9      
Lack of in-house expertise Q4.10      
Market expansion Q4.11      
Improvement in Customer service Q4.12      
 
Q5. CRITICAL 3PL SELECTION FACTORS: What is the Impact of each of the listed factors in determining a 
successful selection & outsourcing relationship with a 3PL Provider? (1=not critical, 5=very critical)  
 
Factors 
 
CODE 
Level of impact 
1 2 3 4 5 
National/geographical spread Q5.1      
Innovation Q5.2      
Organizational culture Q5.3      
Customer orientation Q5.4      
Service reliability Q5.5      
Financial strength Q5.6      
Operational flexibility Q5.7      
Pedigree/history of performance Q5.8      
Stable industrial relations Q5.9      
Corporate values Q5.10      
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Availability of latest ICT tools Q5.11      
Quality policies and procedures Q5.12      
Management structure & expertise Q5.13      
Speed of service delivery Q5.14      
Flexible payment regimen Q5.15      
Indemnity  Q5.16      
 
Q6. CRITICAL RISK FACTORS: What is the Level of potential risk that each of the listed factors presents in 
your outsourcing relationship? (1=very low, 5=very high) 
 
Factors 
 
CODE 
Risk level 
1 2 3 4 5 
3PL (3rd Party) Underperformance Q6.1      
Loss of control of outsourced function Q6.2      
Loss of expertise Q6.3      
Hidden costs Q6.4      
Corporate governance  Q6.5      
Vendor employee turnover Q6.6      
Undertrained vendor’s employees Q6.7      
Obsolete Technology  Q6.8      
Loss of confidentiality Q6.9      
Internal HR issues Q6.10      
Cost reduction not realised Q6.11      
Service levels not achieved Q6.12      
Loss of flexibility Q6.13      
No continuous improvement by 3PL (3rd 
Party Logistics) Provider 
Q6.14      
Value misalignment Q6.15      
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Q7. PRE-SELECTION ACTIVITIES: To what Extent do you engage in the following pre-selection activities? 
(1=very low, 5=very high) 
 
Factors 
 
CODE 
Extent 
1 2 3 4 5 
Analysing present costs of function(s)  
Q7.1 
     
Adequate due diligence Q7.2      
Advertising a Request for proposal  (RFP)  
Q7.3 
     
Engaging present clients of potential 3PL 
partner 
 
Q7.4 
     
Verification of listed references Q7.5      
Developing service levels agreement 
(SLA) 
Q7.6      
Preparing an exit plans/provisions Q7.7      
Developing a transition plan Q7.8      
Developing a back-up plan Q7.9      
Contract negotiation Q7.10      
Contract preparation Q7.11      
Visiting 3PLs’ locations Q7.12      
Corporate governance checks Q7.13      
Appointing a relationship manager Q7.14      
Developing critical proactive Corrective 
And Preventive Action (CAPA) plans 
Q7.15      
 
Q8. CHALLENGES OF THE OUTBOUND VALUE CHAIN: How do you rate the impact of each of the listed 
challenges on your outbound supply chains? (1= low, 5=very high) 
 
Factors 
 
CODE 
Impact level 
1 2 3 4 5 
Road Infrastructure Q8.1      
Power Infrastructure Q8.2      
Inadequate Policy & Regulation Q8.3      
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Absence of competent 3rd Party Service 
Providers 
Q8.4      
Lack of skilled personnel Q8.5      
Pilferages along the chain Q8.6      
 
Q9. DESIRED OUTCOMES OF OUTSOURCING: To identify the desired outcomes of outsourcing your 
outbound value chains (1=low, 5=high) 
 
Role 
 
CODE 
Extent of benefits 
1 2 3 4 5 
Cost advantage/benefit Q9.1      
Reduced manpower Q9.2      
Focus on core competency Q9.3      
Reduced Capital expenditure Q9.4      
Geographical representation Q9.5      
Efficiency  Q9.6      
Access to Specialised skills Q9.7      
Market expansion Q9.8      
Improvement in Customer service Q9.9      
Speed & Agility Q9.10      
Market share Q9.11      
Indigenous expertise  Q9.12      
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PERSONAL INFORMATION 
Title  
Qualification  
Specialisation  
Years of experience (pharma 
management etc.) 
 
Current employer  
Position  
 
Thank you for completing this survey.  
Should you have any questions relating to this study, please contact me or my supervisor, Professor Charles 
Mbohwa.  
 
Prof. Charles Mbohwa 
Dept. of Quality & Operations Management 
University of Johannesburg 
DEng: Mechanical Engineering, Tokyo metropolitan Inst of Technology 
  
Telephone: 011 559 1202/6361 
E-mail: cmbohwa@uj.ac.za  
Website: www.uj.ac.za  
Office: 198 Maropeng Building Doornfontein Campus/ A-Ring 
 
